{
  "title": "Experimental Design Report: Promoter Activity Prediction Model Construction using MPRA Data for flanking sequences of E. coli promoters",
  "summary": "Based on the task background and data set information, after 0 rounds of expert design, a complete experimental design scheme is generated. The overall feasibility score: 9.1/10",
  "overall_score": 9.125,
  "priority_recommendations": [
    "Confirm MPRA target semantics before any transform: determine whether expr represents raw activity, RNA/DNA log-ratio, or a limma-style log fold-change (mpralm). Only apply log1p/Box-Cox if justified by positivity and skewness; otherwise standardize using train-set mean/std only.",
    "If barcode-level data exist upstream, incorporate MPRA-aware QC consistent with community pipelines: enforce minimum DNA coverage per element, detect/remove outlier barcodes before aggregation, and record barcode bias as a potential confound (supported by MPRA tooling/standards and barcode outlier discussions in MPRA-focused processing frameworks) [Rosen et al., 2025 bioRxiv; Keukeleire et al., 2025 BMC Bioinformatics].",
    "Add an explicit leakage-mitigation split option: cluster sequences by edit distance (or k-mer/Jaccard similarity / MinHash) and split by cluster so close variants do not cross train/val/test. Use this as the primary split if the library is a variant-scan design; otherwise report both random and cluster-split results.",
    "Agree with using Huber as the default primary loss; set δ in standardized label units (e.g., δ=1.0 after train-set z-scoring) and keep plain MSE as an ablation for reporting robustness.",
    "If adding a Pearson-correlation auxiliary loss, apply guardrails: (i) use effective batch size ≥256 via gradient accumulation, (ii) compute correlation over a moving window or full-epoch predictions rather than per-mini-batch when feasible, and (iii) tune λ_corr in {0, 0.05, 0.1}; default to 0.05 or 0.0 if validation is unstable.",
    "Treat reverse-complement augmentation as OFF by default; enable only after confirming the assay/construct is strand-invariant. If uncertain, run an explicit ablation (RC p=0 vs 0.5) and select based on validation Pearson/Spearman and motif sanity checks.",
    "Agree with Data Management: finalize L from full-file length stats (mode or P95 rounded to multiple of 8) and explicitly compare center-crop vs left-anchored crop; do not assume a TSS anchor exists without metadata.",
    "Agree with Methodology/Result Analyst: add a leakage-resistant evaluation option—cluster sequences by edit distance (threshold 5–10) and perform a second CV run to quantify sensitivity of Pearson/Spearman to leakage.",
    "Architecture correction/clarification: gate self-attention behind downsampling so token length ≤ L/8 (or ≤256 tokens). If L>1024, use only dilated residual CNN + SE until length is reduced (pool/strided conv), then optional 2–4 head MHA with small d_model (128–256).",
    "Make bootstrap the primary statistical comparison method for model-vs-model on the same test set: use paired bootstrap over test samples (or over sequences) to estimate ΔPearson/ΔSpearman/ΔMAE with 95% CIs and two-sided p-values; treat Steiger/Williams as optional sensitivity analysis only when assumptions are defensible."
  ],
  "task_information": {
    "description": "Promoter Activity Prediction Model Construction using MPRA Data for flanking sequences of E. coli promoters",
    "background": "Goal: Construct a deep learning model to predict the relative expression activity ('expr' column) of E. coli flanking sequences based on their sequence features derived from the MPRA dataset.\nRequirements: The model should be a deep learning model, and the model should be able to predict the relative expression activity of the promoter.",
    "dataset_info": "File path: task/data/ecoli_165_cgan_wanglab/ecoli_mpra_3_laco.csv; Data type: Massive Parallel Reporter Assay (MPRA) Results for flanking sequences of E. coli promoters; Input features: s, e, q; Target variable: expr; Constraint: The sequence data is in the 'seq' column, and the target variable is in the 'expr' column."
  },
  "experimental_design": {
    "1_data_usage_plan": {
      "design_recommendations": "Dataset characteristic analysis: The CSV inspection confirms only two columns named exactly 'seq' and 'expr', consistent with a processed MPRA design matrix where each row is a regulatory sequence and the label is a continuous activity measurement. The file has 5,921 total lines including the header, implying N=5,920 samples, which is a medium dataset (<10k) and supports a QC-first approach with limited augmentation. Because this is MPRA, sequence directionality can matter (especially for bacterial promoters), so reverse-complement augmentation is not assumed valid by default and should be tested only as an ablation. Sequence lengths must be summarized (min/median/max and P95) to choose a fixed model input length L; the preview suggests all sequences are of similar length (on the order of ~160–180 bp), but L must be computed from the full file. Feature dimensionality under one-hot is L×4 per sample (dense), while k-mer count features are sparse with vocabulary size 4^k (e.g., k=5 gives 1024 dims) and can be efficient for linear baselines; the dataset size supports either representation. Expression (expr) must be profiled for mean/variance/skewness and outliers; we will flag extremes using |z|>5 (computed on the training fold) and/or winsorize at 0.1%/99.9% quantiles to stabilize training while keeping labels continuous.\n\nData source selection and evaluation: The immediate source is the provided E. coli MPRA CSV, which appears to already be aggregated per sequence (no barcodes), meaning upstream MPRA counting/QC is not available in this file; therefore we treat it as a post-quantification dataset. For extensibility and benchmarking, we recommend optionally pulling comparable MPRA datasets (e.g., via MPRAbase for public MPRA repositories) to test generalization across conditions/species, but not mixing them into training unless labels are harmonized (as cautioned by the motivation for uniform processing in standardized MPRA pipelines such as MPRAsnakeflow/MPRAlib). The plan should record metadata if available (plasmid vs genomic integration, growth conditions, library design) because those can induce batch effects; if absent, we assume single-condition and focus on internal consistency checks. We also recommend keeping a “data card” documenting file hash, download path, and parsing rules for reproducibility aligned with the community push for harmonized formats and uniform processing (MPRAsnakeflow/MPRAlib). esMPRA emphasizes standardized QC metrics and stepwise monitoring; while we cannot run its raw-read stages, we can emulate its spirit by producing stage-specific diagnostics: parsing/sequence validity, length uniformity, label distribution, and train/val/test drift checks. If later raw counts become available, the pipeline should be upgradeable to incorporate barcode-level outlier handling and RNA/DNA ratio modeling, consistent with MPRA best practices referenced in the retrieved literature (esMPRA; individual barcode robustness discussions in MPRA analysis frameworks).\n\nPreprocessing pipeline (QC + cleaning, with explicit parameters): Parsing must enforce schema: columns exactly {seq, expr}, seq as string, expr castable to float; rows failing parse are dropped and counted in QC. Sequence cleaning uses an allowed alphabet {A,C,G,T} (uppercase); any lowercase is uppercased, and whitespace is stripped; empty seq is dropped (threshold: length==0). Non-ACGT handling is thresholded: compute fraction f_nonACGT per sequence; if f_nonACGT > 0.01 (i.e., >1% characters not in A/C/G/T), drop the sequence; if 0 < f_nonACGT ≤ 0.01, replace non-ACGT characters with 'N' then encode them as an all-zero channel (i.e., [0,0,0,0]) to avoid introducing spurious signal (this matches the requirement “padding symbol all-0” and keeps ambiguity neutral). Duplicate sequences: compute exact duplicates on cleaned seq; if duplicates exist with identical expr, keep one and drop the rest; if duplicates have different expr (technical inconsistency), keep one with expr equal to the median of the duplicate group and log the group size as a QC alert (to reduce label noise while avoiding leakage). Expression preprocessing: compute train-set mean/variance/skewness; if skewness > 1.0 and expr is strictly positive, apply log1p(expr) as an alternative target and compare validation performance; otherwise keep raw but always standardize: y_std=(y-mean_train)/std_train. Outliers: flag with |z|>5 on the standardized target (training statistics) and additionally compute extreme quantiles; default action is winsorization at [0.1%, 99.9%] on training labels only (apply same caps to val/test) to prevent a few points from dominating MSE, while retaining sample count in a medium dataset.\n\nLength handling and encoding (explicit L and settings): After computing the full length distribution, set fixed length L to P95(length) rounded up to a convenient multiple of 8 (for GPU efficiency); if P95 is, for example, 170 bp, set L=176; if the distribution is extremely tight (max-min ≤ 5), set L=max to avoid trimming. Trimming rule: if len(seq) > L, trim symmetrically around the center (center-crop) for generic regulatory elements; however for bacterial promoters with positional motifs relative to TSS, prefer right-crop or left-crop depending on how sequences were constructed—default to right-padding and right-cropping only if the library is aligned at the 5' end; because that metadata is absent, we recommend center-crop as the neutral default and report sensitivity in an ablation. Padding: right-pad with all-zero vectors to reach L; do not pad with 'A' because that introduces signal. Primary encoding is one-hot: tensor shape (L,4) with channels ordered A,C,G,T; ambiguous 'N' or masked bases are [0,0,0,0]. Optional baseline encoding for classical models: overlapping k-mer counts with stride=1, k in {3,4,5}; vocab sizes 64/256/1024 respectively; use normalized counts (divide by total k-mers) to reduce length effects; these features are sparse-ish but manageable at N=5.9k and are valuable for sanity-check baselines.\n\nData splitting strategy (reproducible, stratified, plus CV backup): Use train/val/test = 0.8/0.1/0.1 with random seed = 42 and shuffling enabled, but stratify by expr distribution to avoid label-shift: bin expr into 10 quantile bins (deciles) computed on the full dataset (or better: compute bins on train then assign others; practically, full-data deciles are acceptable for stratification as it does not leak sequence information). Ensure no duplicate sequences are split across folds by deduplicating before splitting; if near-duplicates are suspected (e.g., designed variants), optionally cluster by Hamming distance ≤ 3 and split by cluster to reduce leakage (report as an advanced option). Provide a 5-fold cross-validation alternative (KFold=5, shuffle=True, seed=42) for robust model selection; keep the test set held out and untouched, using CV only within the 90% train+val portion. After splitting, compute and report drift metrics: length distribution KS test between splits, and expr mean/std/skew per split; if drift exceeds thresholds (e.g., |mean_diff|>0.1 std units or KS p<1e-3), re-split with the same stratification but adjusted binning (e.g., 20 bins) to improve match.\n\nLightweight data augmentation (explicit parameters, MPRA-specific cautions): Because N≈5.9k is medium, augmentation should be light and should not distort promoter directionality in bacteria. Reverse-complement (RC) augmentation is not used by default; run it only as a controlled ablation: add RC sequences for 50% of training samples (augmentation ratio 0.5) and compare validation—if performance degrades, conclude directionality is important and keep RC off. Random point-mutation augmentation: for each training sequence, with probability p_aug=0.3 generate one mutated copy; within that copy, mutate each position with p_mut=0.01 but enforce a maximum of m_max=3 mutations/sequence; substitutions are uniform among the other three bases; do not mutate padded positions. Random masking: with probability p_aug_mask=0.3 generate one masked copy; independently mask each position with p_mask=0.02 by setting it to all-zero [0,0,0,0]; cap masks to at most 5 positions/sequence to avoid destroying key motifs. Label handling for augmented samples: keep the same expr label (invariance assumption) for masking and very-low-rate mutation, but down-weight augmented samples in loss with weight=0.5 relative to originals to reduce the risk of introducing label noise; this is appropriate for a medium dataset where we can afford to prioritize clean supervision.\n\nQuality control report items (actionable checklist aligned with MPRA QC principles): Produce a “Parsing & Schema” table: column names, dtypes, number of rows read, number dropped due to parse errors. “Sequence validity” section: length min/median/max/P95, fraction of empty sequences, fraction with any non-ACGT, fraction dropped due to f_nonACGT>0.01, and histogram of non-ACGT fraction. “Duplicate analysis”: count exact duplicates, distribution of duplicate group sizes, and number of inconsistent-label duplicate groups (plus the chosen resolution rule). “Expression distribution”: mean/variance/skewness/kurtosis, histogram + KDE, fraction negative, fraction zero, and outlier counts under |z|>5 and beyond 0.1%/99.9% quantiles; explicitly record winsorization caps if applied. “Split diagnostics”: per-split N, expr mean/std/skew, length distribution summary, and drift tests (KS statistics) to ensure comparability. These QC emphases are motivated by the broader MPRA community’s push for standardized QC and reproducible processing (esMPRA stepwise diagnostics; MPRAsnakeflow/MPRAlib uniform processing and awareness of technical variability sources).\n\nBias and confounding mitigation: Species/assay bias is inherent (E. coli MPRA), so the model should not be expected to generalize to eukaryotic enhancers; document this explicitly and avoid mixing multi-species datasets without harmonization. Directionality confounding is likely in bacterial promoter libraries; therefore, avoid RC augmentation by default and treat it as a hypothesis test rather than a routine augmentation. Sequence composition bias (e.g., GC content correlated with expr) can cause shortcut learning; include QC plots of expr vs GC%, and consider adding a covariate baseline (linear regression on GC%) to quantify how much signal is composition-driven. If the library contains designed variants around a motif, random splitting can leak motif families; mitigate by optional cluster-based splitting (Hamming threshold) and report both random and cluster-split performance. Platform/condition biases cannot be assessed without metadata; mitigate by strict reproducibility practices (fixed seeds, logged preprocessing parameters, dataset hash) and by keeping a fully held-out test set untouched until final evaluation."
    },
    "2_method_design": {
      "design_recommendations": {
        "dataset_characteristics_and_preprocessing": "This task targets MPRA-style regression where each sequence has an activity derived from barcode RNA and DNA counts (often using log(RNA/DNA) or model-based transcription rate estimates), and such assays are known to exhibit barcode-level outliers and technical variability. Literature on MPRA analysis highlights that tools modeling barcode counts (e.g., MPRAnalyze / mpralm variants) address inherent variation and outlier sensitivity, and newer frameworks emphasize barcode sequence bias and outlier barcodes as major technical factors; therefore, preprocessing should include barcode QC and robust aggregation (Keukeleire et al., 2025; Rosen et al., 2025 from the knowledge base). Assume a typical MPRA dataset size is medium-to-large (1e4–1e5 sequences) with fixed oligo length (commonly 150–230 bp plus adapters); if length varies, pad/trim to a fixed L (recommended L=200) and track true-length masks for attention layers. Perform barcode filtering: remove barcodes with DNA counts < 10 (or < 20 for stricter QC) and optionally trim the top 0.5–1% barcodes by RNA/DNA ratio per element as outliers; then aggregate per element by median-of-barcodes or robust mean (Huber mean) to reduce influence of extreme barcodes. Use train/val/test splits that prevent leakage from highly similar sequence variants (e.g., allelic pairs or designed mutational neighborhoods): split by \"parent element\" or edit distance clusters when available, to avoid inflated correlations. Finally, standardize input encoding as one-hot (A,C,G,T plus N=all zeros) with optional additional channels (e.g., GC content track or positional prior track) kept fixed across models for controlled comparisons.",
        "target_transformation_policy": "Because MPRA activity can be negative (e.g., log fold-change below baseline) and often heavy-tailed, define a conditional target transform policy that is data-driven and reversible for reporting. Compute skewness on the training targets; if absolute skewness > 1.0, enable a power transform (Yeo–Johnson) fitted on training only, because it handles zeros and negative values unlike Box–Cox. If absolute skewness <= 1.0, default to z-score standardization (y_z = (y - mean_train) / std_train) for stable optimization and comparability across experiments. If strong outliers are present (e.g., >2% of points beyond 3×IQR), use RobustScaler (center=median, scale=IQR) instead of z-score to reduce sensitivity; this is particularly relevant given known barcode-level outliers in MPRA pipelines (Keukeleire et al., 2025). Explicit negative-value handling: do not clamp negatives; instead, preserve sign and use Yeo–Johnson when skewness triggers or RobustScaler when outlier fraction triggers. For reporting, always invert the transform back to the original scale for MAE/MSE on the raw units, and also report correlation on raw and transformed scales to ensure interpretability. Log1p transforms are not recommended unless the target is strictly non-negative count-derived (rare after log(RNA/DNA)); if used, only enable when min(y) >= 0 and skewness > 1.0, with epsilon=1e-3.",
        "loss_functions": "Use Huber loss as the default main loss to be robust to heavy-tailed errors and outliers typical in MPRA measurements (barcode-level variability and occasional extreme activities), while still behaving like MSE near zero error. Set Huber delta (\"transition\") explicitly to delta=1.0 on the standardized target scale; if using RobustScaler, set delta=1.5 to account for the smaller effective scale of IQR normalization. Define the primary loss as L_main = Huber(y_pred, y_true; delta), averaged over the batch. Optionally add a correlation-alignment auxiliary loss to better match evaluation metrics: L_corr = 1 - PearsonCorr(y_pred, y_true) computed within-batch (with batch_size >= 64), then use total loss L = L_main + λ_corr * L_corr with λ_corr=0.1. If rank consistency is a key goal (e.g., selecting top enhancers), add a pairwise ranking loss on within-batch pairs: L_rank = mean(log(1 + exp(-(y_pred_i - y_pred_j) * sign(y_true_i - y_true_j)))) sampled from 256 random pairs per batch; weight it λ_rank=0.05, and keep λ_corr=0.05 when both auxiliaries are enabled. For ablations, compare MSE as baseline (L_main = MSE) to quantify gains from robustness; expect Huber to reduce sensitivity to outlier barcodes/elements and stabilize early stopping. Ensure loss is computed on transformed targets, while metrics (Pearson/Spearman/R2) are computed on inverse-transformed predictions for interpretability.",
        "optimizer_and_hyperparameters": "Use AdamW as the default optimizer for all neural models due to its stability on one-hot sequence inputs and compatibility with weight decay decoupling. Set AdamW hyperparameters explicitly: lr=1e-3 (starting), betas=(0.9, 0.999), eps=1e-8, weight_decay=1e-4; these values are a strong default for CNN/attention models on MPRA-scale regression. Apply gradient clipping to prevent rare large gradients from destabilizing training, using clip_norm=1.0 (global norm). Use mixed precision (fp16/bf16) only if it does not change numerical stability of Pearson auxiliary loss; if enabled, compute correlation loss in fp32. As a classical comparator, run SGD+momentum on CNN models: lr=0.05, momentum=0.9, weight_decay=5e-4, Nesterov=True; this acts as an optimizer ablation to show whether adaptive methods are needed. Use EMA of weights (optional) with decay=0.999 to stabilize validation correlation, especially for CNN+attention. For batch sizes, use 128 as default on GPU memory permitting; if sequences are long or attention is heavy, reduce to 64 and compensate with gradient accumulation steps=2 to keep an effective batch of 128.",
        "learning_rate_schedule_and_warmup": "Adopt a warmup phase to avoid early training instability when using AdamW and potentially correlation/ranking auxiliary losses. Set warmup_steps=500 (or warmup_ratio=0.05 if total_steps is small), linearly increasing lr from 1e-5 to the base lr (1e-3). After warmup, use CosineAnnealingLR down to min_lr=1e-6 over the remaining steps; cosine works well for large sequence datasets and reduces the need for manual plateau tuning. As an alternative scheduler for smaller/ noisier datasets, use ReduceLROnPlateau monitoring val_loss with factor=0.5, patience=5 epochs, threshold=1e-4, cooldown=0, min_lr=1e-6; this is useful when validation correlation fluctuates due to measurement noise. If using ReduceLROnPlateau, disable cosine and keep a fixed lr during warmup then hand over to plateau schedule. For cosine, consider restarts only if training is long (>200 epochs), otherwise keep a single cycle for up to 100 epochs. Log the effective lr each epoch and ensure early stopping patience (10) exceeds scheduler patience (5) so the scheduler has time to act before stopping.",
        "training_configuration_and_early_stopping": "Use a maximum of epochs=100 with early stopping to prevent overfitting on motif-rich but noisy MPRA targets. Default batch_size=128 (fallback 64) and set num_workers=4–8 for data loading; use shuffle=True for training and deterministic=False for speed, while fixing random seeds for reproducibility. Early stopping should monitor val_pearson (preferred when the goal is ranking/relative prediction) with mode='max', patience=10, min_delta=1e-4; as a secondary criterion, also record val_loss and stop if both degrade for 10 epochs. When correlation is unstable due to small validation sets, switch monitor to val_loss with mode='min', patience=10, min_delta=1e-4. Use k-fold cross-validation (k=5) when dataset size is small (<5k sequences) or when the split-by-cluster constraint reduces effective validation size; aggregate by mean±std of Pearson and Spearman. Maintain a fixed evaluation suite: Pearson, Spearman, R2, and MAE on inverse-transformed targets; report also calibration plots (pred vs true) and residual vs GC content to detect systematic bias. Save best checkpoints by val_pearson and also last checkpoint; always evaluate test only once per model configuration to avoid implicit tuning on test.",
        "regularization_strategies": "Use dropout in the network body with a tunable range 0.1–0.5; set default dropout=0.2 for CNN blocks and 0.3 for attention/MLP heads, as attention models typically overfit more. Apply input dropout (a biologically plausible \"sequencing uncertainty\" proxy) by randomly masking 1–3% of positions per sequence (mask_prob=0.02) during training; implement as setting one-hot vector to all zeros (N) at masked positions. Additionally, apply channel dropout on one-hot channels with p=0.05 to simulate minor base-calling ambiguity without destroying motifs. Clarify L2 vs weight decay: for AdamW, use weight_decay=1e-4 as the primary L2-like regularizer (decoupled), and do not add an additional L2 penalty in the loss to avoid double-regularization; for SGD, weight_decay acts as classic L2. BatchNorm (if used) adds regularization; set BatchNorm momentum=0.1 and epsilon=1e-5 in CNN blocks, but consider removing BatchNorm for very small batch sizes (<=32) where statistics are noisy. Label smoothing is explicitly not used because this is regression; instead use robust losses (Huber) and augmentation for stability. If overfitting persists (train Pearson much higher than val), increase dropout by +0.1 and/or increase weight_decay to 3e-4; if underfitting, reduce dropout to 0.1 and weight_decay to 3e-5.",
        "prior_knowledge_integration_motifs_pwms": "Integrate biological priors by adding motif/PWM channels and auxiliary tasks that encourage the model to respect known TF binding logic. Precompute motif scan scores using a curated PWM set (e.g., JASPAR core vertebrates) and compute per-position log-likelihood ratio scores; feed as additional input channels M (e.g., top 32 motifs) alongside one-hot, producing an input tensor of shape (L, 4+M). Add an auxiliary head to predict motif presence/occupancy summary (e.g., max motif score per motif) from intermediate features, trained with MSE or BCE depending on label definition; weight this auxiliary loss λ_motif=0.05 to avoid overpowering expression regression. Use a \"motif attribution consistency\" regularizer: compute in-silico mutagenesis on a small subset each epoch (e.g., 128 sequences) and penalize cases where mutating high-scoring motif cores does not change prediction directionally; weight λ_consistency=0.01 to keep compute manageable. Constrain augmentations to preserve biological plausibility: if the assay is orientation-specific (promoter direction matters), do not use reverse-complement augmentation; if orientation-invariant enhancer assays, enable reverse-complement with probability 0.5 and enforce RC-consistency loss L_rc = mean((f(x)-f(RC(x)))^2) with weight 0.05. Use prior-guided initialization by including a first-layer convolution bank whose kernels are initialized from PWMs (convert PWM to log-odds and map to conv weights), then allow them to fine-tune with a smaller lr multiplier (e.g., 0.5× base lr) to retain interpretability. This approach is consistent with motif-centric interpretation practices described broadly in regulatory DL evaluation/interpretation toolkits (e.g., CREME focuses on perturbation-based motif logic extraction; knowledge base: Toneyan & Koo, 2024).",
        "data_augmentation": "Use augmentation that respects DNA biology and the MPRA experimental construct. If the assay design indicates orientation invariance (common for enhancer tiling without fixed promoter orientation), apply reverse-complement augmentation with p=0.5; otherwise set p=0.0 and rely on other augmentations. Apply small positional jitter when sequences contain flanks: randomly shift the window by up to ±5 bp (shift_max=5) and pad with 'N' at the ends; this helps the model become robust to slight boundary differences and synthesis artifacts. Apply random masking (as above) mask_prob=0.02 and optionally contiguous span masking with span_length=3 and span_prob=0.01 to simulate local errors and encourage distributed representations. Avoid arbitrary nucleotide substitution at high rates because it can destroy motifs; if used for robustness, keep mutation_rate<=0.005 (0.5% positions) and only outside known motif cores (based on PWM scan threshold, e.g., score > 8.0). For medium datasets (1k–10k), increase augmentation intensity slightly (mask_prob=0.03, shift_max=8) to reduce overfitting; for very large datasets (>100k), keep augmentation mild (mask_prob=0.01) and focus on QC/outlier handling as recommended by MPRA pipeline best-practice discussions (Rosen et al., 2025). If training includes CNN+attention, use stochastic depth (drop-path) with rate=0.1 in residual blocks as an additional augmentation-like regularizer.",
        "model_architectures_and_exact_parameters": "Baseline 1 (Linear k-mer): represent each sequence by counts of k-mers with k=6 (feature dim up to 4^6=4096, optionally reduce via hashing to 2048); train Ridge regression with alpha=1.0 and also ElasticNet with alpha=0.1, l1_ratio=0.1, both on transformed targets. Baseline 2 (Simple linear on GC/motif summaries): features = GC%, CpG count, max PWM scores for top 32 motifs; model = linear regression + HuberRegressor (epsilon=1.35) to quantify robustness. Model A (CNN): Input (L=200, C=4) -> Conv1D(64 filters, kernel=15, stride=1, padding='same') + BatchNorm + GELU + Dropout(0.2); then 3 residual blocks each: Conv1D(64, k=11) -> GELU -> Conv1D(64, k=11) with skip, Dropout(0.2); then MaxPool1D(pool=2) to length 100; then Conv1D(128, k=7) + GELU + Dropout(0.3); GlobalAveragePooling; MLP head: Dense(256) + GELU + Dropout(0.3) + Dense(1). Model B (CNN+Attention): same CNN stem up to length 100 and channels 128, then add 2 Transformer encoder blocks with d_model=128, n_heads=8, ff_dim=512, dropout=0.1, attention_dropout=0.1, layernorm eps=1e-5; then attention pooling (learned query) to a 128-d vector; MLP head Dense(256)->GELU->Dropout(0.3)->Dense(1). Initialize conv/linear weights with Xavier/Glorot uniform (gain=1.0) and set final layer bias to mean(y_train_transformed) to speed convergence. Estimated capacity targets: CNN ~1–3M params, CNN+Attention ~3–6M params; keep parameter count within this band to avoid overfitting on typical MPRA sizes. Train all neural models with identical optimizer/scheduler/early stopping for fair comparison, varying only architecture modules.",
        "hyperparameter_search_plan": "Run an executable Optuna study with 50 trials per architecture family (CNN and CNN+Attention separately) using the same train/val split and early stopping rules. Search space: lr ∈ [1e-4, 3e-3] log-uniform; weight_decay ∈ [1e-6, 3e-4] log-uniform; dropout ∈ [0.1, 0.5] uniform; kernel_size ∈ {7, 11, 15}; filters ∈ {64, 128}; num_res_blocks ∈ {2, 3, 4}; for attention models additionally search n_heads ∈ {4, 8}, n_layers ∈ {1, 2, 3}, ff_dim ∈ {256, 512, 768}, attention_dropout ∈ [0.0, 0.2]. Also tune Huber delta ∈ {0.5, 1.0, 1.5} on the transformed scale and λ_corr ∈ {0.0, 0.05, 0.1}; constrain total auxiliary weight (λ_corr+λ_rank+λ_motif) <= 0.2 to maintain regression focus. Use the objective as max(val_pearson) with a pruning strategy (MedianPruner) after 10 epochs to save compute; fix max_epochs=100 but rely on early stopping. Record trial-level metrics: best val_pearson, val_spearman, val_loss, and calibration slope; reject models with calibration slope outside [0.8, 1.2] even if correlation is high. After selecting top 3 trials, retrain each with 3 seeds and report mean±std to ensure robustness. This search plan is designed to be computationally feasible and aligned with MPRA regression goals, while controlling for overfitting via early stopping and regularization.",
        "training_pipeline_workflow_and_controls": "Step 1: Ingest raw MPRA counts (RNA/DNA per barcode), apply barcode QC (DNA>=10) and robust aggregation to element-level activity, consistent with knowledge-base emphasis on barcode-level modeling/outliers (Keukeleire et al., 2025). Step 2: Fit target transform on training only (z-score/robust/Yeo–Johnson) according to the skewness/outlier policy; store transformer for inverse mapping. Step 3: Build stratified splits by activity quantiles and by sequence cluster/parent to prevent leakage; lock splits for all experiments. Step 4: Train baselines first (k-mer ridge, motif summary linear/HuberRegressor) to set a sanity floor and detect data leakage; require that neural models beat baselines by at least +0.03 Pearson to justify complexity. Step 5: Train CNN and CNN+Attention with the shared recipe: AdamW(lr=1e-3, wd=1e-4), warmup_steps=500, cosine to min_lr=1e-6, batch_size=128, clip_norm=1.0, Huber(delta=1.0) + optional λ_corr=0.1; early stop on val_pearson with patience=10. Step 6: Run the experimental matrix and ablations: loss (MSE vs Huber), scheduler (cosine vs plateau), augmentation (none vs RC/jitter/mask), and priors (no motif channels vs motif channels + λ_motif=0.05). Step 7: Final evaluation on test with locked checkpoint selection rules; report Pearson/Spearman/R2/MAE and include interpretability checks via motif perturbation consistency (inspired by perturbation-based regulatory logic analysis tools like CREME; Toneyan & Koo, 2024). Step 8: Document all hyperparameters, random seeds, and transformations; export model cards and training curves for publication-grade reproducibility."
      }
    },
    "3_model_design": {
      "design_recommendations": "Dataset characterization and fixed-length selection: The dataset is MPRA-like (sequence paired with a quantitative activity), implying input is a one-hot encoded DNA sequence of shape (batch, L, 4) and a scalar regression target (often log-transformed activity). With ~5.9k samples, this is a medium dataset, so the model should be moderately expressive but still heavily regularized; a large vanilla Transformer would likely overfit and is computationally wasteful. The fixed length L should be chosen from data statistics: set L to the median/most common length if sequences are mostly uniform; if there is a distribution, select L = 95th percentile length and pad shorter sequences with Ns encoded as all-zeros (or uniform 0.25 if you prefer), and truncate longer sequences centrally or from flanks depending on assay design. Preprocessing should include: (i) one-hot encoding with consistent A/C/G/T ordering, (ii) target normalization (z-score on training set or log1p then z-score), (iii) train/val/test split stratified by GC-content or activity quantiles to reduce distribution shift, and (iv) mild augmentation appropriate for MPRA such as reverse-complement augmentation at 50% probability if the assay is strand-invariant (otherwise disable). Training defaults (both models): AdamW optimizer (lr=1e-3 for baseline, lr=7e-4 for improved), weight_decay=1e-4, batch_size=64 (or 128 if GPU allows), epochs=100 with early stopping patience=12 on validation Pearson/Spearman and MSE, gradient clipping at 1.0, and cosine LR schedule with 5-epoch warmup (warmup_lr_start=1e-5). Evaluation metrics: report Pearson r, Spearman ρ, MSE, and R2 on held-out test; for MPRA it is common to emphasize rank correlation and replicate-consistency if replicates exist. Interpretability is mandatory: follow the spirit of prior sequence-to-function work that uses convolutional filters, attention maps, and in silico mutagenesis to understand learned motifs and dependencies (PMC: sequence-to-function frameworks for engineered riboregulators) and use IG/saliency settings as specified below."
    },
    "4_result_summary": {
      "design_recommendations": "1) Dataset characterization and preprocessing implications (regression MPRA context): Treat the dataset as MPRA-derived continuous expression, typically computed from RNA/DNA barcode count ratios; therefore, define and freeze a single target transformation before any splitting (recommend: log2(RNA/DNA + 1e-6) followed by z-score within experiment/batch if multiple batches). Before modeling, quantify sequence length distribution (mean/median/range) and remove/flag outliers beyond the designed oligo length (e.g., exclude sequences outside [L_design-2, L_design+2] bp, or pad/trim to exactly L_design with centered padding) so metrics are not confounded by inconsistent inputs. Quantify dataset size (N) and label distribution skew; if N > 10k, prioritize QC/outlier filtering (e.g., drop sequences with low DNA counts: DNA_count < 20 in >50% replicates; drop sequences with high replicate discordance: replicate Pearson r < 0.7), while if N < 1k, report wider uncertainty and consider augmentation only for training (e.g., reverse-complement augmentation at 1:1 ratio if biology allows). Ensure that replicate handling is consistent: if multiple barcodes/replicates per sequence exist, aggregate to a single target value per sequence using a robust estimator (median of replicate log-ratios; also report mean and MAD for QC). Align QC concepts with MPRA pipelines that emphasize stepwise quality monitoring and standardized metrics (esMPRA) and MPRA statistical considerations such as bias/variation sources (@MPRA) by explicitly reporting barcode-level depth distributions and replicate concordance as part of the final appendix. Finally, pre-register all evaluation parameters (seeds, folds, thresholds, transforms) in a run manifest (YAML/JSON) stored with outputs.\n\n2) Metric suite selection, definitions, and thresholds (primary + secondary metrics): Compute Pearson correlation r between y_true and y_pred as the primary ranking metric on the held-out test set (Pearson_test is the single-number headline), because it captures linear agreement of predicted activity with measured expression and is widely comparable across MPRA regression benchmarks. Also compute Spearman ρ to measure monotonic ranking performance (useful if the model is calibrated poorly but orders sequences correctly), R^2 to quantify explained variance (report both standard R^2 and, optionally, adjusted R^2 if including additional covariates), and MSE/MAE to quantify absolute errors in the target scale (recommend: MAE as the more robust error metric; report MSE to penalize large errors). Define metric computation precisely: Pearson/Spearman on the sample-level aggregated targets; R^2 = 1 - SSE/SST using the test-set mean of y_true for SST; MSE/MAE computed on the same target scale after final transformation (e.g., z-scored log-ratio). Establish explicit acceptance thresholds for “model is usable”: Pearson_test ≥ 0.50, Spearman_test ≥ 0.50, and R^2_test ≥ 0.20 (these are pragmatic MPRA-regression bars; adjust upward if baseline models already exceed them), and additionally require calibration sanity by MAE_test ≤ 0.75 (in z-score units) or an equivalent domain-specific bound. Always include a baseline comparator: (i) predicting the training mean (expected Pearson≈0), and (ii) a simple linear model on k-mer counts; require the final model to exceed baseline Pearson by ≥ 0.10 on test to be considered meaningfully improved. Report metrics both on the final hold-out test and as cross-validated means ± SD to separate “best-case performance” from “stability under resampling.”\n\n3) Validation strategy (single hold-out + 5-fold CV with explicit parameters): Use a single fixed hold-out test split of 15% of sequences, created once and never touched during model selection; the remaining 85% is used for training/validation and 5-fold cross-validation for robustness estimation. Use a fixed global random seed (seed_holdout = 202501) for the hold-out split and fixed fold seeds (seed_cv = 202502) to ensure exact reproducibility; document them in the parameter table and output manifest. To avoid label-distribution drift, stratify splits by expression bins: compute deciles on the full dataset target (10 bins by y quantiles) and apply stratified sampling such that each split/fold preserves the bin proportions (stratify_by_expr = true, n_bins = 10). Additionally, if multiple measurements per underlying sequence exist (e.g., multiple barcodes, conditions, or replicates), enforce group splitting (group_id = sequence_id) so that the same sequence never appears in both train and test/folds, preventing leakage. For 5-fold CV, run K=5, shuffle=true, stratified by expression bins, and report for each metric: mean ± standard deviation across the 5 held-out folds, plus the per-fold values in a supplementary table. Within each CV fold, allow an inner validation split for early stopping/hyperparameter selection (e.g., 10% of the fold’s training portion, seed_inner = 202503), but prohibit using the final 15% test set for any tuning. If external validation is available (e.g., a separate MPRA library or a different growth condition), evaluate the frozen final model there and report the full metric suite; otherwise, explicitly state that generalization is assessed only via hold-out + CV.\n\n4) Statistical testing design for model comparisons (correlation differences + multiple testing control): For each pair of models A vs B evaluated on the same test set, estimate uncertainty of Pearson r and Spearman ρ using nonparametric bootstrap with B = 10,000 resamples of test points (sampling with replacement, size = N_test), producing 95% confidence intervals via percentile method (2.5th–97.5th) and reporting the bootstrap mean and standard error. Define significance for correlation improvement by checking whether the bootstrap distribution of Δr = r_A - r_B excludes 0 at α = 0.05 (two-sided), and report the p-value as 2 * min(P(Δr ≤ 0), P(Δr ≥ 0)). Where assumptions allow and predictions are dependent (same y_true, correlated predictions), additionally apply a dependent-correlation test such as Steiger’s test (or Williams test variant) to compare r(y, A) vs r(y, B) accounting for r(A, B); report the test statistic, degrees of freedom, and p-value, and use it as a confirmatory analysis alongside bootstrap. For cross-validation comparisons, compute per-fold metric differences and apply a paired test on fold-wise values (recommended: Wilcoxon signed-rank on Δr across 5 folds due to small n; also report the mean Δr and its bootstrap CI over folds if repeating CV multiple times). Set the global significance level to α = 0.05 and correct for multiple pairwise comparisons across models using Benjamini–Hochberg FDR (q = 0.05); explicitly state the number of hypotheses (m) and report both raw p and BH-adjusted p (p_adj). To avoid p-hacking, predefine the comparison set (e.g., all models vs the current best baseline and vs each other only if within 0.02 Pearson) and report the full comparison matrix in supplementary materials.\n\n5) Error analysis and diagnostic visualizations (quantile bins, residuals, heteroscedasticity): Perform stratified error analysis by binning sequences into 10 equal-frequency bins by y_true (deciles) on the evaluated split (test or each CV fold) and compute per-bin MAE (and optionally median absolute error) to identify regimes where the model fails (e.g., extreme high-expression sequences). Report a table with columns: bin_index (1–10), y_true_range (min/max), n_bin, MAE_bin, and also include bias (mean residual) per bin; aggregate across folds by reporting mean ± SD per bin. Create a prediction-vs-truth scatter plot on the test set with: (i) y=x reference line, (ii) a fitted least-squares line (report slope, intercept), and (iii) the Pearson r annotated; for dense plots, use hexbin density with fixed gridsize (e.g., gridsize=50) to avoid overplotting. Analyze residuals e = y_pred - y_true: plot residual histogram and Q–Q plot, and compute summary stats (mean, SD, skewness); check heteroscedasticity by plotting |residual| vs y_true and performing a formal test (Breusch–Pagan at α=0.05) plus reporting the correlation between |e| and y_true. If strong heteroscedasticity exists, recommend reporting additionally a weighted error metric (e.g., MAE in z-space and MAE in original space, if available) and/or calibrating via isotonic regression on a validation set, but keep the primary metric unchanged for comparability. Finally, include an outlier analysis: list the top 1% absolute residual sequences, their true/pred values, GC%, and presence of known motifs, to connect quantitative error to biological features.\n\n6) Biological plausibility and interpretability (motifs, ISM, and -10/-35 enrichment for E. coli): Motif contribution from high-prediction sequences: take the top 1% (or top K=500, whichever is smaller) sequences by y_pred on the test set, extract enriched k-mers with k=6 and k=8 using a background of all test sequences (match GC content by stratified background sampling, e.g., 5 GC bins), and report top-N=20 enriched k-mers with log2 enrichment and BH-FDR adjusted p-values from Fisher’s exact test. For CNN-based models, convert first-layer convolutional filters into PWMs by collecting sequence windows that maximally activate each filter (e.g., top 1,000 windows), align them, and compute nucleotide frequencies with pseudocount 0.5; then report top-N=20 filters ranked by information content or association with high predictions, and optionally match to known bacterial motifs using a motif similarity tool (if available) while clearly stating matching thresholds (e.g., TOMTOM q<0.05). In silico mutagenesis (ISM): for each test sequence, mutate each position to the other three nucleotides, compute Δprediction, and derive per-position importance as the maximum absolute Δ across substitutions; summarize across sequences by reporting mean importance ± standard error (SE = SD/sqrt(n)) at each position, and provide stratified summaries for top-expression vs bottom-expression deciles. For statistical reporting of ISM, perform bootstrap over sequences (B=1,000 for ISM summaries due to compute cost) to generate 95% CIs for average importance at each position or for regional averages. E. coli -10/-35 box enrichment (optional but recommended when sequences are promoter-like): define windows relative to the annotated transcription start site (TSS): -35 region = [-40, -30], -10 region = [-15, -5]; define consensus-like matches using a PWM or simple consensus scoring (e.g., allow ≤1 mismatch to TTGACA for -35 and TATAAT for -10, or use a PWM with score threshold at the 80th percentile of genome-wide promoter matches). Test whether high-prediction sequences are enriched for strong -10/-35 matches compared with matched-background sequences using Fisher’s exact test (or logistic regression controlling for GC% and dinucleotide frequencies), report odds ratio with 95% CI, and apply BH-FDR across tested regions/motifs; this ties interpretability to known promoter biology and provides a mechanistic sanity check.\n\n7) Summary deliverables: evaluation & visualization checklist + parameter table + final report artifacts: Provide an “Evaluation & Visualization Checklist” that enumerates every required metric, split strategy, statistical test, diagnostic plot, and interpretability analysis, with a checkmark status per experiment run and links/paths to generated files. Provide a single “Parameter Table” (machine-readable JSON + human-readable markdown) containing: hold-out fraction=0.15, seed_holdout=202501, CV folds=5, seed_cv=202502, stratify_by_expr=true, expr_bins=10, bootstrap_resamples=10000, CI_level=95%, alpha=0.05, BH_FDR_q=0.05, ISM_bootstrap=1000, topN_kmers=20, kmer_sizes=[6,8], -10 window=[-15,-5], -35 window=[-40,-30], and any target-transform details. Final report should include a standardized set of tables/figures: (Table 1) dataset summary + QC metrics (replicate concordance, depth), (Table 2) hold-out test metrics for all models, (Table 3) 5-fold CV mean±SD metrics, (Table 4) pairwise statistical comparison matrix with Δr, CI, p, p_adj, (Table 5) decile-bin MAE and bias; (Fig 1) scatter/hexbin y_pred vs y_true with fit, (Fig 2) residual diagnostics (hist + |e| vs y_true + Q–Q), (Fig 3) MAE-by-decile barplot, (Fig 4) top motifs/k-mers and filter PWMs, (Fig 5) ISM average importance map with SE band, (Fig 6) -10/-35 enrichment odds ratios. Throughout, ground the MPRA-specific QC framing in established MPRA analysis toolkits/pipelines (e.g., esMPRA for stepwise QC reporting and @MPRA for MPRA statistical considerations), and include a reproducibility appendix listing software versions, exact seeds, and file hashes."
    }
  },
  "expert_analyses": {
    "data_management": {
      "score": 8.8,
      "design_summary": "This dataset is an E. coli MPRA sequence-to-expression regression table with exactly two fields (seq, expr), which implies the core preprocessing focus is sequence validity/length standardization plus robust handling of the continuous expression target. The file contains 5,920 data rows (excluding the header), placing it in the medium-size regime (1K–10K), so the plan emphasizes stringent QC and cleaning with only lightweight augmentation rather than heavy synthetic generation. Because MPRA activity values are often derived from log ratios or normalized reporter output, we explicitly check whether expr is already on a log-like scale and then standardize using train-set statistics for stable model training. We propose conservative sequence cleaning with explicit thresholds for non-ACGT content and duplicate handling to prevent leakage and memorization, and we define a fixed sequence length L based on the empirical P95 length to minimize padding overhead. Data splitting is designed to be reproducible (seeded) and distribution-preserving via stratification on binned expr, with an optional 5-fold cross-validation backup for model selection. QC deliverables are defined as a set of actionable report items aligned with MPRA QC principles (stage-wise diagnostics and outlier awareness) as emphasized by esMPRA and standardized MPRA processing efforts (esMPRA; MPRAsnakeflow/MPRAlib best-practice motivation for uniform, reproducible processing).",
      "implementation_plan": {
        "design_recommendations": "Dataset characteristic analysis: The CSV inspection confirms only two columns named exactly 'seq' and 'expr', consistent with a processed MPRA design matrix where each row is a regulatory sequence and the label is a continuous activity measurement. The file has 5,921 total lines including the header, implying N=5,920 samples, which is a medium dataset (<10k) and supports a QC-first approach with limited augmentation. Because this is MPRA, sequence directionality can matter (especially for bacterial promoters), so reverse-complement augmentation is not assumed valid by default and should be tested only as an ablation. Sequence lengths must be summarized (min/median/max and P95) to choose a fixed model input length L; the preview suggests all sequences are of similar length (on the order of ~160–180 bp), but L must be computed from the full file. Feature dimensionality under one-hot is L×4 per sample (dense), while k-mer count features are sparse with vocabulary size 4^k (e.g., k=5 gives 1024 dims) and can be efficient for linear baselines; the dataset size supports either representation. Expression (expr) must be profiled for mean/variance/skewness and outliers; we will flag extremes using |z|>5 (computed on the training fold) and/or winsorize at 0.1%/99.9% quantiles to stabilize training while keeping labels continuous.\n\nData source selection and evaluation: The immediate source is the provided E. coli MPRA CSV, which appears to already be aggregated per sequence (no barcodes), meaning upstream MPRA counting/QC is not available in this file; therefore we treat it as a post-quantification dataset. For extensibility and benchmarking, we recommend optionally pulling comparable MPRA datasets (e.g., via MPRAbase for public MPRA repositories) to test generalization across conditions/species, but not mixing them into training unless labels are harmonized (as cautioned by the motivation for uniform processing in standardized MPRA pipelines such as MPRAsnakeflow/MPRAlib). The plan should record metadata if available (plasmid vs genomic integration, growth conditions, library design) because those can induce batch effects; if absent, we assume single-condition and focus on internal consistency checks. We also recommend keeping a “data card” documenting file hash, download path, and parsing rules for reproducibility aligned with the community push for harmonized formats and uniform processing (MPRAsnakeflow/MPRAlib). esMPRA emphasizes standardized QC metrics and stepwise monitoring; while we cannot run its raw-read stages, we can emulate its spirit by producing stage-specific diagnostics: parsing/sequence validity, length uniformity, label distribution, and train/val/test drift checks. If later raw counts become available, the pipeline should be upgradeable to incorporate barcode-level outlier handling and RNA/DNA ratio modeling, consistent with MPRA best practices referenced in the retrieved literature (esMPRA; individual barcode robustness discussions in MPRA analysis frameworks).\n\nPreprocessing pipeline (QC + cleaning, with explicit parameters): Parsing must enforce schema: columns exactly {seq, expr}, seq as string, expr castable to float; rows failing parse are dropped and counted in QC. Sequence cleaning uses an allowed alphabet {A,C,G,T} (uppercase); any lowercase is uppercased, and whitespace is stripped; empty seq is dropped (threshold: length==0). Non-ACGT handling is thresholded: compute fraction f_nonACGT per sequence; if f_nonACGT > 0.01 (i.e., >1% characters not in A/C/G/T), drop the sequence; if 0 < f_nonACGT ≤ 0.01, replace non-ACGT characters with 'N' then encode them as an all-zero channel (i.e., [0,0,0,0]) to avoid introducing spurious signal (this matches the requirement “padding symbol all-0” and keeps ambiguity neutral). Duplicate sequences: compute exact duplicates on cleaned seq; if duplicates exist with identical expr, keep one and drop the rest; if duplicates have different expr (technical inconsistency), keep one with expr equal to the median of the duplicate group and log the group size as a QC alert (to reduce label noise while avoiding leakage). Expression preprocessing: compute train-set mean/variance/skewness; if skewness > 1.0 and expr is strictly positive, apply log1p(expr) as an alternative target and compare validation performance; otherwise keep raw but always standardize: y_std=(y-mean_train)/std_train. Outliers: flag with |z|>5 on the standardized target (training statistics) and additionally compute extreme quantiles; default action is winsorization at [0.1%, 99.9%] on training labels only (apply same caps to val/test) to prevent a few points from dominating MSE, while retaining sample count in a medium dataset.\n\nLength handling and encoding (explicit L and settings): After computing the full length distribution, set fixed length L to P95(length) rounded up to a convenient multiple of 8 (for GPU efficiency); if P95 is, for example, 170 bp, set L=176; if the distribution is extremely tight (max-min ≤ 5), set L=max to avoid trimming. Trimming rule: if len(seq) > L, trim symmetrically around the center (center-crop) for generic regulatory elements; however for bacterial promoters with positional motifs relative to TSS, prefer right-crop or left-crop depending on how sequences were constructed—default to right-padding and right-cropping only if the library is aligned at the 5' end; because that metadata is absent, we recommend center-crop as the neutral default and report sensitivity in an ablation. Padding: right-pad with all-zero vectors to reach L; do not pad with 'A' because that introduces signal. Primary encoding is one-hot: tensor shape (L,4) with channels ordered A,C,G,T; ambiguous 'N' or masked bases are [0,0,0,0]. Optional baseline encoding for classical models: overlapping k-mer counts with stride=1, k in {3,4,5}; vocab sizes 64/256/1024 respectively; use normalized counts (divide by total k-mers) to reduce length effects; these features are sparse-ish but manageable at N=5.9k and are valuable for sanity-check baselines.\n\nData splitting strategy (reproducible, stratified, plus CV backup): Use train/val/test = 0.8/0.1/0.1 with random seed = 42 and shuffling enabled, but stratify by expr distribution to avoid label-shift: bin expr into 10 quantile bins (deciles) computed on the full dataset (or better: compute bins on train then assign others; practically, full-data deciles are acceptable for stratification as it does not leak sequence information). Ensure no duplicate sequences are split across folds by deduplicating before splitting; if near-duplicates are suspected (e.g., designed variants), optionally cluster by Hamming distance ≤ 3 and split by cluster to reduce leakage (report as an advanced option). Provide a 5-fold cross-validation alternative (KFold=5, shuffle=True, seed=42) for robust model selection; keep the test set held out and untouched, using CV only within the 90% train+val portion. After splitting, compute and report drift metrics: length distribution KS test between splits, and expr mean/std/skew per split; if drift exceeds thresholds (e.g., |mean_diff|>0.1 std units or KS p<1e-3), re-split with the same stratification but adjusted binning (e.g., 20 bins) to improve match.\n\nLightweight data augmentation (explicit parameters, MPRA-specific cautions): Because N≈5.9k is medium, augmentation should be light and should not distort promoter directionality in bacteria. Reverse-complement (RC) augmentation is not used by default; run it only as a controlled ablation: add RC sequences for 50% of training samples (augmentation ratio 0.5) and compare validation—if performance degrades, conclude directionality is important and keep RC off. Random point-mutation augmentation: for each training sequence, with probability p_aug=0.3 generate one mutated copy; within that copy, mutate each position with p_mut=0.01 but enforce a maximum of m_max=3 mutations/sequence; substitutions are uniform among the other three bases; do not mutate padded positions. Random masking: with probability p_aug_mask=0.3 generate one masked copy; independently mask each position with p_mask=0.02 by setting it to all-zero [0,0,0,0]; cap masks to at most 5 positions/sequence to avoid destroying key motifs. Label handling for augmented samples: keep the same expr label (invariance assumption) for masking and very-low-rate mutation, but down-weight augmented samples in loss with weight=0.5 relative to originals to reduce the risk of introducing label noise; this is appropriate for a medium dataset where we can afford to prioritize clean supervision.\n\nQuality control report items (actionable checklist aligned with MPRA QC principles): Produce a “Parsing & Schema” table: column names, dtypes, number of rows read, number dropped due to parse errors. “Sequence validity” section: length min/median/max/P95, fraction of empty sequences, fraction with any non-ACGT, fraction dropped due to f_nonACGT>0.01, and histogram of non-ACGT fraction. “Duplicate analysis”: count exact duplicates, distribution of duplicate group sizes, and number of inconsistent-label duplicate groups (plus the chosen resolution rule). “Expression distribution”: mean/variance/skewness/kurtosis, histogram + KDE, fraction negative, fraction zero, and outlier counts under |z|>5 and beyond 0.1%/99.9% quantiles; explicitly record winsorization caps if applied. “Split diagnostics”: per-split N, expr mean/std/skew, length distribution summary, and drift tests (KS statistics) to ensure comparability. These QC emphases are motivated by the broader MPRA community’s push for standardized QC and reproducible processing (esMPRA stepwise diagnostics; MPRAsnakeflow/MPRAlib uniform processing and awareness of technical variability sources).\n\nBias and confounding mitigation: Species/assay bias is inherent (E. coli MPRA), so the model should not be expected to generalize to eukaryotic enhancers; document this explicitly and avoid mixing multi-species datasets without harmonization. Directionality confounding is likely in bacterial promoter libraries; therefore, avoid RC augmentation by default and treat it as a hypothesis test rather than a routine augmentation. Sequence composition bias (e.g., GC content correlated with expr) can cause shortcut learning; include QC plots of expr vs GC%, and consider adding a covariate baseline (linear regression on GC%) to quantify how much signal is composition-driven. If the library contains designed variants around a motif, random splitting can leak motif families; mitigate by optional cluster-based splitting (Hamming threshold) and report both random and cluster-split performance. Platform/condition biases cannot be assessed without metadata; mitigate by strict reproducibility practices (fixed seeds, logged preprocessing parameters, dataset hash) and by keeping a fully held-out test set untouched until final evaluation."
      },
      "recommendations": [
        "Confirm MPRA target semantics before any transform: determine whether expr represents raw activity, RNA/DNA log-ratio, or a limma-style log fold-change (mpralm). Only apply log1p/Box-Cox if justified by positivity and skewness; otherwise standardize using train-set mean/std only.",
        "If barcode-level data exist upstream, incorporate MPRA-aware QC consistent with community pipelines: enforce minimum DNA coverage per element, detect/remove outlier barcodes before aggregation, and record barcode bias as a potential confound (supported by MPRA tooling/standards and barcode outlier discussions in MPRA-focused processing frameworks) [Rosen et al., 2025 bioRxiv; Keukeleire et al., 2025 BMC Bioinformatics].",
        "Add an explicit leakage-mitigation split option: cluster sequences by edit distance (or k-mer/Jaccard similarity / MinHash) and split by cluster so close variants do not cross train/val/test. Use this as the primary split if the library is a variant-scan design; otherwise report both random and cluster-split results.",
        "Finalize sequence length policy after full-file parsing: report min/median/P95/max length; choose L based on mode or P95, then document padding/truncation and run an anchored-vs-centered cropping sensitivity analysis (especially important for promoter-like constructs where position relative to TSS matters).",
        "Keep reverse-complement augmentation OFF by default; only enable after verifying orientation invariance of the construct (many MPRA designs are strand/direction dependent). If enabled, treat it as an ablation and report impact.",
        "Retain conservative augmentation (small-rate point mutations/masking) only on training and down-weight augmented samples in the loss to limit label noise; avoid heavy synthetic generation given N~5.9k.",
        "Strengthen QC reporting: (i) % sequences dropped for invalid chars/length, (ii) non-ACGT rate distribution, (iii) GC% distribution per split, (iv) label distribution per split, (v) replicate/duplicate sequence detection and handling policy.",
        "Bias mitigation: explicitly check for GC-content or k-mer frequency differences across splits (and between high/low expr bins). If present, consider stratification by GC bins in addition to expr deciles, or include GC as a covariate feature for diagnostics (not necessarily for final model)."
      ],
      "retrieved_knowledge": [
        {
          "id": "46a98b85c5d33450",
          "title": "Statistical considerations for the analysis of massively parallel reporter assays data.",
          "content": "Analysis Toolset for MPRA (@MPRA), an R package for the design and analyses of MPRA experiments. It is publicly available at http://github.com/redaq/atMPRA.",
          "source": "PubMed",
          "relevance_score": 0.8326
        },
        {
          "id": "d5451a372eaa1a02",
          "title": "MPRAbase: A Massively Parallel Reporter Assay Database.",
          "content": "129 experiments, encompassing 17,718,677 elements tested across 35 cell types and 4 organisms. The MPRAbase web interface (http://www.mprabase.com) serves as a centralized user-friendly repository to download existing MPRA data for independent analysis and is designed with the ability to allow researchers to share their published data for rapid dissemination to the community.",
          "source": "PubMed",
          "relevance_score": 0.7813
        },
        {
          "id": "3f5f453a68d61113",
          "title": "Optimizing sequence design strategies for perturbation MPRAs: a computational evaluation framework.",
          "content": "Optimizing sequence design strategies for perturbation MPRAs: a computational evaluation framework.",
          "source": "PubMed",
          "relevance_score": 0.5805
        },
        {
          "id": "51febf8054037101",
          "title": "esMPRA: an easy-to-use systematic pipeline for MPRA experiment quality control and data analysis.",
          "content": "esMPRA: an easy-to-use systematic pipeline for MPRA experiment quality control and data analysis.",
          "source": "PubMed",
          "relevance_score": 0.4282
        },
        {
          "id": "289c49d0ab8509e2",
          "title": "SnailHeater",
          "content": "SnailHeater\n\n多功能焊台（T12/JBC245、烤箱回流焊、加热台、风枪、可调电源、简易双通道示波器、函数发生器、高精度PWM脉冲）",
          "source": "GitHub",
          "relevance_score": 0.2239
        },
        {
          "id": "",
          "title": "",
          "content": "MOTIVATION: Massively Parallel Reporter Assays (MPRAs) have emerged as pivotal tools for systematically profiling cis-regulatory element activity, playing critical roles in deciphering gene regulation mechanisms and synthetic regulatory element engineering. However, MPRA experiments involve multi-step library processing procedures coupled with high-throughput sequencing. Operational errors during these complex workflows can lead to substantial resource depletion and experimental delays. Thus rob",
          "source": "PubMed",
          "relevance_score": 0.3342
        },
        {
          "id": "",
          "title": "",
          "content": "MOTIVATION: Massively Parallel Reporter Assays (MPRAs) have emerged as pivotal tools for systematically profiling cis-regulatory element activity, playing critical roles in deciphering gene regulation mechanisms and synthetic regulatory element engineering. However, MPRA experiments involve multi-step library processing procedures coupled with high-throughput sequencing. Operational errors during these complex workflows can lead to substantial resource depletion and experimental delays. Thus rob",
          "source": "PubMed",
          "relevance_score": 0.7987
        },
        {
          "id": "",
          "title": "",
          "content": "HybridQC: Machine Learning-Augmented Quality Control for Single-Cell RNA-seq Data\n\nHybridQC is an R package that streamlines quality control (QC) of single-cell RNA sequencing (scRNA-seq) data by combining traditional threshold-based filtering with machine learning-based outlier detection. It provides an efficient and adaptive framework to identify low-quality cells in noisy or shallow-depth datasets using techniques such as Isolation Forest, while remaining compatible with widely adopted format",
          "source": "arXiv",
          "relevance_score": 0.3016
        }
      ],
      "full_metadata": {
        "query": "Experimental design: MPRA序列数据读取、质控、编码与划分方案",
        "knowledge_results": 8,
        "retrieved_knowledge": [
          {
            "id": "46a98b85c5d33450",
            "title": "Statistical considerations for the analysis of massively parallel reporter assays data.",
            "content": "Analysis Toolset for MPRA (@MPRA), an R package for the design and analyses of MPRA experiments. It is publicly available at http://github.com/redaq/atMPRA.",
            "source": "PubMed",
            "relevance_score": 0.8326
          },
          {
            "id": "d5451a372eaa1a02",
            "title": "MPRAbase: A Massively Parallel Reporter Assay Database.",
            "content": "129 experiments, encompassing 17,718,677 elements tested across 35 cell types and 4 organisms. The MPRAbase web interface (http://www.mprabase.com) serves as a centralized user-friendly repository to download existing MPRA data for independent analysis and is designed with the ability to allow researchers to share their published data for rapid dissemination to the community.",
            "source": "PubMed",
            "relevance_score": 0.7813
          },
          {
            "id": "3f5f453a68d61113",
            "title": "Optimizing sequence design strategies for perturbation MPRAs: a computational evaluation framework.",
            "content": "Optimizing sequence design strategies for perturbation MPRAs: a computational evaluation framework.",
            "source": "PubMed",
            "relevance_score": 0.5805
          },
          {
            "id": "51febf8054037101",
            "title": "esMPRA: an easy-to-use systematic pipeline for MPRA experiment quality control and data analysis.",
            "content": "esMPRA: an easy-to-use systematic pipeline for MPRA experiment quality control and data analysis.",
            "source": "PubMed",
            "relevance_score": 0.4282
          },
          {
            "id": "289c49d0ab8509e2",
            "title": "SnailHeater",
            "content": "SnailHeater\n\n多功能焊台（T12/JBC245、烤箱回流焊、加热台、风枪、可调电源、简易双通道示波器、函数发生器、高精度PWM脉冲）",
            "source": "GitHub",
            "relevance_score": 0.2239
          },
          {
            "id": "",
            "title": "",
            "content": "MOTIVATION: Massively Parallel Reporter Assays (MPRAs) have emerged as pivotal tools for systematically profiling cis-regulatory element activity, playing critical roles in deciphering gene regulation mechanisms and synthetic regulatory element engineering. However, MPRA experiments involve multi-step library processing procedures coupled with high-throughput sequencing. Operational errors during these complex workflows can lead to substantial resource depletion and experimental delays. Thus rob",
            "source": "PubMed",
            "relevance_score": 0.3342
          },
          {
            "id": "",
            "title": "",
            "content": "MOTIVATION: Massively Parallel Reporter Assays (MPRAs) have emerged as pivotal tools for systematically profiling cis-regulatory element activity, playing critical roles in deciphering gene regulation mechanisms and synthetic regulatory element engineering. However, MPRA experiments involve multi-step library processing procedures coupled with high-throughput sequencing. Operational errors during these complex workflows can lead to substantial resource depletion and experimental delays. Thus rob",
            "source": "PubMed",
            "relevance_score": 0.7987
          },
          {
            "id": "",
            "title": "",
            "content": "HybridQC: Machine Learning-Augmented Quality Control for Single-Cell RNA-seq Data\n\nHybridQC is an R package that streamlines quality control (QC) of single-cell RNA sequencing (scRNA-seq) data by combining traditional threshold-based filtering with machine learning-based outlier detection. It provides an efficient and adaptive framework to identify low-quality cells in noisy or shallow-depth datasets using techniques such as Isolation Forest, while remaining compatible with widely adopted format",
            "source": "arXiv",
            "relevance_score": 0.3016
          }
        ],
        "model": "gpt-5.2",
        "design_summary": "This dataset is an E. coli MPRA sequence-to-expression regression table with exactly two fields (seq, expr), which implies the core preprocessing focus is sequence validity/length standardization plus robust handling of the continuous expression target. The file contains 5,920 data rows (excluding the header), placing it in the medium-size regime (1K–10K), so the plan emphasizes stringent QC and cleaning with only lightweight augmentation rather than heavy synthetic generation. Because MPRA activity values are often derived from log ratios or normalized reporter output, we explicitly check whether expr is already on a log-like scale and then standardize using train-set statistics for stable model training. We propose conservative sequence cleaning with explicit thresholds for non-ACGT content and duplicate handling to prevent leakage and memorization, and we define a fixed sequence length L based on the empirical P95 length to minimize padding overhead. Data splitting is designed to be reproducible (seeded) and distribution-preserving via stratification on binned expr, with an optional 5-fold cross-validation backup for model selection. QC deliverables are defined as a set of actionable report items aligned with MPRA QC principles (stage-wise diagnostics and outlier awareness) as emphasized by esMPRA and standardized MPRA processing efforts (esMPRA; MPRAsnakeflow/MPRAlib best-practice motivation for uniform, reproducible processing).",
        "detailed_design": {
          "design_recommendations": "Dataset characteristic analysis: The CSV inspection confirms only two columns named exactly 'seq' and 'expr', consistent with a processed MPRA design matrix where each row is a regulatory sequence and the label is a continuous activity measurement. The file has 5,921 total lines including the header, implying N=5,920 samples, which is a medium dataset (<10k) and supports a QC-first approach with limited augmentation. Because this is MPRA, sequence directionality can matter (especially for bacterial promoters), so reverse-complement augmentation is not assumed valid by default and should be tested only as an ablation. Sequence lengths must be summarized (min/median/max and P95) to choose a fixed model input length L; the preview suggests all sequences are of similar length (on the order of ~160–180 bp), but L must be computed from the full file. Feature dimensionality under one-hot is L×4 per sample (dense), while k-mer count features are sparse with vocabulary size 4^k (e.g., k=5 gives 1024 dims) and can be efficient for linear baselines; the dataset size supports either representation. Expression (expr) must be profiled for mean/variance/skewness and outliers; we will flag extremes using |z|>5 (computed on the training fold) and/or winsorize at 0.1%/99.9% quantiles to stabilize training while keeping labels continuous.\n\nData source selection and evaluation: The immediate source is the provided E. coli MPRA CSV, which appears to already be aggregated per sequence (no barcodes), meaning upstream MPRA counting/QC is not available in this file; therefore we treat it as a post-quantification dataset. For extensibility and benchmarking, we recommend optionally pulling comparable MPRA datasets (e.g., via MPRAbase for public MPRA repositories) to test generalization across conditions/species, but not mixing them into training unless labels are harmonized (as cautioned by the motivation for uniform processing in standardized MPRA pipelines such as MPRAsnakeflow/MPRAlib). The plan should record metadata if available (plasmid vs genomic integration, growth conditions, library design) because those can induce batch effects; if absent, we assume single-condition and focus on internal consistency checks. We also recommend keeping a “data card” documenting file hash, download path, and parsing rules for reproducibility aligned with the community push for harmonized formats and uniform processing (MPRAsnakeflow/MPRAlib). esMPRA emphasizes standardized QC metrics and stepwise monitoring; while we cannot run its raw-read stages, we can emulate its spirit by producing stage-specific diagnostics: parsing/sequence validity, length uniformity, label distribution, and train/val/test drift checks. If later raw counts become available, the pipeline should be upgradeable to incorporate barcode-level outlier handling and RNA/DNA ratio modeling, consistent with MPRA best practices referenced in the retrieved literature (esMPRA; individual barcode robustness discussions in MPRA analysis frameworks).\n\nPreprocessing pipeline (QC + cleaning, with explicit parameters): Parsing must enforce schema: columns exactly {seq, expr}, seq as string, expr castable to float; rows failing parse are dropped and counted in QC. Sequence cleaning uses an allowed alphabet {A,C,G,T} (uppercase); any lowercase is uppercased, and whitespace is stripped; empty seq is dropped (threshold: length==0). Non-ACGT handling is thresholded: compute fraction f_nonACGT per sequence; if f_nonACGT > 0.01 (i.e., >1% characters not in A/C/G/T), drop the sequence; if 0 < f_nonACGT ≤ 0.01, replace non-ACGT characters with 'N' then encode them as an all-zero channel (i.e., [0,0,0,0]) to avoid introducing spurious signal (this matches the requirement “padding symbol all-0” and keeps ambiguity neutral). Duplicate sequences: compute exact duplicates on cleaned seq; if duplicates exist with identical expr, keep one and drop the rest; if duplicates have different expr (technical inconsistency), keep one with expr equal to the median of the duplicate group and log the group size as a QC alert (to reduce label noise while avoiding leakage). Expression preprocessing: compute train-set mean/variance/skewness; if skewness > 1.0 and expr is strictly positive, apply log1p(expr) as an alternative target and compare validation performance; otherwise keep raw but always standardize: y_std=(y-mean_train)/std_train. Outliers: flag with |z|>5 on the standardized target (training statistics) and additionally compute extreme quantiles; default action is winsorization at [0.1%, 99.9%] on training labels only (apply same caps to val/test) to prevent a few points from dominating MSE, while retaining sample count in a medium dataset.\n\nLength handling and encoding (explicit L and settings): After computing the full length distribution, set fixed length L to P95(length) rounded up to a convenient multiple of 8 (for GPU efficiency); if P95 is, for example, 170 bp, set L=176; if the distribution is extremely tight (max-min ≤ 5), set L=max to avoid trimming. Trimming rule: if len(seq) > L, trim symmetrically around the center (center-crop) for generic regulatory elements; however for bacterial promoters with positional motifs relative to TSS, prefer right-crop or left-crop depending on how sequences were constructed—default to right-padding and right-cropping only if the library is aligned at the 5' end; because that metadata is absent, we recommend center-crop as the neutral default and report sensitivity in an ablation. Padding: right-pad with all-zero vectors to reach L; do not pad with 'A' because that introduces signal. Primary encoding is one-hot: tensor shape (L,4) with channels ordered A,C,G,T; ambiguous 'N' or masked bases are [0,0,0,0]. Optional baseline encoding for classical models: overlapping k-mer counts with stride=1, k in {3,4,5}; vocab sizes 64/256/1024 respectively; use normalized counts (divide by total k-mers) to reduce length effects; these features are sparse-ish but manageable at N=5.9k and are valuable for sanity-check baselines.\n\nData splitting strategy (reproducible, stratified, plus CV backup): Use train/val/test = 0.8/0.1/0.1 with random seed = 42 and shuffling enabled, but stratify by expr distribution to avoid label-shift: bin expr into 10 quantile bins (deciles) computed on the full dataset (or better: compute bins on train then assign others; practically, full-data deciles are acceptable for stratification as it does not leak sequence information). Ensure no duplicate sequences are split across folds by deduplicating before splitting; if near-duplicates are suspected (e.g., designed variants), optionally cluster by Hamming distance ≤ 3 and split by cluster to reduce leakage (report as an advanced option). Provide a 5-fold cross-validation alternative (KFold=5, shuffle=True, seed=42) for robust model selection; keep the test set held out and untouched, using CV only within the 90% train+val portion. After splitting, compute and report drift metrics: length distribution KS test between splits, and expr mean/std/skew per split; if drift exceeds thresholds (e.g., |mean_diff|>0.1 std units or KS p<1e-3), re-split with the same stratification but adjusted binning (e.g., 20 bins) to improve match.\n\nLightweight data augmentation (explicit parameters, MPRA-specific cautions): Because N≈5.9k is medium, augmentation should be light and should not distort promoter directionality in bacteria. Reverse-complement (RC) augmentation is not used by default; run it only as a controlled ablation: add RC sequences for 50% of training samples (augmentation ratio 0.5) and compare validation—if performance degrades, conclude directionality is important and keep RC off. Random point-mutation augmentation: for each training sequence, with probability p_aug=0.3 generate one mutated copy; within that copy, mutate each position with p_mut=0.01 but enforce a maximum of m_max=3 mutations/sequence; substitutions are uniform among the other three bases; do not mutate padded positions. Random masking: with probability p_aug_mask=0.3 generate one masked copy; independently mask each position with p_mask=0.02 by setting it to all-zero [0,0,0,0]; cap masks to at most 5 positions/sequence to avoid destroying key motifs. Label handling for augmented samples: keep the same expr label (invariance assumption) for masking and very-low-rate mutation, but down-weight augmented samples in loss with weight=0.5 relative to originals to reduce the risk of introducing label noise; this is appropriate for a medium dataset where we can afford to prioritize clean supervision.\n\nQuality control report items (actionable checklist aligned with MPRA QC principles): Produce a “Parsing & Schema” table: column names, dtypes, number of rows read, number dropped due to parse errors. “Sequence validity” section: length min/median/max/P95, fraction of empty sequences, fraction with any non-ACGT, fraction dropped due to f_nonACGT>0.01, and histogram of non-ACGT fraction. “Duplicate analysis”: count exact duplicates, distribution of duplicate group sizes, and number of inconsistent-label duplicate groups (plus the chosen resolution rule). “Expression distribution”: mean/variance/skewness/kurtosis, histogram + KDE, fraction negative, fraction zero, and outlier counts under |z|>5 and beyond 0.1%/99.9% quantiles; explicitly record winsorization caps if applied. “Split diagnostics”: per-split N, expr mean/std/skew, length distribution summary, and drift tests (KS statistics) to ensure comparability. These QC emphases are motivated by the broader MPRA community’s push for standardized QC and reproducible processing (esMPRA stepwise diagnostics; MPRAsnakeflow/MPRAlib uniform processing and awareness of technical variability sources).\n\nBias and confounding mitigation: Species/assay bias is inherent (E. coli MPRA), so the model should not be expected to generalize to eukaryotic enhancers; document this explicitly and avoid mixing multi-species datasets without harmonization. Directionality confounding is likely in bacterial promoter libraries; therefore, avoid RC augmentation by default and treat it as a hypothesis test rather than a routine augmentation. Sequence composition bias (e.g., GC content correlated with expr) can cause shortcut learning; include QC plots of expr vs GC%, and consider adding a covariate baseline (linear regression on GC%) to quantify how much signal is composition-driven. If the library contains designed variants around a motif, random splitting can leak motif families; mitigate by optional cluster-based splitting (Hamming threshold) and report both random and cluster-split performance. Platform/condition biases cannot be assessed without metadata; mitigate by strict reproducibility practices (fixed seeds, logged preprocessing parameters, dataset hash) and by keeping a fully held-out test set untouched until final evaluation."
        },
        "discussion_notes": "Overall, the other experts’ opinions are largely consistent with the existing data-management analysis: the dataset is treated as MPRA-like sequence-to-expression regression of medium size, so QC/cleaning and careful splitting matter more than aggressive augmentation. I agree strongly with (a) avoiding reverse-complement augmentation unless assay orientation invariance is proven, and (b) adding leakage control via sequence clustering for variant libraries. I also agree that MPRA targets often come from RNA/DNA barcode ratios and can be sensitive to barcode outliers; MPRA-focused literature emphasizes barcode-level modeling/robustness and uniform processing standards [Keukeleire et al., 2025; Rosen et al., 2025]. Since we may only have aggregated (seq, expr), the plan should explicitly state this limitation and, where possible, request or reconstruct barcode-level QC summaries. The main correction is to elevate cluster-based splitting and target-definition verification from ‘optional’ to ‘core decision points’ because they can materially change reported generalization.",
        "updated_after_discussion": true
      }
    },
    "methodology": {
      "score": 9.3,
      "design_summary": "This experimental plan specifies an end-to-end, reproducible training methodology for sequence-to-continuous expression (MPRA activity) regression, emphasizing robustness to outliers and strong biological validity. The pipeline begins with MPRA-aware preprocessing (barcode-level QC, RNA/DNA ratio-derived targets) and explicit target transformations that adapt to skewness and negative values. The training objective uses a robust main loss (Huber) with optional correlation/ranking auxiliary losses to align optimization with evaluation metrics like Pearson/Spearman. Optimization is centered on AdamW with explicit hyperparameters, gradient clipping, warmup, and either cosine annealing or plateau-based scheduling to stabilize training across model capacities. Regularization combines weight decay, dropout (including input dropout/random masking), and careful early stopping; label smoothing is explicitly excluded as it is not appropriate for regression. The model comparison matrix includes interpretable baselines (linear/k-mer), a CNN, and a CNN+attention model, all trained under the same recipe for fair comparison. Prior knowledge is integrated via motif/PWM-based auxiliary supervision and constrained augmentations (e.g., reverse-complement where appropriate), improving sample efficiency especially in medium-sized MPRA datasets.",
      "implementation_plan": {
        "design_recommendations": {
          "dataset_characteristics_and_preprocessing": "This task targets MPRA-style regression where each sequence has an activity derived from barcode RNA and DNA counts (often using log(RNA/DNA) or model-based transcription rate estimates), and such assays are known to exhibit barcode-level outliers and technical variability. Literature on MPRA analysis highlights that tools modeling barcode counts (e.g., MPRAnalyze / mpralm variants) address inherent variation and outlier sensitivity, and newer frameworks emphasize barcode sequence bias and outlier barcodes as major technical factors; therefore, preprocessing should include barcode QC and robust aggregation (Keukeleire et al., 2025; Rosen et al., 2025 from the knowledge base). Assume a typical MPRA dataset size is medium-to-large (1e4–1e5 sequences) with fixed oligo length (commonly 150–230 bp plus adapters); if length varies, pad/trim to a fixed L (recommended L=200) and track true-length masks for attention layers. Perform barcode filtering: remove barcodes with DNA counts < 10 (or < 20 for stricter QC) and optionally trim the top 0.5–1% barcodes by RNA/DNA ratio per element as outliers; then aggregate per element by median-of-barcodes or robust mean (Huber mean) to reduce influence of extreme barcodes. Use train/val/test splits that prevent leakage from highly similar sequence variants (e.g., allelic pairs or designed mutational neighborhoods): split by \"parent element\" or edit distance clusters when available, to avoid inflated correlations. Finally, standardize input encoding as one-hot (A,C,G,T plus N=all zeros) with optional additional channels (e.g., GC content track or positional prior track) kept fixed across models for controlled comparisons.",
          "target_transformation_policy": "Because MPRA activity can be negative (e.g., log fold-change below baseline) and often heavy-tailed, define a conditional target transform policy that is data-driven and reversible for reporting. Compute skewness on the training targets; if absolute skewness > 1.0, enable a power transform (Yeo–Johnson) fitted on training only, because it handles zeros and negative values unlike Box–Cox. If absolute skewness <= 1.0, default to z-score standardization (y_z = (y - mean_train) / std_train) for stable optimization and comparability across experiments. If strong outliers are present (e.g., >2% of points beyond 3×IQR), use RobustScaler (center=median, scale=IQR) instead of z-score to reduce sensitivity; this is particularly relevant given known barcode-level outliers in MPRA pipelines (Keukeleire et al., 2025). Explicit negative-value handling: do not clamp negatives; instead, preserve sign and use Yeo–Johnson when skewness triggers or RobustScaler when outlier fraction triggers. For reporting, always invert the transform back to the original scale for MAE/MSE on the raw units, and also report correlation on raw and transformed scales to ensure interpretability. Log1p transforms are not recommended unless the target is strictly non-negative count-derived (rare after log(RNA/DNA)); if used, only enable when min(y) >= 0 and skewness > 1.0, with epsilon=1e-3.",
          "loss_functions": "Use Huber loss as the default main loss to be robust to heavy-tailed errors and outliers typical in MPRA measurements (barcode-level variability and occasional extreme activities), while still behaving like MSE near zero error. Set Huber delta (\"transition\") explicitly to delta=1.0 on the standardized target scale; if using RobustScaler, set delta=1.5 to account for the smaller effective scale of IQR normalization. Define the primary loss as L_main = Huber(y_pred, y_true; delta), averaged over the batch. Optionally add a correlation-alignment auxiliary loss to better match evaluation metrics: L_corr = 1 - PearsonCorr(y_pred, y_true) computed within-batch (with batch_size >= 64), then use total loss L = L_main + λ_corr * L_corr with λ_corr=0.1. If rank consistency is a key goal (e.g., selecting top enhancers), add a pairwise ranking loss on within-batch pairs: L_rank = mean(log(1 + exp(-(y_pred_i - y_pred_j) * sign(y_true_i - y_true_j)))) sampled from 256 random pairs per batch; weight it λ_rank=0.05, and keep λ_corr=0.05 when both auxiliaries are enabled. For ablations, compare MSE as baseline (L_main = MSE) to quantify gains from robustness; expect Huber to reduce sensitivity to outlier barcodes/elements and stabilize early stopping. Ensure loss is computed on transformed targets, while metrics (Pearson/Spearman/R2) are computed on inverse-transformed predictions for interpretability.",
          "optimizer_and_hyperparameters": "Use AdamW as the default optimizer for all neural models due to its stability on one-hot sequence inputs and compatibility with weight decay decoupling. Set AdamW hyperparameters explicitly: lr=1e-3 (starting), betas=(0.9, 0.999), eps=1e-8, weight_decay=1e-4; these values are a strong default for CNN/attention models on MPRA-scale regression. Apply gradient clipping to prevent rare large gradients from destabilizing training, using clip_norm=1.0 (global norm). Use mixed precision (fp16/bf16) only if it does not change numerical stability of Pearson auxiliary loss; if enabled, compute correlation loss in fp32. As a classical comparator, run SGD+momentum on CNN models: lr=0.05, momentum=0.9, weight_decay=5e-4, Nesterov=True; this acts as an optimizer ablation to show whether adaptive methods are needed. Use EMA of weights (optional) with decay=0.999 to stabilize validation correlation, especially for CNN+attention. For batch sizes, use 128 as default on GPU memory permitting; if sequences are long or attention is heavy, reduce to 64 and compensate with gradient accumulation steps=2 to keep an effective batch of 128.",
          "learning_rate_schedule_and_warmup": "Adopt a warmup phase to avoid early training instability when using AdamW and potentially correlation/ranking auxiliary losses. Set warmup_steps=500 (or warmup_ratio=0.05 if total_steps is small), linearly increasing lr from 1e-5 to the base lr (1e-3). After warmup, use CosineAnnealingLR down to min_lr=1e-6 over the remaining steps; cosine works well for large sequence datasets and reduces the need for manual plateau tuning. As an alternative scheduler for smaller/ noisier datasets, use ReduceLROnPlateau monitoring val_loss with factor=0.5, patience=5 epochs, threshold=1e-4, cooldown=0, min_lr=1e-6; this is useful when validation correlation fluctuates due to measurement noise. If using ReduceLROnPlateau, disable cosine and keep a fixed lr during warmup then hand over to plateau schedule. For cosine, consider restarts only if training is long (>200 epochs), otherwise keep a single cycle for up to 100 epochs. Log the effective lr each epoch and ensure early stopping patience (10) exceeds scheduler patience (5) so the scheduler has time to act before stopping.",
          "training_configuration_and_early_stopping": "Use a maximum of epochs=100 with early stopping to prevent overfitting on motif-rich but noisy MPRA targets. Default batch_size=128 (fallback 64) and set num_workers=4–8 for data loading; use shuffle=True for training and deterministic=False for speed, while fixing random seeds for reproducibility. Early stopping should monitor val_pearson (preferred when the goal is ranking/relative prediction) with mode='max', patience=10, min_delta=1e-4; as a secondary criterion, also record val_loss and stop if both degrade for 10 epochs. When correlation is unstable due to small validation sets, switch monitor to val_loss with mode='min', patience=10, min_delta=1e-4. Use k-fold cross-validation (k=5) when dataset size is small (<5k sequences) or when the split-by-cluster constraint reduces effective validation size; aggregate by mean±std of Pearson and Spearman. Maintain a fixed evaluation suite: Pearson, Spearman, R2, and MAE on inverse-transformed targets; report also calibration plots (pred vs true) and residual vs GC content to detect systematic bias. Save best checkpoints by val_pearson and also last checkpoint; always evaluate test only once per model configuration to avoid implicit tuning on test.",
          "regularization_strategies": "Use dropout in the network body with a tunable range 0.1–0.5; set default dropout=0.2 for CNN blocks and 0.3 for attention/MLP heads, as attention models typically overfit more. Apply input dropout (a biologically plausible \"sequencing uncertainty\" proxy) by randomly masking 1–3% of positions per sequence (mask_prob=0.02) during training; implement as setting one-hot vector to all zeros (N) at masked positions. Additionally, apply channel dropout on one-hot channels with p=0.05 to simulate minor base-calling ambiguity without destroying motifs. Clarify L2 vs weight decay: for AdamW, use weight_decay=1e-4 as the primary L2-like regularizer (decoupled), and do not add an additional L2 penalty in the loss to avoid double-regularization; for SGD, weight_decay acts as classic L2. BatchNorm (if used) adds regularization; set BatchNorm momentum=0.1 and epsilon=1e-5 in CNN blocks, but consider removing BatchNorm for very small batch sizes (<=32) where statistics are noisy. Label smoothing is explicitly not used because this is regression; instead use robust losses (Huber) and augmentation for stability. If overfitting persists (train Pearson much higher than val), increase dropout by +0.1 and/or increase weight_decay to 3e-4; if underfitting, reduce dropout to 0.1 and weight_decay to 3e-5.",
          "prior_knowledge_integration_motifs_pwms": "Integrate biological priors by adding motif/PWM channels and auxiliary tasks that encourage the model to respect known TF binding logic. Precompute motif scan scores using a curated PWM set (e.g., JASPAR core vertebrates) and compute per-position log-likelihood ratio scores; feed as additional input channels M (e.g., top 32 motifs) alongside one-hot, producing an input tensor of shape (L, 4+M). Add an auxiliary head to predict motif presence/occupancy summary (e.g., max motif score per motif) from intermediate features, trained with MSE or BCE depending on label definition; weight this auxiliary loss λ_motif=0.05 to avoid overpowering expression regression. Use a \"motif attribution consistency\" regularizer: compute in-silico mutagenesis on a small subset each epoch (e.g., 128 sequences) and penalize cases where mutating high-scoring motif cores does not change prediction directionally; weight λ_consistency=0.01 to keep compute manageable. Constrain augmentations to preserve biological plausibility: if the assay is orientation-specific (promoter direction matters), do not use reverse-complement augmentation; if orientation-invariant enhancer assays, enable reverse-complement with probability 0.5 and enforce RC-consistency loss L_rc = mean((f(x)-f(RC(x)))^2) with weight 0.05. Use prior-guided initialization by including a first-layer convolution bank whose kernels are initialized from PWMs (convert PWM to log-odds and map to conv weights), then allow them to fine-tune with a smaller lr multiplier (e.g., 0.5× base lr) to retain interpretability. This approach is consistent with motif-centric interpretation practices described broadly in regulatory DL evaluation/interpretation toolkits (e.g., CREME focuses on perturbation-based motif logic extraction; knowledge base: Toneyan & Koo, 2024).",
          "data_augmentation": "Use augmentation that respects DNA biology and the MPRA experimental construct. If the assay design indicates orientation invariance (common for enhancer tiling without fixed promoter orientation), apply reverse-complement augmentation with p=0.5; otherwise set p=0.0 and rely on other augmentations. Apply small positional jitter when sequences contain flanks: randomly shift the window by up to ±5 bp (shift_max=5) and pad with 'N' at the ends; this helps the model become robust to slight boundary differences and synthesis artifacts. Apply random masking (as above) mask_prob=0.02 and optionally contiguous span masking with span_length=3 and span_prob=0.01 to simulate local errors and encourage distributed representations. Avoid arbitrary nucleotide substitution at high rates because it can destroy motifs; if used for robustness, keep mutation_rate<=0.005 (0.5% positions) and only outside known motif cores (based on PWM scan threshold, e.g., score > 8.0). For medium datasets (1k–10k), increase augmentation intensity slightly (mask_prob=0.03, shift_max=8) to reduce overfitting; for very large datasets (>100k), keep augmentation mild (mask_prob=0.01) and focus on QC/outlier handling as recommended by MPRA pipeline best-practice discussions (Rosen et al., 2025). If training includes CNN+attention, use stochastic depth (drop-path) with rate=0.1 in residual blocks as an additional augmentation-like regularizer.",
          "model_architectures_and_exact_parameters": "Baseline 1 (Linear k-mer): represent each sequence by counts of k-mers with k=6 (feature dim up to 4^6=4096, optionally reduce via hashing to 2048); train Ridge regression with alpha=1.0 and also ElasticNet with alpha=0.1, l1_ratio=0.1, both on transformed targets. Baseline 2 (Simple linear on GC/motif summaries): features = GC%, CpG count, max PWM scores for top 32 motifs; model = linear regression + HuberRegressor (epsilon=1.35) to quantify robustness. Model A (CNN): Input (L=200, C=4) -> Conv1D(64 filters, kernel=15, stride=1, padding='same') + BatchNorm + GELU + Dropout(0.2); then 3 residual blocks each: Conv1D(64, k=11) -> GELU -> Conv1D(64, k=11) with skip, Dropout(0.2); then MaxPool1D(pool=2) to length 100; then Conv1D(128, k=7) + GELU + Dropout(0.3); GlobalAveragePooling; MLP head: Dense(256) + GELU + Dropout(0.3) + Dense(1). Model B (CNN+Attention): same CNN stem up to length 100 and channels 128, then add 2 Transformer encoder blocks with d_model=128, n_heads=8, ff_dim=512, dropout=0.1, attention_dropout=0.1, layernorm eps=1e-5; then attention pooling (learned query) to a 128-d vector; MLP head Dense(256)->GELU->Dropout(0.3)->Dense(1). Initialize conv/linear weights with Xavier/Glorot uniform (gain=1.0) and set final layer bias to mean(y_train_transformed) to speed convergence. Estimated capacity targets: CNN ~1–3M params, CNN+Attention ~3–6M params; keep parameter count within this band to avoid overfitting on typical MPRA sizes. Train all neural models with identical optimizer/scheduler/early stopping for fair comparison, varying only architecture modules.",
          "hyperparameter_search_plan": "Run an executable Optuna study with 50 trials per architecture family (CNN and CNN+Attention separately) using the same train/val split and early stopping rules. Search space: lr ∈ [1e-4, 3e-3] log-uniform; weight_decay ∈ [1e-6, 3e-4] log-uniform; dropout ∈ [0.1, 0.5] uniform; kernel_size ∈ {7, 11, 15}; filters ∈ {64, 128}; num_res_blocks ∈ {2, 3, 4}; for attention models additionally search n_heads ∈ {4, 8}, n_layers ∈ {1, 2, 3}, ff_dim ∈ {256, 512, 768}, attention_dropout ∈ [0.0, 0.2]. Also tune Huber delta ∈ {0.5, 1.0, 1.5} on the transformed scale and λ_corr ∈ {0.0, 0.05, 0.1}; constrain total auxiliary weight (λ_corr+λ_rank+λ_motif) <= 0.2 to maintain regression focus. Use the objective as max(val_pearson) with a pruning strategy (MedianPruner) after 10 epochs to save compute; fix max_epochs=100 but rely on early stopping. Record trial-level metrics: best val_pearson, val_spearman, val_loss, and calibration slope; reject models with calibration slope outside [0.8, 1.2] even if correlation is high. After selecting top 3 trials, retrain each with 3 seeds and report mean±std to ensure robustness. This search plan is designed to be computationally feasible and aligned with MPRA regression goals, while controlling for overfitting via early stopping and regularization.",
          "training_pipeline_workflow_and_controls": "Step 1: Ingest raw MPRA counts (RNA/DNA per barcode), apply barcode QC (DNA>=10) and robust aggregation to element-level activity, consistent with knowledge-base emphasis on barcode-level modeling/outliers (Keukeleire et al., 2025). Step 2: Fit target transform on training only (z-score/robust/Yeo–Johnson) according to the skewness/outlier policy; store transformer for inverse mapping. Step 3: Build stratified splits by activity quantiles and by sequence cluster/parent to prevent leakage; lock splits for all experiments. Step 4: Train baselines first (k-mer ridge, motif summary linear/HuberRegressor) to set a sanity floor and detect data leakage; require that neural models beat baselines by at least +0.03 Pearson to justify complexity. Step 5: Train CNN and CNN+Attention with the shared recipe: AdamW(lr=1e-3, wd=1e-4), warmup_steps=500, cosine to min_lr=1e-6, batch_size=128, clip_norm=1.0, Huber(delta=1.0) + optional λ_corr=0.1; early stop on val_pearson with patience=10. Step 6: Run the experimental matrix and ablations: loss (MSE vs Huber), scheduler (cosine vs plateau), augmentation (none vs RC/jitter/mask), and priors (no motif channels vs motif channels + λ_motif=0.05). Step 7: Final evaluation on test with locked checkpoint selection rules; report Pearson/Spearman/R2/MAE and include interpretability checks via motif perturbation consistency (inspired by perturbation-based regulatory logic analysis tools like CREME; Toneyan & Koo, 2024). Step 8: Document all hyperparameters, random seeds, and transformations; export model cards and training curves for publication-grade reproducibility."
        }
      },
      "recommendations": [
        "Agree with using Huber as the default primary loss; set δ in standardized label units (e.g., δ=1.0 after train-set z-scoring) and keep plain MSE as an ablation for reporting robustness.",
        "If adding a Pearson-correlation auxiliary loss, apply guardrails: (i) use effective batch size ≥256 via gradient accumulation, (ii) compute correlation over a moving window or full-epoch predictions rather than per-mini-batch when feasible, and (iii) tune λ_corr in {0, 0.05, 0.1}; default to 0.05 or 0.0 if validation is unstable.",
        "Treat reverse-complement augmentation as OFF by default; enable only after confirming the assay/construct is strand-invariant. If uncertain, run an explicit ablation (RC p=0 vs 0.5) and select based on validation Pearson/Spearman and motif sanity checks.",
        "Adopt leakage-resistant splitting when sequences are variant libraries: perform clustering by edit distance / k-mer similarity and split by cluster; otherwise, keep stratified split by expression deciles as the baseline (as the Data Management Expert suggested).",
        "Incorporate motif/PWM knowledge primarily as (a) evaluation/interpretability (PWM extraction from first-layer filters; top-activation window alignment) and (b) optional regularization only if a trusted motif set exists for the experimental condition; avoid hard constraints that force motif presence/position unless the library design enforces it. This aligns with CNN-filter-to-PWM extraction practice and reduces bias risk.",
        "Use lightweight augmentations only (small substitution/masking rates) and down-weight augmented samples in the loss (e.g., 0.5) to limit label-noise amplification—consistent with the Data Management recommendations.",
        "Optimization defaults: AdamW, lr in {3e-4, 7e-4, 1e-3} depending on model size; weight_decay 1e-4 baseline and 3e-4 if overfitting; warmup 5% of steps; cosine decay or ReduceLROnPlateau; clip_norm=1.0; early stopping patience ~10–12 epochs.",
        "Explicitly branch the pipeline based on metadata: if only (seq, expr) are available, skip barcode-level QC and instead apply label winsorization/outlier flagging; if barcode counts become available later, add element-level aggregation with barcode trimming (top/bottom ratios) and minimum DNA/RNA thresholds.",
        "Support the Result Analyst’s emphasis on bootstrap CIs as the primary inference method for correlation differences; treat dependent-correlation tests (Steiger/Williams) as optional/secondary due to assumptions and rank ties."
      ],
      "retrieved_knowledge": [
        {
          "id": "289c49d0ab8509e2",
          "title": "SnailHeater",
          "content": "SnailHeater\n\n多功能焊台（T12/JBC245、烤箱回流焊、加热台、风枪、可调电源、简易双通道示波器、函数发生器、高精度PWM脉冲）",
          "source": "GitHub",
          "relevance_score": 0.5078
        },
        {
          "id": "46a98b85c5d33450",
          "title": "Statistical considerations for the analysis of massively parallel reporter assays data.",
          "content": "Analysis Toolset for MPRA (@MPRA), an R package for the design and analyses of MPRA experiments. It is publicly available at http://github.com/redaq/atMPRA.",
          "source": "PubMed",
          "relevance_score": 0.1296
        },
        {
          "id": "96c44521a93e1e50",
          "title": "Robust design of biological circuits: evolutionary systems biology approach.",
          "content": "Robust design of biological circuits: evolutionary systems biology approach.",
          "source": "PubMed",
          "relevance_score": 0.1288
        },
        {
          "id": "8dbddb133792021d",
          "title": "GOLDBAR: A Framework for Combinatorial Biological Design.",
          "content": "GOLDBAR: A Framework for Combinatorial Biological Design.",
          "source": "PubMed",
          "relevance_score": 0.128
        },
        {
          "id": "1df426e502a9cfc1",
          "title": "GenoCAD for iGEM: a grammatical approach to the design of standard-compliant constructs",
          "content": "been developed to model the structure of constructs compliant with six popular assembly standards. Its implementation in GenoCAD makes it possible for users to quickly assemble from a rich library of genetic parts, constructs compliant with any of six existing standards.",
          "source": "PMC",
          "relevance_score": 0.1274
        },
        {
          "id": "",
          "title": "",
          "content": "Gene regulation involves complex interactions between transcription factors. While early attempts to predict gene expression were trained using naturally occurring promoters, gigantic parallel reporter assays have vastly expanded potential training data. Despite this, it is still unclear how to best use deep learning to study gene regulation. Here, we investigate the association between promoters and expression using Camformer, a residual convolutional neural network that ranked fourth in the Ra",
          "source": "PMC",
          "relevance_score": 0.1494
        },
        {
          "id": "",
          "title": "",
          "content": "BACKGROUND: Massively parallel reporter assays (MPRAs) are an experimental technology for measuring the activity of thousands of candidate regulatory sequences or their variants in parallel, where the activity of individual sequences is measured from pools of sequence-tagged reporter genes. Activity is derived from the ratio of transcribed RNA to input DNA counts of associated tag sequences in each reporter construct, so-called barcodes. Recently, tools specifically designed to analyze MPRA data",
          "source": "PubMed",
          "relevance_score": 0.749
        },
        {
          "id": "",
          "title": "",
          "content": "A key challenge in differential abundance analysis of microbial samples is that the counts for each sample are compositional, resulting in biased comparisons of the absolute abundance across study groups. Normalization-based differential abundance analysis methods rely on external normalization factors that account for the compositionality by standardizing the counts onto a common numerical scale. However, existing normalization methods have struggled at maintaining the false discovery rate in s",
          "source": "arXiv",
          "relevance_score": 0.1513
        }
      ],
      "full_metadata": {
        "query": "Experimental design: 训练方法学：损失函数、优化器、正则化与超参搜索",
        "knowledge_results": 8,
        "retrieved_knowledge": [
          {
            "id": "289c49d0ab8509e2",
            "title": "SnailHeater",
            "content": "SnailHeater\n\n多功能焊台（T12/JBC245、烤箱回流焊、加热台、风枪、可调电源、简易双通道示波器、函数发生器、高精度PWM脉冲）",
            "source": "GitHub",
            "relevance_score": 0.5078
          },
          {
            "id": "46a98b85c5d33450",
            "title": "Statistical considerations for the analysis of massively parallel reporter assays data.",
            "content": "Analysis Toolset for MPRA (@MPRA), an R package for the design and analyses of MPRA experiments. It is publicly available at http://github.com/redaq/atMPRA.",
            "source": "PubMed",
            "relevance_score": 0.1296
          },
          {
            "id": "96c44521a93e1e50",
            "title": "Robust design of biological circuits: evolutionary systems biology approach.",
            "content": "Robust design of biological circuits: evolutionary systems biology approach.",
            "source": "PubMed",
            "relevance_score": 0.1288
          },
          {
            "id": "8dbddb133792021d",
            "title": "GOLDBAR: A Framework for Combinatorial Biological Design.",
            "content": "GOLDBAR: A Framework for Combinatorial Biological Design.",
            "source": "PubMed",
            "relevance_score": 0.128
          },
          {
            "id": "1df426e502a9cfc1",
            "title": "GenoCAD for iGEM: a grammatical approach to the design of standard-compliant constructs",
            "content": "been developed to model the structure of constructs compliant with six popular assembly standards. Its implementation in GenoCAD makes it possible for users to quickly assemble from a rich library of genetic parts, constructs compliant with any of six existing standards.",
            "source": "PMC",
            "relevance_score": 0.1274
          },
          {
            "id": "",
            "title": "",
            "content": "Gene regulation involves complex interactions between transcription factors. While early attempts to predict gene expression were trained using naturally occurring promoters, gigantic parallel reporter assays have vastly expanded potential training data. Despite this, it is still unclear how to best use deep learning to study gene regulation. Here, we investigate the association between promoters and expression using Camformer, a residual convolutional neural network that ranked fourth in the Ra",
            "source": "PMC",
            "relevance_score": 0.1494
          },
          {
            "id": "",
            "title": "",
            "content": "BACKGROUND: Massively parallel reporter assays (MPRAs) are an experimental technology for measuring the activity of thousands of candidate regulatory sequences or their variants in parallel, where the activity of individual sequences is measured from pools of sequence-tagged reporter genes. Activity is derived from the ratio of transcribed RNA to input DNA counts of associated tag sequences in each reporter construct, so-called barcodes. Recently, tools specifically designed to analyze MPRA data",
            "source": "PubMed",
            "relevance_score": 0.749
          },
          {
            "id": "",
            "title": "",
            "content": "A key challenge in differential abundance analysis of microbial samples is that the counts for each sample are compositional, resulting in biased comparisons of the absolute abundance across study groups. Normalization-based differential abundance analysis methods rely on external normalization factors that account for the compositionality by standardizing the counts onto a common numerical scale. However, existing normalization methods have struggled at maintaining the false discovery rate in s",
            "source": "arXiv",
            "relevance_score": 0.1513
          }
        ],
        "model": "gpt-5.2",
        "design_summary": "This experimental plan specifies an end-to-end, reproducible training methodology for sequence-to-continuous expression (MPRA activity) regression, emphasizing robustness to outliers and strong biological validity. The pipeline begins with MPRA-aware preprocessing (barcode-level QC, RNA/DNA ratio-derived targets) and explicit target transformations that adapt to skewness and negative values. The training objective uses a robust main loss (Huber) with optional correlation/ranking auxiliary losses to align optimization with evaluation metrics like Pearson/Spearman. Optimization is centered on AdamW with explicit hyperparameters, gradient clipping, warmup, and either cosine annealing or plateau-based scheduling to stabilize training across model capacities. Regularization combines weight decay, dropout (including input dropout/random masking), and careful early stopping; label smoothing is explicitly excluded as it is not appropriate for regression. The model comparison matrix includes interpretable baselines (linear/k-mer), a CNN, and a CNN+attention model, all trained under the same recipe for fair comparison. Prior knowledge is integrated via motif/PWM-based auxiliary supervision and constrained augmentations (e.g., reverse-complement where appropriate), improving sample efficiency especially in medium-sized MPRA datasets.",
        "detailed_design": {
          "design_recommendations": {
            "dataset_characteristics_and_preprocessing": "This task targets MPRA-style regression where each sequence has an activity derived from barcode RNA and DNA counts (often using log(RNA/DNA) or model-based transcription rate estimates), and such assays are known to exhibit barcode-level outliers and technical variability. Literature on MPRA analysis highlights that tools modeling barcode counts (e.g., MPRAnalyze / mpralm variants) address inherent variation and outlier sensitivity, and newer frameworks emphasize barcode sequence bias and outlier barcodes as major technical factors; therefore, preprocessing should include barcode QC and robust aggregation (Keukeleire et al., 2025; Rosen et al., 2025 from the knowledge base). Assume a typical MPRA dataset size is medium-to-large (1e4–1e5 sequences) with fixed oligo length (commonly 150–230 bp plus adapters); if length varies, pad/trim to a fixed L (recommended L=200) and track true-length masks for attention layers. Perform barcode filtering: remove barcodes with DNA counts < 10 (or < 20 for stricter QC) and optionally trim the top 0.5–1% barcodes by RNA/DNA ratio per element as outliers; then aggregate per element by median-of-barcodes or robust mean (Huber mean) to reduce influence of extreme barcodes. Use train/val/test splits that prevent leakage from highly similar sequence variants (e.g., allelic pairs or designed mutational neighborhoods): split by \"parent element\" or edit distance clusters when available, to avoid inflated correlations. Finally, standardize input encoding as one-hot (A,C,G,T plus N=all zeros) with optional additional channels (e.g., GC content track or positional prior track) kept fixed across models for controlled comparisons.",
            "target_transformation_policy": "Because MPRA activity can be negative (e.g., log fold-change below baseline) and often heavy-tailed, define a conditional target transform policy that is data-driven and reversible for reporting. Compute skewness on the training targets; if absolute skewness > 1.0, enable a power transform (Yeo–Johnson) fitted on training only, because it handles zeros and negative values unlike Box–Cox. If absolute skewness <= 1.0, default to z-score standardization (y_z = (y - mean_train) / std_train) for stable optimization and comparability across experiments. If strong outliers are present (e.g., >2% of points beyond 3×IQR), use RobustScaler (center=median, scale=IQR) instead of z-score to reduce sensitivity; this is particularly relevant given known barcode-level outliers in MPRA pipelines (Keukeleire et al., 2025). Explicit negative-value handling: do not clamp negatives; instead, preserve sign and use Yeo–Johnson when skewness triggers or RobustScaler when outlier fraction triggers. For reporting, always invert the transform back to the original scale for MAE/MSE on the raw units, and also report correlation on raw and transformed scales to ensure interpretability. Log1p transforms are not recommended unless the target is strictly non-negative count-derived (rare after log(RNA/DNA)); if used, only enable when min(y) >= 0 and skewness > 1.0, with epsilon=1e-3.",
            "loss_functions": "Use Huber loss as the default main loss to be robust to heavy-tailed errors and outliers typical in MPRA measurements (barcode-level variability and occasional extreme activities), while still behaving like MSE near zero error. Set Huber delta (\"transition\") explicitly to delta=1.0 on the standardized target scale; if using RobustScaler, set delta=1.5 to account for the smaller effective scale of IQR normalization. Define the primary loss as L_main = Huber(y_pred, y_true; delta), averaged over the batch. Optionally add a correlation-alignment auxiliary loss to better match evaluation metrics: L_corr = 1 - PearsonCorr(y_pred, y_true) computed within-batch (with batch_size >= 64), then use total loss L = L_main + λ_corr * L_corr with λ_corr=0.1. If rank consistency is a key goal (e.g., selecting top enhancers), add a pairwise ranking loss on within-batch pairs: L_rank = mean(log(1 + exp(-(y_pred_i - y_pred_j) * sign(y_true_i - y_true_j)))) sampled from 256 random pairs per batch; weight it λ_rank=0.05, and keep λ_corr=0.05 when both auxiliaries are enabled. For ablations, compare MSE as baseline (L_main = MSE) to quantify gains from robustness; expect Huber to reduce sensitivity to outlier barcodes/elements and stabilize early stopping. Ensure loss is computed on transformed targets, while metrics (Pearson/Spearman/R2) are computed on inverse-transformed predictions for interpretability.",
            "optimizer_and_hyperparameters": "Use AdamW as the default optimizer for all neural models due to its stability on one-hot sequence inputs and compatibility with weight decay decoupling. Set AdamW hyperparameters explicitly: lr=1e-3 (starting), betas=(0.9, 0.999), eps=1e-8, weight_decay=1e-4; these values are a strong default for CNN/attention models on MPRA-scale regression. Apply gradient clipping to prevent rare large gradients from destabilizing training, using clip_norm=1.0 (global norm). Use mixed precision (fp16/bf16) only if it does not change numerical stability of Pearson auxiliary loss; if enabled, compute correlation loss in fp32. As a classical comparator, run SGD+momentum on CNN models: lr=0.05, momentum=0.9, weight_decay=5e-4, Nesterov=True; this acts as an optimizer ablation to show whether adaptive methods are needed. Use EMA of weights (optional) with decay=0.999 to stabilize validation correlation, especially for CNN+attention. For batch sizes, use 128 as default on GPU memory permitting; if sequences are long or attention is heavy, reduce to 64 and compensate with gradient accumulation steps=2 to keep an effective batch of 128.",
            "learning_rate_schedule_and_warmup": "Adopt a warmup phase to avoid early training instability when using AdamW and potentially correlation/ranking auxiliary losses. Set warmup_steps=500 (or warmup_ratio=0.05 if total_steps is small), linearly increasing lr from 1e-5 to the base lr (1e-3). After warmup, use CosineAnnealingLR down to min_lr=1e-6 over the remaining steps; cosine works well for large sequence datasets and reduces the need for manual plateau tuning. As an alternative scheduler for smaller/ noisier datasets, use ReduceLROnPlateau monitoring val_loss with factor=0.5, patience=5 epochs, threshold=1e-4, cooldown=0, min_lr=1e-6; this is useful when validation correlation fluctuates due to measurement noise. If using ReduceLROnPlateau, disable cosine and keep a fixed lr during warmup then hand over to plateau schedule. For cosine, consider restarts only if training is long (>200 epochs), otherwise keep a single cycle for up to 100 epochs. Log the effective lr each epoch and ensure early stopping patience (10) exceeds scheduler patience (5) so the scheduler has time to act before stopping.",
            "training_configuration_and_early_stopping": "Use a maximum of epochs=100 with early stopping to prevent overfitting on motif-rich but noisy MPRA targets. Default batch_size=128 (fallback 64) and set num_workers=4–8 for data loading; use shuffle=True for training and deterministic=False for speed, while fixing random seeds for reproducibility. Early stopping should monitor val_pearson (preferred when the goal is ranking/relative prediction) with mode='max', patience=10, min_delta=1e-4; as a secondary criterion, also record val_loss and stop if both degrade for 10 epochs. When correlation is unstable due to small validation sets, switch monitor to val_loss with mode='min', patience=10, min_delta=1e-4. Use k-fold cross-validation (k=5) when dataset size is small (<5k sequences) or when the split-by-cluster constraint reduces effective validation size; aggregate by mean±std of Pearson and Spearman. Maintain a fixed evaluation suite: Pearson, Spearman, R2, and MAE on inverse-transformed targets; report also calibration plots (pred vs true) and residual vs GC content to detect systematic bias. Save best checkpoints by val_pearson and also last checkpoint; always evaluate test only once per model configuration to avoid implicit tuning on test.",
            "regularization_strategies": "Use dropout in the network body with a tunable range 0.1–0.5; set default dropout=0.2 for CNN blocks and 0.3 for attention/MLP heads, as attention models typically overfit more. Apply input dropout (a biologically plausible \"sequencing uncertainty\" proxy) by randomly masking 1–3% of positions per sequence (mask_prob=0.02) during training; implement as setting one-hot vector to all zeros (N) at masked positions. Additionally, apply channel dropout on one-hot channels with p=0.05 to simulate minor base-calling ambiguity without destroying motifs. Clarify L2 vs weight decay: for AdamW, use weight_decay=1e-4 as the primary L2-like regularizer (decoupled), and do not add an additional L2 penalty in the loss to avoid double-regularization; for SGD, weight_decay acts as classic L2. BatchNorm (if used) adds regularization; set BatchNorm momentum=0.1 and epsilon=1e-5 in CNN blocks, but consider removing BatchNorm for very small batch sizes (<=32) where statistics are noisy. Label smoothing is explicitly not used because this is regression; instead use robust losses (Huber) and augmentation for stability. If overfitting persists (train Pearson much higher than val), increase dropout by +0.1 and/or increase weight_decay to 3e-4; if underfitting, reduce dropout to 0.1 and weight_decay to 3e-5.",
            "prior_knowledge_integration_motifs_pwms": "Integrate biological priors by adding motif/PWM channels and auxiliary tasks that encourage the model to respect known TF binding logic. Precompute motif scan scores using a curated PWM set (e.g., JASPAR core vertebrates) and compute per-position log-likelihood ratio scores; feed as additional input channels M (e.g., top 32 motifs) alongside one-hot, producing an input tensor of shape (L, 4+M). Add an auxiliary head to predict motif presence/occupancy summary (e.g., max motif score per motif) from intermediate features, trained with MSE or BCE depending on label definition; weight this auxiliary loss λ_motif=0.05 to avoid overpowering expression regression. Use a \"motif attribution consistency\" regularizer: compute in-silico mutagenesis on a small subset each epoch (e.g., 128 sequences) and penalize cases where mutating high-scoring motif cores does not change prediction directionally; weight λ_consistency=0.01 to keep compute manageable. Constrain augmentations to preserve biological plausibility: if the assay is orientation-specific (promoter direction matters), do not use reverse-complement augmentation; if orientation-invariant enhancer assays, enable reverse-complement with probability 0.5 and enforce RC-consistency loss L_rc = mean((f(x)-f(RC(x)))^2) with weight 0.05. Use prior-guided initialization by including a first-layer convolution bank whose kernels are initialized from PWMs (convert PWM to log-odds and map to conv weights), then allow them to fine-tune with a smaller lr multiplier (e.g., 0.5× base lr) to retain interpretability. This approach is consistent with motif-centric interpretation practices described broadly in regulatory DL evaluation/interpretation toolkits (e.g., CREME focuses on perturbation-based motif logic extraction; knowledge base: Toneyan & Koo, 2024).",
            "data_augmentation": "Use augmentation that respects DNA biology and the MPRA experimental construct. If the assay design indicates orientation invariance (common for enhancer tiling without fixed promoter orientation), apply reverse-complement augmentation with p=0.5; otherwise set p=0.0 and rely on other augmentations. Apply small positional jitter when sequences contain flanks: randomly shift the window by up to ±5 bp (shift_max=5) and pad with 'N' at the ends; this helps the model become robust to slight boundary differences and synthesis artifacts. Apply random masking (as above) mask_prob=0.02 and optionally contiguous span masking with span_length=3 and span_prob=0.01 to simulate local errors and encourage distributed representations. Avoid arbitrary nucleotide substitution at high rates because it can destroy motifs; if used for robustness, keep mutation_rate<=0.005 (0.5% positions) and only outside known motif cores (based on PWM scan threshold, e.g., score > 8.0). For medium datasets (1k–10k), increase augmentation intensity slightly (mask_prob=0.03, shift_max=8) to reduce overfitting; for very large datasets (>100k), keep augmentation mild (mask_prob=0.01) and focus on QC/outlier handling as recommended by MPRA pipeline best-practice discussions (Rosen et al., 2025). If training includes CNN+attention, use stochastic depth (drop-path) with rate=0.1 in residual blocks as an additional augmentation-like regularizer.",
            "model_architectures_and_exact_parameters": "Baseline 1 (Linear k-mer): represent each sequence by counts of k-mers with k=6 (feature dim up to 4^6=4096, optionally reduce via hashing to 2048); train Ridge regression with alpha=1.0 and also ElasticNet with alpha=0.1, l1_ratio=0.1, both on transformed targets. Baseline 2 (Simple linear on GC/motif summaries): features = GC%, CpG count, max PWM scores for top 32 motifs; model = linear regression + HuberRegressor (epsilon=1.35) to quantify robustness. Model A (CNN): Input (L=200, C=4) -> Conv1D(64 filters, kernel=15, stride=1, padding='same') + BatchNorm + GELU + Dropout(0.2); then 3 residual blocks each: Conv1D(64, k=11) -> GELU -> Conv1D(64, k=11) with skip, Dropout(0.2); then MaxPool1D(pool=2) to length 100; then Conv1D(128, k=7) + GELU + Dropout(0.3); GlobalAveragePooling; MLP head: Dense(256) + GELU + Dropout(0.3) + Dense(1). Model B (CNN+Attention): same CNN stem up to length 100 and channels 128, then add 2 Transformer encoder blocks with d_model=128, n_heads=8, ff_dim=512, dropout=0.1, attention_dropout=0.1, layernorm eps=1e-5; then attention pooling (learned query) to a 128-d vector; MLP head Dense(256)->GELU->Dropout(0.3)->Dense(1). Initialize conv/linear weights with Xavier/Glorot uniform (gain=1.0) and set final layer bias to mean(y_train_transformed) to speed convergence. Estimated capacity targets: CNN ~1–3M params, CNN+Attention ~3–6M params; keep parameter count within this band to avoid overfitting on typical MPRA sizes. Train all neural models with identical optimizer/scheduler/early stopping for fair comparison, varying only architecture modules.",
            "hyperparameter_search_plan": "Run an executable Optuna study with 50 trials per architecture family (CNN and CNN+Attention separately) using the same train/val split and early stopping rules. Search space: lr ∈ [1e-4, 3e-3] log-uniform; weight_decay ∈ [1e-6, 3e-4] log-uniform; dropout ∈ [0.1, 0.5] uniform; kernel_size ∈ {7, 11, 15}; filters ∈ {64, 128}; num_res_blocks ∈ {2, 3, 4}; for attention models additionally search n_heads ∈ {4, 8}, n_layers ∈ {1, 2, 3}, ff_dim ∈ {256, 512, 768}, attention_dropout ∈ [0.0, 0.2]. Also tune Huber delta ∈ {0.5, 1.0, 1.5} on the transformed scale and λ_corr ∈ {0.0, 0.05, 0.1}; constrain total auxiliary weight (λ_corr+λ_rank+λ_motif) <= 0.2 to maintain regression focus. Use the objective as max(val_pearson) with a pruning strategy (MedianPruner) after 10 epochs to save compute; fix max_epochs=100 but rely on early stopping. Record trial-level metrics: best val_pearson, val_spearman, val_loss, and calibration slope; reject models with calibration slope outside [0.8, 1.2] even if correlation is high. After selecting top 3 trials, retrain each with 3 seeds and report mean±std to ensure robustness. This search plan is designed to be computationally feasible and aligned with MPRA regression goals, while controlling for overfitting via early stopping and regularization.",
            "training_pipeline_workflow_and_controls": "Step 1: Ingest raw MPRA counts (RNA/DNA per barcode), apply barcode QC (DNA>=10) and robust aggregation to element-level activity, consistent with knowledge-base emphasis on barcode-level modeling/outliers (Keukeleire et al., 2025). Step 2: Fit target transform on training only (z-score/robust/Yeo–Johnson) according to the skewness/outlier policy; store transformer for inverse mapping. Step 3: Build stratified splits by activity quantiles and by sequence cluster/parent to prevent leakage; lock splits for all experiments. Step 4: Train baselines first (k-mer ridge, motif summary linear/HuberRegressor) to set a sanity floor and detect data leakage; require that neural models beat baselines by at least +0.03 Pearson to justify complexity. Step 5: Train CNN and CNN+Attention with the shared recipe: AdamW(lr=1e-3, wd=1e-4), warmup_steps=500, cosine to min_lr=1e-6, batch_size=128, clip_norm=1.0, Huber(delta=1.0) + optional λ_corr=0.1; early stop on val_pearson with patience=10. Step 6: Run the experimental matrix and ablations: loss (MSE vs Huber), scheduler (cosine vs plateau), augmentation (none vs RC/jitter/mask), and priors (no motif channels vs motif channels + λ_motif=0.05). Step 7: Final evaluation on test with locked checkpoint selection rules; report Pearson/Spearman/R2/MAE and include interpretability checks via motif perturbation consistency (inspired by perturbation-based regulatory logic analysis tools like CREME; Toneyan & Koo, 2024). Step 8: Document all hyperparameters, random seeds, and transformations; export model cards and training curves for publication-grade reproducibility."
          }
        },
        "discussion_notes": "The other experts’ opinions are largely consistent with the existing methodology. The main corrections are to (1) constrain correlation-based auxiliary losses because they are batch-statistics-sensitive, (2) tighten biological assumptions around reverse-complement invariance (default OFF, ablation-gated), and (3) explicitly condition MPRA-specific QC steps on the availability of barcode/replicate metadata since the described dataset appears to only contain sequence and a single aggregated expression value. The retrieved Proformer paper highlights the importance of strand embedding and specialized heads to stabilize training on smaller datasets, reinforcing the need for strand-awareness and stabilization strategies rather than assuming RC invariance (Kwak et al., 2024; PMC, doi:10.1186/s12859-024-05645-5). MPRAdecoder underscores that barcode-level processing is a distinct pipeline stage when raw MPRA data are available, supporting our recommendation to branch methodology by metadata availability (Letiagina et al., 2021; PMC, doi:10.3389/fgene.2021.618189).",
        "updated_after_discussion": true
      }
    },
    "model_architect": {
      "score": 9.1,
      "design_summary": "This plan targets MPRA-style sequence-to-activity regression with ~5.9k labeled samples, which falls in the medium-data regime (1K–10K). Given this scale and the supervisor constraint (avoid oversized Transformers), the core modeling choice is a multi-scale 1D-CNN backbone with strong regularization and only lightweight attention (SE or small MHA) to capture limited long-range dependencies. I assume a fixed sequence length L derived from dataset statistics; in typical MPRA designs L is constant by construction, but if small variability exists, sequences should be padded/truncated to the chosen L and masked only if attention is used. Two architectures are proposed: (A) a compact baseline CNN regressor (<1M parameters) for robust training and as an ablation anchor, and (B) an improved multi-scale residual CNN with SE and a light self-attention block (1M–5M parameters) to increase expressiveness without overfitting. Both models use global average pooling to reduce sensitivity to position and to keep parameter counts low, and both use explicit interpretability hooks (first-layer motif PWMs, saliency/Integrated Gradients, and in silico mutagenesis). The interpretability plan is aligned with literature patterns that “un-box” sequence-to-function models using convolutional filters, attention maps, and in silico mutagenesis (e.g., the STORM/NuSpeak framework) and with standard IG-based feature attribution practices highlighted in recent XAI sequence studies retrieved from the knowledge base.",
      "implementation_plan": {
        "design_recommendations": "Dataset characterization and fixed-length selection: The dataset is MPRA-like (sequence paired with a quantitative activity), implying input is a one-hot encoded DNA sequence of shape (batch, L, 4) and a scalar regression target (often log-transformed activity). With ~5.9k samples, this is a medium dataset, so the model should be moderately expressive but still heavily regularized; a large vanilla Transformer would likely overfit and is computationally wasteful. The fixed length L should be chosen from data statistics: set L to the median/most common length if sequences are mostly uniform; if there is a distribution, select L = 95th percentile length and pad shorter sequences with Ns encoded as all-zeros (or uniform 0.25 if you prefer), and truncate longer sequences centrally or from flanks depending on assay design. Preprocessing should include: (i) one-hot encoding with consistent A/C/G/T ordering, (ii) target normalization (z-score on training set or log1p then z-score), (iii) train/val/test split stratified by GC-content or activity quantiles to reduce distribution shift, and (iv) mild augmentation appropriate for MPRA such as reverse-complement augmentation at 50% probability if the assay is strand-invariant (otherwise disable). Training defaults (both models): AdamW optimizer (lr=1e-3 for baseline, lr=7e-4 for improved), weight_decay=1e-4, batch_size=64 (or 128 if GPU allows), epochs=100 with early stopping patience=12 on validation Pearson/Spearman and MSE, gradient clipping at 1.0, and cosine LR schedule with 5-epoch warmup (warmup_lr_start=1e-5). Evaluation metrics: report Pearson r, Spearman ρ, MSE, and R2 on held-out test; for MPRA it is common to emphasize rank correlation and replicate-consistency if replicates exist. Interpretability is mandatory: follow the spirit of prior sequence-to-function work that uses convolutional filters, attention maps, and in silico mutagenesis to understand learned motifs and dependencies (PMC: sequence-to-function frameworks for engineered riboregulators) and use IG/saliency settings as specified below."
      },
      "recommendations": [
        "Agree with Data Management: finalize L from full-file length stats (mode or P95 rounded to multiple of 8) and explicitly compare center-crop vs left-anchored crop; do not assume a TSS anchor exists without metadata.",
        "Agree with Methodology/Result Analyst: add a leakage-resistant evaluation option—cluster sequences by edit distance (threshold 5–10) and perform a second CV run to quantify sensitivity of Pearson/Spearman to leakage.",
        "Architecture correction/clarification: gate self-attention behind downsampling so token length ≤ L/8 (or ≤256 tokens). If L>1024, use only dilated residual CNN + SE until length is reduced (pool/strided conv), then optional 2–4 head MHA with small d_model (128–256).",
        "Parameter control strategy: target ~0.5–1.0M params for the baseline and ~1.5–3.5M for the enhanced model at N≈5.9k; increase capacity only if repeated-CV variance is low and train–val gap is small. Prefer widening channels modestly over adding many layers.",
        "Interpretability enhancement: in addition to IG/ISM, include a constrained interaction probe (CREME-style perturbation tests) on a small, fixed subset (e.g., 256–512 sequences) to identify motif–motif interaction rules while keeping compute manageable (PMC doc_id: 18f7db2839e5abe5).",
        "Operationalize RC uncertainty: run two training ablations—RC=off and RC=0.5—report both; choose based on validation under the biologically correct orientation assumption.",
        "Efficiency: implement mixed precision, gradient checkpointing only if needed, and batch IG/ISM computations; predefine an ISM budget (e.g., top 500 test sequences) to avoid runaway runtime."
      ],
      "retrieved_knowledge": [
        {
          "id": "46a98b85c5d33450",
          "title": "Statistical considerations for the analysis of massively parallel reporter assays data.",
          "content": "Analysis Toolset for MPRA (@MPRA), an R package for the design and analyses of MPRA experiments. It is publicly available at http://github.com/redaq/atMPRA.",
          "source": "PubMed",
          "relevance_score": 0.3611
        },
        {
          "id": "289c49d0ab8509e2",
          "title": "SnailHeater",
          "content": "SnailHeater\n\n多功能焊台（T12/JBC245、烤箱回流焊、加热台、风枪、可调电源、简易双通道示波器、函数发生器、高精度PWM脉冲）",
          "source": "GitHub",
          "relevance_score": 0.2783
        },
        {
          "id": "3f5f453a68d61113",
          "title": "Optimizing sequence design strategies for perturbation MPRAs: a computational evaluation framework.",
          "content": "Optimizing sequence design strategies for perturbation MPRAs: a computational evaluation framework.",
          "source": "PubMed",
          "relevance_score": 0.1414
        },
        {
          "id": "51febf8054037101",
          "title": "esMPRA: an easy-to-use systematic pipeline for MPRA experiment quality control and data analysis.",
          "content": "esMPRA: an easy-to-use systematic pipeline for MPRA experiment quality control and data analysis.",
          "source": "PubMed",
          "relevance_score": 0.1352
        },
        {
          "id": "9156dd406f5d5a31",
          "title": "PINNs-based-MPC",
          "content": "PINNs-based-MPC",
          "source": "GitHub",
          "relevance_score": 0.1309
        },
        {
          "id": "",
          "title": "",
          "content": "ESM-2 is used for embedding the protein sequences followed by convolutional neural network (CNN). Subsequently multi-head self-attention mechanism is applied for the contextual information while label-aware attention is used to compute class-specific representations by attending to the sequence in a way that is tailored to each label (DBP, RBP and non-NABP) in a multi-label setup. We have also included a novel cross-label attention mechanism to explicitly capture dependencies between DNA- and RN",
          "source": "arXiv",
          "relevance_score": 0.1844
        },
        {
          "id": "",
          "title": "",
          "content": "While synthetic biology has revolutionized our approaches to medicine, agriculture, and energy, the design of completely novel biological circuit components beyond naturally-derived templates remains challenging due to poorly understood design rules. Toehold switches, which are programmable nucleic acid sensors, face an analogous design bottleneck; our limited understanding of how sequence impacts functionality often necessitates expensive, time-consuming screens to identify effective switches. ",
          "source": "PMC",
          "relevance_score": 0.169
        }
      ],
      "full_metadata": {
        "query": "Experimental design: 模型架构设计：适配~5.9k MPRA样本的序列回归网络",
        "knowledge_results": 7,
        "retrieved_knowledge": [
          {
            "id": "46a98b85c5d33450",
            "title": "Statistical considerations for the analysis of massively parallel reporter assays data.",
            "content": "Analysis Toolset for MPRA (@MPRA), an R package for the design and analyses of MPRA experiments. It is publicly available at http://github.com/redaq/atMPRA.",
            "source": "PubMed",
            "relevance_score": 0.3611
          },
          {
            "id": "289c49d0ab8509e2",
            "title": "SnailHeater",
            "content": "SnailHeater\n\n多功能焊台（T12/JBC245、烤箱回流焊、加热台、风枪、可调电源、简易双通道示波器、函数发生器、高精度PWM脉冲）",
            "source": "GitHub",
            "relevance_score": 0.2783
          },
          {
            "id": "3f5f453a68d61113",
            "title": "Optimizing sequence design strategies for perturbation MPRAs: a computational evaluation framework.",
            "content": "Optimizing sequence design strategies for perturbation MPRAs: a computational evaluation framework.",
            "source": "PubMed",
            "relevance_score": 0.1414
          },
          {
            "id": "51febf8054037101",
            "title": "esMPRA: an easy-to-use systematic pipeline for MPRA experiment quality control and data analysis.",
            "content": "esMPRA: an easy-to-use systematic pipeline for MPRA experiment quality control and data analysis.",
            "source": "PubMed",
            "relevance_score": 0.1352
          },
          {
            "id": "9156dd406f5d5a31",
            "title": "PINNs-based-MPC",
            "content": "PINNs-based-MPC",
            "source": "GitHub",
            "relevance_score": 0.1309
          },
          {
            "id": "",
            "title": "",
            "content": "ESM-2 is used for embedding the protein sequences followed by convolutional neural network (CNN). Subsequently multi-head self-attention mechanism is applied for the contextual information while label-aware attention is used to compute class-specific representations by attending to the sequence in a way that is tailored to each label (DBP, RBP and non-NABP) in a multi-label setup. We have also included a novel cross-label attention mechanism to explicitly capture dependencies between DNA- and RN",
            "source": "arXiv",
            "relevance_score": 0.1844
          },
          {
            "id": "",
            "title": "",
            "content": "While synthetic biology has revolutionized our approaches to medicine, agriculture, and energy, the design of completely novel biological circuit components beyond naturally-derived templates remains challenging due to poorly understood design rules. Toehold switches, which are programmable nucleic acid sensors, face an analogous design bottleneck; our limited understanding of how sequence impacts functionality often necessitates expensive, time-consuming screens to identify effective switches. ",
            "source": "PMC",
            "relevance_score": 0.169
          }
        ],
        "model": "gpt-5.2",
        "design_summary": "This plan targets MPRA-style sequence-to-activity regression with ~5.9k labeled samples, which falls in the medium-data regime (1K–10K). Given this scale and the supervisor constraint (avoid oversized Transformers), the core modeling choice is a multi-scale 1D-CNN backbone with strong regularization and only lightweight attention (SE or small MHA) to capture limited long-range dependencies. I assume a fixed sequence length L derived from dataset statistics; in typical MPRA designs L is constant by construction, but if small variability exists, sequences should be padded/truncated to the chosen L and masked only if attention is used. Two architectures are proposed: (A) a compact baseline CNN regressor (<1M parameters) for robust training and as an ablation anchor, and (B) an improved multi-scale residual CNN with SE and a light self-attention block (1M–5M parameters) to increase expressiveness without overfitting. Both models use global average pooling to reduce sensitivity to position and to keep parameter counts low, and both use explicit interpretability hooks (first-layer motif PWMs, saliency/Integrated Gradients, and in silico mutagenesis). The interpretability plan is aligned with literature patterns that “un-box” sequence-to-function models using convolutional filters, attention maps, and in silico mutagenesis (e.g., the STORM/NuSpeak framework) and with standard IG-based feature attribution practices highlighted in recent XAI sequence studies retrieved from the knowledge base.",
        "detailed_design": {
          "design_recommendations": "Dataset characterization and fixed-length selection: The dataset is MPRA-like (sequence paired with a quantitative activity), implying input is a one-hot encoded DNA sequence of shape (batch, L, 4) and a scalar regression target (often log-transformed activity). With ~5.9k samples, this is a medium dataset, so the model should be moderately expressive but still heavily regularized; a large vanilla Transformer would likely overfit and is computationally wasteful. The fixed length L should be chosen from data statistics: set L to the median/most common length if sequences are mostly uniform; if there is a distribution, select L = 95th percentile length and pad shorter sequences with Ns encoded as all-zeros (or uniform 0.25 if you prefer), and truncate longer sequences centrally or from flanks depending on assay design. Preprocessing should include: (i) one-hot encoding with consistent A/C/G/T ordering, (ii) target normalization (z-score on training set or log1p then z-score), (iii) train/val/test split stratified by GC-content or activity quantiles to reduce distribution shift, and (iv) mild augmentation appropriate for MPRA such as reverse-complement augmentation at 50% probability if the assay is strand-invariant (otherwise disable). Training defaults (both models): AdamW optimizer (lr=1e-3 for baseline, lr=7e-4 for improved), weight_decay=1e-4, batch_size=64 (or 128 if GPU allows), epochs=100 with early stopping patience=12 on validation Pearson/Spearman and MSE, gradient clipping at 1.0, and cosine LR schedule with 5-epoch warmup (warmup_lr_start=1e-5). Evaluation metrics: report Pearson r, Spearman ρ, MSE, and R2 on held-out test; for MPRA it is common to emphasize rank correlation and replicate-consistency if replicates exist. Interpretability is mandatory: follow the spirit of prior sequence-to-function work that uses convolutional filters, attention maps, and in silico mutagenesis to understand learned motifs and dependencies (PMC: sequence-to-function frameworks for engineered riboregulators) and use IG/saliency settings as specified below."
        },
        "discussion_notes": "Overall, the other experts’ opinions are consistent with my original architecture stance: medium-size data favors a regularized CNN-first design with carefully limited attention. I agree strongly with (i) stratified/robust splitting and outlier handling, (ii) treating reverse-complement augmentation as an explicit ablation due to potential strand-specific MPRA designs, and (iii) leakage controls via edit-distance clustering. I supplemented my analysis with literature support that CNN-based MPRA predictors are a proven baseline (Movva et al., 2019; PubMed doc_id: 714ecddbaa180dee) and that modern perturbation toolkits (CREME; PMC doc_id: 18f7db2839e5abe5) can extend interpretability beyond simple motif attribution. The main correction is to hard-gate attention behind downsampling/token-length thresholds and to more explicitly bound interpretability compute.",
        "updated_after_discussion": true
      }
    },
    "result_analyst": {
      "score": 9.3,
      "design_summary": "This evaluation plan targets an MPRA expression regression task and is designed to be fully comparable, reproducible, and statistically rigorous across models. The core performance suite includes Pearson r, Spearman ρ, R^2, and MSE/MAE, with Pearson r on the held-out test set explicitly defined as the primary metric for model ranking. The plan combines a single fixed hold-out split (for a final, untouched test) with 5-fold cross-validation on the remaining data to quantify robustness; all results are reported as mean ± standard deviation across folds and repeated with fixed random seeds. Statistical testing focuses on pairwise model comparisons via bootstrap confidence intervals for correlation metrics and, where applicable, dependent-correlation tests (e.g., Steiger/Williams) because predictions share the same ground-truth labels. Error analysis is stratified by expression quantiles (10 bins) to expose performance heterogeneity, and includes residual distribution and heteroscedasticity diagnostics to detect systematic biases typical of MPRA-derived signals. Biological interpretability is enforced through motif/k-mer extraction from high-prediction sequences, in silico mutagenesis (ISM) importance summarization with uncertainty estimates, and an optional targeted enrichment test over predefined E. coli promoter elements (-10/-35 boxes) to check mechanistic plausibility. The reporting format is a strict checklist plus parameter table, and a standardized set of tables/figures so that all future experiments can be compared directly; MPRA-specific QC principles are aligned with MPRA analysis toolkits/pipelines discussed in the literature (e.g., esMPRA stepwise monitoring/QC concepts and MPRA-focused statistical considerations in @MPRA).",
      "implementation_plan": {
        "design_recommendations": "1) Dataset characterization and preprocessing implications (regression MPRA context): Treat the dataset as MPRA-derived continuous expression, typically computed from RNA/DNA barcode count ratios; therefore, define and freeze a single target transformation before any splitting (recommend: log2(RNA/DNA + 1e-6) followed by z-score within experiment/batch if multiple batches). Before modeling, quantify sequence length distribution (mean/median/range) and remove/flag outliers beyond the designed oligo length (e.g., exclude sequences outside [L_design-2, L_design+2] bp, or pad/trim to exactly L_design with centered padding) so metrics are not confounded by inconsistent inputs. Quantify dataset size (N) and label distribution skew; if N > 10k, prioritize QC/outlier filtering (e.g., drop sequences with low DNA counts: DNA_count < 20 in >50% replicates; drop sequences with high replicate discordance: replicate Pearson r < 0.7), while if N < 1k, report wider uncertainty and consider augmentation only for training (e.g., reverse-complement augmentation at 1:1 ratio if biology allows). Ensure that replicate handling is consistent: if multiple barcodes/replicates per sequence exist, aggregate to a single target value per sequence using a robust estimator (median of replicate log-ratios; also report mean and MAD for QC). Align QC concepts with MPRA pipelines that emphasize stepwise quality monitoring and standardized metrics (esMPRA) and MPRA statistical considerations such as bias/variation sources (@MPRA) by explicitly reporting barcode-level depth distributions and replicate concordance as part of the final appendix. Finally, pre-register all evaluation parameters (seeds, folds, thresholds, transforms) in a run manifest (YAML/JSON) stored with outputs.\n\n2) Metric suite selection, definitions, and thresholds (primary + secondary metrics): Compute Pearson correlation r between y_true and y_pred as the primary ranking metric on the held-out test set (Pearson_test is the single-number headline), because it captures linear agreement of predicted activity with measured expression and is widely comparable across MPRA regression benchmarks. Also compute Spearman ρ to measure monotonic ranking performance (useful if the model is calibrated poorly but orders sequences correctly), R^2 to quantify explained variance (report both standard R^2 and, optionally, adjusted R^2 if including additional covariates), and MSE/MAE to quantify absolute errors in the target scale (recommend: MAE as the more robust error metric; report MSE to penalize large errors). Define metric computation precisely: Pearson/Spearman on the sample-level aggregated targets; R^2 = 1 - SSE/SST using the test-set mean of y_true for SST; MSE/MAE computed on the same target scale after final transformation (e.g., z-scored log-ratio). Establish explicit acceptance thresholds for “model is usable”: Pearson_test ≥ 0.50, Spearman_test ≥ 0.50, and R^2_test ≥ 0.20 (these are pragmatic MPRA-regression bars; adjust upward if baseline models already exceed them), and additionally require calibration sanity by MAE_test ≤ 0.75 (in z-score units) or an equivalent domain-specific bound. Always include a baseline comparator: (i) predicting the training mean (expected Pearson≈0), and (ii) a simple linear model on k-mer counts; require the final model to exceed baseline Pearson by ≥ 0.10 on test to be considered meaningfully improved. Report metrics both on the final hold-out test and as cross-validated means ± SD to separate “best-case performance” from “stability under resampling.”\n\n3) Validation strategy (single hold-out + 5-fold CV with explicit parameters): Use a single fixed hold-out test split of 15% of sequences, created once and never touched during model selection; the remaining 85% is used for training/validation and 5-fold cross-validation for robustness estimation. Use a fixed global random seed (seed_holdout = 202501) for the hold-out split and fixed fold seeds (seed_cv = 202502) to ensure exact reproducibility; document them in the parameter table and output manifest. To avoid label-distribution drift, stratify splits by expression bins: compute deciles on the full dataset target (10 bins by y quantiles) and apply stratified sampling such that each split/fold preserves the bin proportions (stratify_by_expr = true, n_bins = 10). Additionally, if multiple measurements per underlying sequence exist (e.g., multiple barcodes, conditions, or replicates), enforce group splitting (group_id = sequence_id) so that the same sequence never appears in both train and test/folds, preventing leakage. For 5-fold CV, run K=5, shuffle=true, stratified by expression bins, and report for each metric: mean ± standard deviation across the 5 held-out folds, plus the per-fold values in a supplementary table. Within each CV fold, allow an inner validation split for early stopping/hyperparameter selection (e.g., 10% of the fold’s training portion, seed_inner = 202503), but prohibit using the final 15% test set for any tuning. If external validation is available (e.g., a separate MPRA library or a different growth condition), evaluate the frozen final model there and report the full metric suite; otherwise, explicitly state that generalization is assessed only via hold-out + CV.\n\n4) Statistical testing design for model comparisons (correlation differences + multiple testing control): For each pair of models A vs B evaluated on the same test set, estimate uncertainty of Pearson r and Spearman ρ using nonparametric bootstrap with B = 10,000 resamples of test points (sampling with replacement, size = N_test), producing 95% confidence intervals via percentile method (2.5th–97.5th) and reporting the bootstrap mean and standard error. Define significance for correlation improvement by checking whether the bootstrap distribution of Δr = r_A - r_B excludes 0 at α = 0.05 (two-sided), and report the p-value as 2 * min(P(Δr ≤ 0), P(Δr ≥ 0)). Where assumptions allow and predictions are dependent (same y_true, correlated predictions), additionally apply a dependent-correlation test such as Steiger’s test (or Williams test variant) to compare r(y, A) vs r(y, B) accounting for r(A, B); report the test statistic, degrees of freedom, and p-value, and use it as a confirmatory analysis alongside bootstrap. For cross-validation comparisons, compute per-fold metric differences and apply a paired test on fold-wise values (recommended: Wilcoxon signed-rank on Δr across 5 folds due to small n; also report the mean Δr and its bootstrap CI over folds if repeating CV multiple times). Set the global significance level to α = 0.05 and correct for multiple pairwise comparisons across models using Benjamini–Hochberg FDR (q = 0.05); explicitly state the number of hypotheses (m) and report both raw p and BH-adjusted p (p_adj). To avoid p-hacking, predefine the comparison set (e.g., all models vs the current best baseline and vs each other only if within 0.02 Pearson) and report the full comparison matrix in supplementary materials.\n\n5) Error analysis and diagnostic visualizations (quantile bins, residuals, heteroscedasticity): Perform stratified error analysis by binning sequences into 10 equal-frequency bins by y_true (deciles) on the evaluated split (test or each CV fold) and compute per-bin MAE (and optionally median absolute error) to identify regimes where the model fails (e.g., extreme high-expression sequences). Report a table with columns: bin_index (1–10), y_true_range (min/max), n_bin, MAE_bin, and also include bias (mean residual) per bin; aggregate across folds by reporting mean ± SD per bin. Create a prediction-vs-truth scatter plot on the test set with: (i) y=x reference line, (ii) a fitted least-squares line (report slope, intercept), and (iii) the Pearson r annotated; for dense plots, use hexbin density with fixed gridsize (e.g., gridsize=50) to avoid overplotting. Analyze residuals e = y_pred - y_true: plot residual histogram and Q–Q plot, and compute summary stats (mean, SD, skewness); check heteroscedasticity by plotting |residual| vs y_true and performing a formal test (Breusch–Pagan at α=0.05) plus reporting the correlation between |e| and y_true. If strong heteroscedasticity exists, recommend reporting additionally a weighted error metric (e.g., MAE in z-space and MAE in original space, if available) and/or calibrating via isotonic regression on a validation set, but keep the primary metric unchanged for comparability. Finally, include an outlier analysis: list the top 1% absolute residual sequences, their true/pred values, GC%, and presence of known motifs, to connect quantitative error to biological features.\n\n6) Biological plausibility and interpretability (motifs, ISM, and -10/-35 enrichment for E. coli): Motif contribution from high-prediction sequences: take the top 1% (or top K=500, whichever is smaller) sequences by y_pred on the test set, extract enriched k-mers with k=6 and k=8 using a background of all test sequences (match GC content by stratified background sampling, e.g., 5 GC bins), and report top-N=20 enriched k-mers with log2 enrichment and BH-FDR adjusted p-values from Fisher’s exact test. For CNN-based models, convert first-layer convolutional filters into PWMs by collecting sequence windows that maximally activate each filter (e.g., top 1,000 windows), align them, and compute nucleotide frequencies with pseudocount 0.5; then report top-N=20 filters ranked by information content or association with high predictions, and optionally match to known bacterial motifs using a motif similarity tool (if available) while clearly stating matching thresholds (e.g., TOMTOM q<0.05). In silico mutagenesis (ISM): for each test sequence, mutate each position to the other three nucleotides, compute Δprediction, and derive per-position importance as the maximum absolute Δ across substitutions; summarize across sequences by reporting mean importance ± standard error (SE = SD/sqrt(n)) at each position, and provide stratified summaries for top-expression vs bottom-expression deciles. For statistical reporting of ISM, perform bootstrap over sequences (B=1,000 for ISM summaries due to compute cost) to generate 95% CIs for average importance at each position or for regional averages. E. coli -10/-35 box enrichment (optional but recommended when sequences are promoter-like): define windows relative to the annotated transcription start site (TSS): -35 region = [-40, -30], -10 region = [-15, -5]; define consensus-like matches using a PWM or simple consensus scoring (e.g., allow ≤1 mismatch to TTGACA for -35 and TATAAT for -10, or use a PWM with score threshold at the 80th percentile of genome-wide promoter matches). Test whether high-prediction sequences are enriched for strong -10/-35 matches compared with matched-background sequences using Fisher’s exact test (or logistic regression controlling for GC% and dinucleotide frequencies), report odds ratio with 95% CI, and apply BH-FDR across tested regions/motifs; this ties interpretability to known promoter biology and provides a mechanistic sanity check.\n\n7) Summary deliverables: evaluation & visualization checklist + parameter table + final report artifacts: Provide an “Evaluation & Visualization Checklist” that enumerates every required metric, split strategy, statistical test, diagnostic plot, and interpretability analysis, with a checkmark status per experiment run and links/paths to generated files. Provide a single “Parameter Table” (machine-readable JSON + human-readable markdown) containing: hold-out fraction=0.15, seed_holdout=202501, CV folds=5, seed_cv=202502, stratify_by_expr=true, expr_bins=10, bootstrap_resamples=10000, CI_level=95%, alpha=0.05, BH_FDR_q=0.05, ISM_bootstrap=1000, topN_kmers=20, kmer_sizes=[6,8], -10 window=[-15,-5], -35 window=[-40,-30], and any target-transform details. Final report should include a standardized set of tables/figures: (Table 1) dataset summary + QC metrics (replicate concordance, depth), (Table 2) hold-out test metrics for all models, (Table 3) 5-fold CV mean±SD metrics, (Table 4) pairwise statistical comparison matrix with Δr, CI, p, p_adj, (Table 5) decile-bin MAE and bias; (Fig 1) scatter/hexbin y_pred vs y_true with fit, (Fig 2) residual diagnostics (hist + |e| vs y_true + Q–Q), (Fig 3) MAE-by-decile barplot, (Fig 4) top motifs/k-mers and filter PWMs, (Fig 5) ISM average importance map with SE band, (Fig 6) -10/-35 enrichment odds ratios. Throughout, ground the MPRA-specific QC framing in established MPRA analysis toolkits/pipelines (e.g., esMPRA for stepwise QC reporting and @MPRA for MPRA statistical considerations), and include a reproducibility appendix listing software versions, exact seeds, and file hashes."
      },
      "recommendations": [
        "Make bootstrap the primary statistical comparison method for model-vs-model on the same test set: use paired bootstrap over test samples (or over sequences) to estimate ΔPearson/ΔSpearman/ΔMAE with 95% CIs and two-sided p-values; treat Steiger/Williams as optional sensitivity analysis only when assumptions are defensible.",
        "Adopt leakage-resistant splitting as a default when library design is unknown: cluster sequences by edit distance or k-mer/Jaccard similarity and perform GroupKFold (or blocked splits) so close variants do not cross train/test; report both standard split and group split if feasible, clearly labeling which is used for headline claims.",
        "Expand the metric suite slightly with MPRA-appropriate robustness checks: (i) Kendall’s τ or rank-based MAE by expression quantiles, (ii) calibration slope/intercept with CI on the original label scale, and (iii) heteroscedasticity diagnostics (e.g., residual vs fitted plots; optional Breusch–Pagan) with stratified error reporting.",
        "Align biological validation with MPRA best practices by adding: motif recovery (compare discovered PWMs to known E. coli promoter motifs if applicable), GC-matched k-mer enrichment, and in silico mutagenesis summary around expected core promoter regions; explicitly control multiple testing (BH-FDR) across motifs/windows/shifts.",
        "Standardize interpretability compute: predefine a fixed subset size (e.g., 500–1000 representative test sequences stratified by expression), fixed batching, and fixed random seed; report motif/attribution stability across CV folds.",
        "When reporting final performance, present: mean±SD across repeated CV (e.g., 3×5-fold) for robustness + the single untouched test metric with bootstrap CI; explicitly state that hyperparameter selection uses only CV/validation, never the test set."
      ],
      "retrieved_knowledge": [
        {
          "id": "46a98b85c5d33450",
          "title": "Statistical considerations for the analysis of massively parallel reporter assays data.",
          "content": "Analysis Toolset for MPRA (@MPRA), an R package for the design and analyses of MPRA experiments. It is publicly available at http://github.com/redaq/atMPRA.",
          "source": "PubMed",
          "relevance_score": 0.6369
        },
        {
          "id": "289c49d0ab8509e2",
          "title": "SnailHeater",
          "content": "SnailHeater\n\n多功能焊台（T12/JBC245、烤箱回流焊、加热台、风枪、可调电源、简易双通道示波器、函数发生器、高精度PWM脉冲）",
          "source": "GitHub",
          "relevance_score": 0.6276
        },
        {
          "id": "3f5f453a68d61113",
          "title": "Optimizing sequence design strategies for perturbation MPRAs: a computational evaluation framework.",
          "content": "Optimizing sequence design strategies for perturbation MPRAs: a computational evaluation framework.",
          "source": "PubMed",
          "relevance_score": 0.1918
        },
        {
          "id": "51febf8054037101",
          "title": "esMPRA: an easy-to-use systematic pipeline for MPRA experiment quality control and data analysis.",
          "content": "esMPRA: an easy-to-use systematic pipeline for MPRA experiment quality control and data analysis.",
          "source": "PubMed",
          "relevance_score": 0.1688
        },
        {
          "id": "ce95596db3746810",
          "title": "Design of Engineered Living Materials for Martian Construction",
          "content": "Design of Engineered Living Materials for Martian Construction",
          "source": "arXiv",
          "relevance_score": 0.1324
        },
        {
          "id": "",
          "title": "",
          "content": "MOTIVATION: Massively Parallel Reporter Assays (MPRAs) have emerged as pivotal tools for systematically profiling cis-regulatory element activity, playing critical roles in deciphering gene regulation mechanisms and synthetic regulatory element engineering. However, MPRA experiments involve multi-step library processing procedures coupled with high-throughput sequencing. Operational errors during these complex workflows can lead to substantial resource depletion and experimental delays. Thus rob",
          "source": "PubMed",
          "relevance_score": 0.1621
        },
        {
          "id": "",
          "title": "",
          "content": " the Raw MPRA Data With a priori Unknown Sequences of the Region of Interest and Associated Barcodes Massively parallel reporter assays (MPRAs) enable high-throughput functional evaluation of numerous DNA regulatory elements and/or their mutant variants. The assays are based on the construction of reporter plasmid libraries containing two variable parts, a region of interest (ROI) and a barcode (BC), located outside and within the transcription unit, respectively. Importantly, each plasmid molec",
          "source": "PMC",
          "relevance_score": 0.1478
        }
      ],
      "full_metadata": {
        "query": "Experimental design: 评估与统计：MPRA回归性能、稳健性与生物学解释",
        "knowledge_results": 7,
        "retrieved_knowledge": [
          {
            "id": "46a98b85c5d33450",
            "title": "Statistical considerations for the analysis of massively parallel reporter assays data.",
            "content": "Analysis Toolset for MPRA (@MPRA), an R package for the design and analyses of MPRA experiments. It is publicly available at http://github.com/redaq/atMPRA.",
            "source": "PubMed",
            "relevance_score": 0.6369
          },
          {
            "id": "289c49d0ab8509e2",
            "title": "SnailHeater",
            "content": "SnailHeater\n\n多功能焊台（T12/JBC245、烤箱回流焊、加热台、风枪、可调电源、简易双通道示波器、函数发生器、高精度PWM脉冲）",
            "source": "GitHub",
            "relevance_score": 0.6276
          },
          {
            "id": "3f5f453a68d61113",
            "title": "Optimizing sequence design strategies for perturbation MPRAs: a computational evaluation framework.",
            "content": "Optimizing sequence design strategies for perturbation MPRAs: a computational evaluation framework.",
            "source": "PubMed",
            "relevance_score": 0.1918
          },
          {
            "id": "51febf8054037101",
            "title": "esMPRA: an easy-to-use systematic pipeline for MPRA experiment quality control and data analysis.",
            "content": "esMPRA: an easy-to-use systematic pipeline for MPRA experiment quality control and data analysis.",
            "source": "PubMed",
            "relevance_score": 0.1688
          },
          {
            "id": "ce95596db3746810",
            "title": "Design of Engineered Living Materials for Martian Construction",
            "content": "Design of Engineered Living Materials for Martian Construction",
            "source": "arXiv",
            "relevance_score": 0.1324
          },
          {
            "id": "",
            "title": "",
            "content": "MOTIVATION: Massively Parallel Reporter Assays (MPRAs) have emerged as pivotal tools for systematically profiling cis-regulatory element activity, playing critical roles in deciphering gene regulation mechanisms and synthetic regulatory element engineering. However, MPRA experiments involve multi-step library processing procedures coupled with high-throughput sequencing. Operational errors during these complex workflows can lead to substantial resource depletion and experimental delays. Thus rob",
            "source": "PubMed",
            "relevance_score": 0.1621
          },
          {
            "id": "",
            "title": "",
            "content": " the Raw MPRA Data With a priori Unknown Sequences of the Region of Interest and Associated Barcodes Massively parallel reporter assays (MPRAs) enable high-throughput functional evaluation of numerous DNA regulatory elements and/or their mutant variants. The assays are based on the construction of reporter plasmid libraries containing two variable parts, a region of interest (ROI) and a barcode (BC), located outside and within the transcription unit, respectively. Importantly, each plasmid molec",
            "source": "PMC",
            "relevance_score": 0.1478
          }
        ],
        "model": "gpt-5.2",
        "design_summary": "This evaluation plan targets an MPRA expression regression task and is designed to be fully comparable, reproducible, and statistically rigorous across models. The core performance suite includes Pearson r, Spearman ρ, R^2, and MSE/MAE, with Pearson r on the held-out test set explicitly defined as the primary metric for model ranking. The plan combines a single fixed hold-out split (for a final, untouched test) with 5-fold cross-validation on the remaining data to quantify robustness; all results are reported as mean ± standard deviation across folds and repeated with fixed random seeds. Statistical testing focuses on pairwise model comparisons via bootstrap confidence intervals for correlation metrics and, where applicable, dependent-correlation tests (e.g., Steiger/Williams) because predictions share the same ground-truth labels. Error analysis is stratified by expression quantiles (10 bins) to expose performance heterogeneity, and includes residual distribution and heteroscedasticity diagnostics to detect systematic biases typical of MPRA-derived signals. Biological interpretability is enforced through motif/k-mer extraction from high-prediction sequences, in silico mutagenesis (ISM) importance summarization with uncertainty estimates, and an optional targeted enrichment test over predefined E. coli promoter elements (-10/-35 boxes) to check mechanistic plausibility. The reporting format is a strict checklist plus parameter table, and a standardized set of tables/figures so that all future experiments can be compared directly; MPRA-specific QC principles are aligned with MPRA analysis toolkits/pipelines discussed in the literature (e.g., esMPRA stepwise monitoring/QC concepts and MPRA-focused statistical considerations in @MPRA).",
        "detailed_design": {
          "design_recommendations": "1) Dataset characterization and preprocessing implications (regression MPRA context): Treat the dataset as MPRA-derived continuous expression, typically computed from RNA/DNA barcode count ratios; therefore, define and freeze a single target transformation before any splitting (recommend: log2(RNA/DNA + 1e-6) followed by z-score within experiment/batch if multiple batches). Before modeling, quantify sequence length distribution (mean/median/range) and remove/flag outliers beyond the designed oligo length (e.g., exclude sequences outside [L_design-2, L_design+2] bp, or pad/trim to exactly L_design with centered padding) so metrics are not confounded by inconsistent inputs. Quantify dataset size (N) and label distribution skew; if N > 10k, prioritize QC/outlier filtering (e.g., drop sequences with low DNA counts: DNA_count < 20 in >50% replicates; drop sequences with high replicate discordance: replicate Pearson r < 0.7), while if N < 1k, report wider uncertainty and consider augmentation only for training (e.g., reverse-complement augmentation at 1:1 ratio if biology allows). Ensure that replicate handling is consistent: if multiple barcodes/replicates per sequence exist, aggregate to a single target value per sequence using a robust estimator (median of replicate log-ratios; also report mean and MAD for QC). Align QC concepts with MPRA pipelines that emphasize stepwise quality monitoring and standardized metrics (esMPRA) and MPRA statistical considerations such as bias/variation sources (@MPRA) by explicitly reporting barcode-level depth distributions and replicate concordance as part of the final appendix. Finally, pre-register all evaluation parameters (seeds, folds, thresholds, transforms) in a run manifest (YAML/JSON) stored with outputs.\n\n2) Metric suite selection, definitions, and thresholds (primary + secondary metrics): Compute Pearson correlation r between y_true and y_pred as the primary ranking metric on the held-out test set (Pearson_test is the single-number headline), because it captures linear agreement of predicted activity with measured expression and is widely comparable across MPRA regression benchmarks. Also compute Spearman ρ to measure monotonic ranking performance (useful if the model is calibrated poorly but orders sequences correctly), R^2 to quantify explained variance (report both standard R^2 and, optionally, adjusted R^2 if including additional covariates), and MSE/MAE to quantify absolute errors in the target scale (recommend: MAE as the more robust error metric; report MSE to penalize large errors). Define metric computation precisely: Pearson/Spearman on the sample-level aggregated targets; R^2 = 1 - SSE/SST using the test-set mean of y_true for SST; MSE/MAE computed on the same target scale after final transformation (e.g., z-scored log-ratio). Establish explicit acceptance thresholds for “model is usable”: Pearson_test ≥ 0.50, Spearman_test ≥ 0.50, and R^2_test ≥ 0.20 (these are pragmatic MPRA-regression bars; adjust upward if baseline models already exceed them), and additionally require calibration sanity by MAE_test ≤ 0.75 (in z-score units) or an equivalent domain-specific bound. Always include a baseline comparator: (i) predicting the training mean (expected Pearson≈0), and (ii) a simple linear model on k-mer counts; require the final model to exceed baseline Pearson by ≥ 0.10 on test to be considered meaningfully improved. Report metrics both on the final hold-out test and as cross-validated means ± SD to separate “best-case performance” from “stability under resampling.”\n\n3) Validation strategy (single hold-out + 5-fold CV with explicit parameters): Use a single fixed hold-out test split of 15% of sequences, created once and never touched during model selection; the remaining 85% is used for training/validation and 5-fold cross-validation for robustness estimation. Use a fixed global random seed (seed_holdout = 202501) for the hold-out split and fixed fold seeds (seed_cv = 202502) to ensure exact reproducibility; document them in the parameter table and output manifest. To avoid label-distribution drift, stratify splits by expression bins: compute deciles on the full dataset target (10 bins by y quantiles) and apply stratified sampling such that each split/fold preserves the bin proportions (stratify_by_expr = true, n_bins = 10). Additionally, if multiple measurements per underlying sequence exist (e.g., multiple barcodes, conditions, or replicates), enforce group splitting (group_id = sequence_id) so that the same sequence never appears in both train and test/folds, preventing leakage. For 5-fold CV, run K=5, shuffle=true, stratified by expression bins, and report for each metric: mean ± standard deviation across the 5 held-out folds, plus the per-fold values in a supplementary table. Within each CV fold, allow an inner validation split for early stopping/hyperparameter selection (e.g., 10% of the fold’s training portion, seed_inner = 202503), but prohibit using the final 15% test set for any tuning. If external validation is available (e.g., a separate MPRA library or a different growth condition), evaluate the frozen final model there and report the full metric suite; otherwise, explicitly state that generalization is assessed only via hold-out + CV.\n\n4) Statistical testing design for model comparisons (correlation differences + multiple testing control): For each pair of models A vs B evaluated on the same test set, estimate uncertainty of Pearson r and Spearman ρ using nonparametric bootstrap with B = 10,000 resamples of test points (sampling with replacement, size = N_test), producing 95% confidence intervals via percentile method (2.5th–97.5th) and reporting the bootstrap mean and standard error. Define significance for correlation improvement by checking whether the bootstrap distribution of Δr = r_A - r_B excludes 0 at α = 0.05 (two-sided), and report the p-value as 2 * min(P(Δr ≤ 0), P(Δr ≥ 0)). Where assumptions allow and predictions are dependent (same y_true, correlated predictions), additionally apply a dependent-correlation test such as Steiger’s test (or Williams test variant) to compare r(y, A) vs r(y, B) accounting for r(A, B); report the test statistic, degrees of freedom, and p-value, and use it as a confirmatory analysis alongside bootstrap. For cross-validation comparisons, compute per-fold metric differences and apply a paired test on fold-wise values (recommended: Wilcoxon signed-rank on Δr across 5 folds due to small n; also report the mean Δr and its bootstrap CI over folds if repeating CV multiple times). Set the global significance level to α = 0.05 and correct for multiple pairwise comparisons across models using Benjamini–Hochberg FDR (q = 0.05); explicitly state the number of hypotheses (m) and report both raw p and BH-adjusted p (p_adj). To avoid p-hacking, predefine the comparison set (e.g., all models vs the current best baseline and vs each other only if within 0.02 Pearson) and report the full comparison matrix in supplementary materials.\n\n5) Error analysis and diagnostic visualizations (quantile bins, residuals, heteroscedasticity): Perform stratified error analysis by binning sequences into 10 equal-frequency bins by y_true (deciles) on the evaluated split (test or each CV fold) and compute per-bin MAE (and optionally median absolute error) to identify regimes where the model fails (e.g., extreme high-expression sequences). Report a table with columns: bin_index (1–10), y_true_range (min/max), n_bin, MAE_bin, and also include bias (mean residual) per bin; aggregate across folds by reporting mean ± SD per bin. Create a prediction-vs-truth scatter plot on the test set with: (i) y=x reference line, (ii) a fitted least-squares line (report slope, intercept), and (iii) the Pearson r annotated; for dense plots, use hexbin density with fixed gridsize (e.g., gridsize=50) to avoid overplotting. Analyze residuals e = y_pred - y_true: plot residual histogram and Q–Q plot, and compute summary stats (mean, SD, skewness); check heteroscedasticity by plotting |residual| vs y_true and performing a formal test (Breusch–Pagan at α=0.05) plus reporting the correlation between |e| and y_true. If strong heteroscedasticity exists, recommend reporting additionally a weighted error metric (e.g., MAE in z-space and MAE in original space, if available) and/or calibrating via isotonic regression on a validation set, but keep the primary metric unchanged for comparability. Finally, include an outlier analysis: list the top 1% absolute residual sequences, their true/pred values, GC%, and presence of known motifs, to connect quantitative error to biological features.\n\n6) Biological plausibility and interpretability (motifs, ISM, and -10/-35 enrichment for E. coli): Motif contribution from high-prediction sequences: take the top 1% (or top K=500, whichever is smaller) sequences by y_pred on the test set, extract enriched k-mers with k=6 and k=8 using a background of all test sequences (match GC content by stratified background sampling, e.g., 5 GC bins), and report top-N=20 enriched k-mers with log2 enrichment and BH-FDR adjusted p-values from Fisher’s exact test. For CNN-based models, convert first-layer convolutional filters into PWMs by collecting sequence windows that maximally activate each filter (e.g., top 1,000 windows), align them, and compute nucleotide frequencies with pseudocount 0.5; then report top-N=20 filters ranked by information content or association with high predictions, and optionally match to known bacterial motifs using a motif similarity tool (if available) while clearly stating matching thresholds (e.g., TOMTOM q<0.05). In silico mutagenesis (ISM): for each test sequence, mutate each position to the other three nucleotides, compute Δprediction, and derive per-position importance as the maximum absolute Δ across substitutions; summarize across sequences by reporting mean importance ± standard error (SE = SD/sqrt(n)) at each position, and provide stratified summaries for top-expression vs bottom-expression deciles. For statistical reporting of ISM, perform bootstrap over sequences (B=1,000 for ISM summaries due to compute cost) to generate 95% CIs for average importance at each position or for regional averages. E. coli -10/-35 box enrichment (optional but recommended when sequences are promoter-like): define windows relative to the annotated transcription start site (TSS): -35 region = [-40, -30], -10 region = [-15, -5]; define consensus-like matches using a PWM or simple consensus scoring (e.g., allow ≤1 mismatch to TTGACA for -35 and TATAAT for -10, or use a PWM with score threshold at the 80th percentile of genome-wide promoter matches). Test whether high-prediction sequences are enriched for strong -10/-35 matches compared with matched-background sequences using Fisher’s exact test (or logistic regression controlling for GC% and dinucleotide frequencies), report odds ratio with 95% CI, and apply BH-FDR across tested regions/motifs; this ties interpretability to known promoter biology and provides a mechanistic sanity check.\n\n7) Summary deliverables: evaluation & visualization checklist + parameter table + final report artifacts: Provide an “Evaluation & Visualization Checklist” that enumerates every required metric, split strategy, statistical test, diagnostic plot, and interpretability analysis, with a checkmark status per experiment run and links/paths to generated files. Provide a single “Parameter Table” (machine-readable JSON + human-readable markdown) containing: hold-out fraction=0.15, seed_holdout=202501, CV folds=5, seed_cv=202502, stratify_by_expr=true, expr_bins=10, bootstrap_resamples=10000, CI_level=95%, alpha=0.05, BH_FDR_q=0.05, ISM_bootstrap=1000, topN_kmers=20, kmer_sizes=[6,8], -10 window=[-15,-5], -35 window=[-40,-30], and any target-transform details. Final report should include a standardized set of tables/figures: (Table 1) dataset summary + QC metrics (replicate concordance, depth), (Table 2) hold-out test metrics for all models, (Table 3) 5-fold CV mean±SD metrics, (Table 4) pairwise statistical comparison matrix with Δr, CI, p, p_adj, (Table 5) decile-bin MAE and bias; (Fig 1) scatter/hexbin y_pred vs y_true with fit, (Fig 2) residual diagnostics (hist + |e| vs y_true + Q–Q), (Fig 3) MAE-by-decile barplot, (Fig 4) top motifs/k-mers and filter PWMs, (Fig 5) ISM average importance map with SE band, (Fig 6) -10/-35 enrichment odds ratios. Throughout, ground the MPRA-specific QC framing in established MPRA analysis toolkits/pipelines (e.g., esMPRA for stepwise QC reporting and @MPRA for MPRA statistical considerations), and include a reproducibility appendix listing software versions, exact seeds, and file hashes."
        },
        "discussion_notes": "Overall, the other experts’ opinions are consistent with the current evaluation plan: Data Management and Methodology highlight leakage risks (variant libraries) and outlier/heteroscedasticity concerns that directly impact evaluation validity; Model Architect’s strand-specific caveat supports keeping reverse-complement augmentation as an ablation and also affects biological interpretation. I agree with the suggestion to strengthen split-by-cluster/group splitting to prevent inflated test correlations, and to keep bootstrap-based inference as the primary statistical testing approach. I also endorse adding calibration diagnostics (slope/intercept and binned curves) but recommend specifying scale and CI procedures. The MPRA literature emphasizes systematic QC and statistical considerations (e.g., dedicated MPRA analysis toolsets/pipelines and bias awareness), which supports prioritizing robust, assumption-light evaluation and explicit diagnostic reporting (see Qiao et al., 2020, 'Statistical considerations for the analysis of massively parallel reporter assays data' and the esMPRA pipeline description for QC/reporting norms).",
        "updated_after_discussion": true
      }
    }
  },
  "metadata": {
    "iteration_count": 0,
    "task_description": "Promoter Activity Prediction Model Construction using MPRA Data for flanking sequences of E. coli promoters",
    "task_background": "Goal: Construct a deep learning model to predict the relative expression activity ('expr' column) of E. coli flanking sequences based on their sequence features derived from the MPRA dataset.\nRequirements: The model should be a deep learning model, and the model should be able to predict the relative expression activity of the promoter.",
    "dataset_info": "File path: task/data/ecoli_165_cgan_wanglab/ecoli_mpra_3_laco.csv; Data type: Massive Parallel Reporter Assay (MPRA) Results for flanking sequences of E. coli promoters; Input features: s, e, q; Target variable: expr; Constraint: The sequence data is in the 'seq' column, and the target variable is in the 'expr' column.",
    "data_usage_plan": {
      "design_recommendations": "Dataset characteristic analysis: The CSV inspection confirms only two columns named exactly 'seq' and 'expr', consistent with a processed MPRA design matrix where each row is a regulatory sequence and the label is a continuous activity measurement. The file has 5,921 total lines including the header, implying N=5,920 samples, which is a medium dataset (<10k) and supports a QC-first approach with limited augmentation. Because this is MPRA, sequence directionality can matter (especially for bacterial promoters), so reverse-complement augmentation is not assumed valid by default and should be tested only as an ablation. Sequence lengths must be summarized (min/median/max and P95) to choose a fixed model input length L; the preview suggests all sequences are of similar length (on the order of ~160–180 bp), but L must be computed from the full file. Feature dimensionality under one-hot is L×4 per sample (dense), while k-mer count features are sparse with vocabulary size 4^k (e.g., k=5 gives 1024 dims) and can be efficient for linear baselines; the dataset size supports either representation. Expression (expr) must be profiled for mean/variance/skewness and outliers; we will flag extremes using |z|>5 (computed on the training fold) and/or winsorize at 0.1%/99.9% quantiles to stabilize training while keeping labels continuous.\n\nData source selection and evaluation: The immediate source is the provided E. coli MPRA CSV, which appears to already be aggregated per sequence (no barcodes), meaning upstream MPRA counting/QC is not available in this file; therefore we treat it as a post-quantification dataset. For extensibility and benchmarking, we recommend optionally pulling comparable MPRA datasets (e.g., via MPRAbase for public MPRA repositories) to test generalization across conditions/species, but not mixing them into training unless labels are harmonized (as cautioned by the motivation for uniform processing in standardized MPRA pipelines such as MPRAsnakeflow/MPRAlib). The plan should record metadata if available (plasmid vs genomic integration, growth conditions, library design) because those can induce batch effects; if absent, we assume single-condition and focus on internal consistency checks. We also recommend keeping a “data card” documenting file hash, download path, and parsing rules for reproducibility aligned with the community push for harmonized formats and uniform processing (MPRAsnakeflow/MPRAlib). esMPRA emphasizes standardized QC metrics and stepwise monitoring; while we cannot run its raw-read stages, we can emulate its spirit by producing stage-specific diagnostics: parsing/sequence validity, length uniformity, label distribution, and train/val/test drift checks. If later raw counts become available, the pipeline should be upgradeable to incorporate barcode-level outlier handling and RNA/DNA ratio modeling, consistent with MPRA best practices referenced in the retrieved literature (esMPRA; individual barcode robustness discussions in MPRA analysis frameworks).\n\nPreprocessing pipeline (QC + cleaning, with explicit parameters): Parsing must enforce schema: columns exactly {seq, expr}, seq as string, expr castable to float; rows failing parse are dropped and counted in QC. Sequence cleaning uses an allowed alphabet {A,C,G,T} (uppercase); any lowercase is uppercased, and whitespace is stripped; empty seq is dropped (threshold: length==0). Non-ACGT handling is thresholded: compute fraction f_nonACGT per sequence; if f_nonACGT > 0.01 (i.e., >1% characters not in A/C/G/T), drop the sequence; if 0 < f_nonACGT ≤ 0.01, replace non-ACGT characters with 'N' then encode them as an all-zero channel (i.e., [0,0,0,0]) to avoid introducing spurious signal (this matches the requirement “padding symbol all-0” and keeps ambiguity neutral). Duplicate sequences: compute exact duplicates on cleaned seq; if duplicates exist with identical expr, keep one and drop the rest; if duplicates have different expr (technical inconsistency), keep one with expr equal to the median of the duplicate group and log the group size as a QC alert (to reduce label noise while avoiding leakage). Expression preprocessing: compute train-set mean/variance/skewness; if skewness > 1.0 and expr is strictly positive, apply log1p(expr) as an alternative target and compare validation performance; otherwise keep raw but always standardize: y_std=(y-mean_train)/std_train. Outliers: flag with |z|>5 on the standardized target (training statistics) and additionally compute extreme quantiles; default action is winsorization at [0.1%, 99.9%] on training labels only (apply same caps to val/test) to prevent a few points from dominating MSE, while retaining sample count in a medium dataset.\n\nLength handling and encoding (explicit L and settings): After computing the full length distribution, set fixed length L to P95(length) rounded up to a convenient multiple of 8 (for GPU efficiency); if P95 is, for example, 170 bp, set L=176; if the distribution is extremely tight (max-min ≤ 5), set L=max to avoid trimming. Trimming rule: if len(seq) > L, trim symmetrically around the center (center-crop) for generic regulatory elements; however for bacterial promoters with positional motifs relative to TSS, prefer right-crop or left-crop depending on how sequences were constructed—default to right-padding and right-cropping only if the library is aligned at the 5' end; because that metadata is absent, we recommend center-crop as the neutral default and report sensitivity in an ablation. Padding: right-pad with all-zero vectors to reach L; do not pad with 'A' because that introduces signal. Primary encoding is one-hot: tensor shape (L,4) with channels ordered A,C,G,T; ambiguous 'N' or masked bases are [0,0,0,0]. Optional baseline encoding for classical models: overlapping k-mer counts with stride=1, k in {3,4,5}; vocab sizes 64/256/1024 respectively; use normalized counts (divide by total k-mers) to reduce length effects; these features are sparse-ish but manageable at N=5.9k and are valuable for sanity-check baselines.\n\nData splitting strategy (reproducible, stratified, plus CV backup): Use train/val/test = 0.8/0.1/0.1 with random seed = 42 and shuffling enabled, but stratify by expr distribution to avoid label-shift: bin expr into 10 quantile bins (deciles) computed on the full dataset (or better: compute bins on train then assign others; practically, full-data deciles are acceptable for stratification as it does not leak sequence information). Ensure no duplicate sequences are split across folds by deduplicating before splitting; if near-duplicates are suspected (e.g., designed variants), optionally cluster by Hamming distance ≤ 3 and split by cluster to reduce leakage (report as an advanced option). Provide a 5-fold cross-validation alternative (KFold=5, shuffle=True, seed=42) for robust model selection; keep the test set held out and untouched, using CV only within the 90% train+val portion. After splitting, compute and report drift metrics: length distribution KS test between splits, and expr mean/std/skew per split; if drift exceeds thresholds (e.g., |mean_diff|>0.1 std units or KS p<1e-3), re-split with the same stratification but adjusted binning (e.g., 20 bins) to improve match.\n\nLightweight data augmentation (explicit parameters, MPRA-specific cautions): Because N≈5.9k is medium, augmentation should be light and should not distort promoter directionality in bacteria. Reverse-complement (RC) augmentation is not used by default; run it only as a controlled ablation: add RC sequences for 50% of training samples (augmentation ratio 0.5) and compare validation—if performance degrades, conclude directionality is important and keep RC off. Random point-mutation augmentation: for each training sequence, with probability p_aug=0.3 generate one mutated copy; within that copy, mutate each position with p_mut=0.01 but enforce a maximum of m_max=3 mutations/sequence; substitutions are uniform among the other three bases; do not mutate padded positions. Random masking: with probability p_aug_mask=0.3 generate one masked copy; independently mask each position with p_mask=0.02 by setting it to all-zero [0,0,0,0]; cap masks to at most 5 positions/sequence to avoid destroying key motifs. Label handling for augmented samples: keep the same expr label (invariance assumption) for masking and very-low-rate mutation, but down-weight augmented samples in loss with weight=0.5 relative to originals to reduce the risk of introducing label noise; this is appropriate for a medium dataset where we can afford to prioritize clean supervision.\n\nQuality control report items (actionable checklist aligned with MPRA QC principles): Produce a “Parsing & Schema” table: column names, dtypes, number of rows read, number dropped due to parse errors. “Sequence validity” section: length min/median/max/P95, fraction of empty sequences, fraction with any non-ACGT, fraction dropped due to f_nonACGT>0.01, and histogram of non-ACGT fraction. “Duplicate analysis”: count exact duplicates, distribution of duplicate group sizes, and number of inconsistent-label duplicate groups (plus the chosen resolution rule). “Expression distribution”: mean/variance/skewness/kurtosis, histogram + KDE, fraction negative, fraction zero, and outlier counts under |z|>5 and beyond 0.1%/99.9% quantiles; explicitly record winsorization caps if applied. “Split diagnostics”: per-split N, expr mean/std/skew, length distribution summary, and drift tests (KS statistics) to ensure comparability. These QC emphases are motivated by the broader MPRA community’s push for standardized QC and reproducible processing (esMPRA stepwise diagnostics; MPRAsnakeflow/MPRAlib uniform processing and awareness of technical variability sources).\n\nBias and confounding mitigation: Species/assay bias is inherent (E. coli MPRA), so the model should not be expected to generalize to eukaryotic enhancers; document this explicitly and avoid mixing multi-species datasets without harmonization. Directionality confounding is likely in bacterial promoter libraries; therefore, avoid RC augmentation by default and treat it as a hypothesis test rather than a routine augmentation. Sequence composition bias (e.g., GC content correlated with expr) can cause shortcut learning; include QC plots of expr vs GC%, and consider adding a covariate baseline (linear regression on GC%) to quantify how much signal is composition-driven. If the library contains designed variants around a motif, random splitting can leak motif families; mitigate by optional cluster-based splitting (Hamming threshold) and report both random and cluster-split performance. Platform/condition biases cannot be assessed without metadata; mitigate by strict reproducibility practices (fixed seeds, logged preprocessing parameters, dataset hash) and by keeping a fully held-out test set untouched until final evaluation."
    },
    "method_design": {
      "design_recommendations": {
        "dataset_characteristics_and_preprocessing": "This task targets MPRA-style regression where each sequence has an activity derived from barcode RNA and DNA counts (often using log(RNA/DNA) or model-based transcription rate estimates), and such assays are known to exhibit barcode-level outliers and technical variability. Literature on MPRA analysis highlights that tools modeling barcode counts (e.g., MPRAnalyze / mpralm variants) address inherent variation and outlier sensitivity, and newer frameworks emphasize barcode sequence bias and outlier barcodes as major technical factors; therefore, preprocessing should include barcode QC and robust aggregation (Keukeleire et al., 2025; Rosen et al., 2025 from the knowledge base). Assume a typical MPRA dataset size is medium-to-large (1e4–1e5 sequences) with fixed oligo length (commonly 150–230 bp plus adapters); if length varies, pad/trim to a fixed L (recommended L=200) and track true-length masks for attention layers. Perform barcode filtering: remove barcodes with DNA counts < 10 (or < 20 for stricter QC) and optionally trim the top 0.5–1% barcodes by RNA/DNA ratio per element as outliers; then aggregate per element by median-of-barcodes or robust mean (Huber mean) to reduce influence of extreme barcodes. Use train/val/test splits that prevent leakage from highly similar sequence variants (e.g., allelic pairs or designed mutational neighborhoods): split by \"parent element\" or edit distance clusters when available, to avoid inflated correlations. Finally, standardize input encoding as one-hot (A,C,G,T plus N=all zeros) with optional additional channels (e.g., GC content track or positional prior track) kept fixed across models for controlled comparisons.",
        "target_transformation_policy": "Because MPRA activity can be negative (e.g., log fold-change below baseline) and often heavy-tailed, define a conditional target transform policy that is data-driven and reversible for reporting. Compute skewness on the training targets; if absolute skewness > 1.0, enable a power transform (Yeo–Johnson) fitted on training only, because it handles zeros and negative values unlike Box–Cox. If absolute skewness <= 1.0, default to z-score standardization (y_z = (y - mean_train) / std_train) for stable optimization and comparability across experiments. If strong outliers are present (e.g., >2% of points beyond 3×IQR), use RobustScaler (center=median, scale=IQR) instead of z-score to reduce sensitivity; this is particularly relevant given known barcode-level outliers in MPRA pipelines (Keukeleire et al., 2025). Explicit negative-value handling: do not clamp negatives; instead, preserve sign and use Yeo–Johnson when skewness triggers or RobustScaler when outlier fraction triggers. For reporting, always invert the transform back to the original scale for MAE/MSE on the raw units, and also report correlation on raw and transformed scales to ensure interpretability. Log1p transforms are not recommended unless the target is strictly non-negative count-derived (rare after log(RNA/DNA)); if used, only enable when min(y) >= 0 and skewness > 1.0, with epsilon=1e-3.",
        "loss_functions": "Use Huber loss as the default main loss to be robust to heavy-tailed errors and outliers typical in MPRA measurements (barcode-level variability and occasional extreme activities), while still behaving like MSE near zero error. Set Huber delta (\"transition\") explicitly to delta=1.0 on the standardized target scale; if using RobustScaler, set delta=1.5 to account for the smaller effective scale of IQR normalization. Define the primary loss as L_main = Huber(y_pred, y_true; delta), averaged over the batch. Optionally add a correlation-alignment auxiliary loss to better match evaluation metrics: L_corr = 1 - PearsonCorr(y_pred, y_true) computed within-batch (with batch_size >= 64), then use total loss L = L_main + λ_corr * L_corr with λ_corr=0.1. If rank consistency is a key goal (e.g., selecting top enhancers), add a pairwise ranking loss on within-batch pairs: L_rank = mean(log(1 + exp(-(y_pred_i - y_pred_j) * sign(y_true_i - y_true_j)))) sampled from 256 random pairs per batch; weight it λ_rank=0.05, and keep λ_corr=0.05 when both auxiliaries are enabled. For ablations, compare MSE as baseline (L_main = MSE) to quantify gains from robustness; expect Huber to reduce sensitivity to outlier barcodes/elements and stabilize early stopping. Ensure loss is computed on transformed targets, while metrics (Pearson/Spearman/R2) are computed on inverse-transformed predictions for interpretability.",
        "optimizer_and_hyperparameters": "Use AdamW as the default optimizer for all neural models due to its stability on one-hot sequence inputs and compatibility with weight decay decoupling. Set AdamW hyperparameters explicitly: lr=1e-3 (starting), betas=(0.9, 0.999), eps=1e-8, weight_decay=1e-4; these values are a strong default for CNN/attention models on MPRA-scale regression. Apply gradient clipping to prevent rare large gradients from destabilizing training, using clip_norm=1.0 (global norm). Use mixed precision (fp16/bf16) only if it does not change numerical stability of Pearson auxiliary loss; if enabled, compute correlation loss in fp32. As a classical comparator, run SGD+momentum on CNN models: lr=0.05, momentum=0.9, weight_decay=5e-4, Nesterov=True; this acts as an optimizer ablation to show whether adaptive methods are needed. Use EMA of weights (optional) with decay=0.999 to stabilize validation correlation, especially for CNN+attention. For batch sizes, use 128 as default on GPU memory permitting; if sequences are long or attention is heavy, reduce to 64 and compensate with gradient accumulation steps=2 to keep an effective batch of 128.",
        "learning_rate_schedule_and_warmup": "Adopt a warmup phase to avoid early training instability when using AdamW and potentially correlation/ranking auxiliary losses. Set warmup_steps=500 (or warmup_ratio=0.05 if total_steps is small), linearly increasing lr from 1e-5 to the base lr (1e-3). After warmup, use CosineAnnealingLR down to min_lr=1e-6 over the remaining steps; cosine works well for large sequence datasets and reduces the need for manual plateau tuning. As an alternative scheduler for smaller/ noisier datasets, use ReduceLROnPlateau monitoring val_loss with factor=0.5, patience=5 epochs, threshold=1e-4, cooldown=0, min_lr=1e-6; this is useful when validation correlation fluctuates due to measurement noise. If using ReduceLROnPlateau, disable cosine and keep a fixed lr during warmup then hand over to plateau schedule. For cosine, consider restarts only if training is long (>200 epochs), otherwise keep a single cycle for up to 100 epochs. Log the effective lr each epoch and ensure early stopping patience (10) exceeds scheduler patience (5) so the scheduler has time to act before stopping.",
        "training_configuration_and_early_stopping": "Use a maximum of epochs=100 with early stopping to prevent overfitting on motif-rich but noisy MPRA targets. Default batch_size=128 (fallback 64) and set num_workers=4–8 for data loading; use shuffle=True for training and deterministic=False for speed, while fixing random seeds for reproducibility. Early stopping should monitor val_pearson (preferred when the goal is ranking/relative prediction) with mode='max', patience=10, min_delta=1e-4; as a secondary criterion, also record val_loss and stop if both degrade for 10 epochs. When correlation is unstable due to small validation sets, switch monitor to val_loss with mode='min', patience=10, min_delta=1e-4. Use k-fold cross-validation (k=5) when dataset size is small (<5k sequences) or when the split-by-cluster constraint reduces effective validation size; aggregate by mean±std of Pearson and Spearman. Maintain a fixed evaluation suite: Pearson, Spearman, R2, and MAE on inverse-transformed targets; report also calibration plots (pred vs true) and residual vs GC content to detect systematic bias. Save best checkpoints by val_pearson and also last checkpoint; always evaluate test only once per model configuration to avoid implicit tuning on test.",
        "regularization_strategies": "Use dropout in the network body with a tunable range 0.1–0.5; set default dropout=0.2 for CNN blocks and 0.3 for attention/MLP heads, as attention models typically overfit more. Apply input dropout (a biologically plausible \"sequencing uncertainty\" proxy) by randomly masking 1–3% of positions per sequence (mask_prob=0.02) during training; implement as setting one-hot vector to all zeros (N) at masked positions. Additionally, apply channel dropout on one-hot channels with p=0.05 to simulate minor base-calling ambiguity without destroying motifs. Clarify L2 vs weight decay: for AdamW, use weight_decay=1e-4 as the primary L2-like regularizer (decoupled), and do not add an additional L2 penalty in the loss to avoid double-regularization; for SGD, weight_decay acts as classic L2. BatchNorm (if used) adds regularization; set BatchNorm momentum=0.1 and epsilon=1e-5 in CNN blocks, but consider removing BatchNorm for very small batch sizes (<=32) where statistics are noisy. Label smoothing is explicitly not used because this is regression; instead use robust losses (Huber) and augmentation for stability. If overfitting persists (train Pearson much higher than val), increase dropout by +0.1 and/or increase weight_decay to 3e-4; if underfitting, reduce dropout to 0.1 and weight_decay to 3e-5.",
        "prior_knowledge_integration_motifs_pwms": "Integrate biological priors by adding motif/PWM channels and auxiliary tasks that encourage the model to respect known TF binding logic. Precompute motif scan scores using a curated PWM set (e.g., JASPAR core vertebrates) and compute per-position log-likelihood ratio scores; feed as additional input channels M (e.g., top 32 motifs) alongside one-hot, producing an input tensor of shape (L, 4+M). Add an auxiliary head to predict motif presence/occupancy summary (e.g., max motif score per motif) from intermediate features, trained with MSE or BCE depending on label definition; weight this auxiliary loss λ_motif=0.05 to avoid overpowering expression regression. Use a \"motif attribution consistency\" regularizer: compute in-silico mutagenesis on a small subset each epoch (e.g., 128 sequences) and penalize cases where mutating high-scoring motif cores does not change prediction directionally; weight λ_consistency=0.01 to keep compute manageable. Constrain augmentations to preserve biological plausibility: if the assay is orientation-specific (promoter direction matters), do not use reverse-complement augmentation; if orientation-invariant enhancer assays, enable reverse-complement with probability 0.5 and enforce RC-consistency loss L_rc = mean((f(x)-f(RC(x)))^2) with weight 0.05. Use prior-guided initialization by including a first-layer convolution bank whose kernels are initialized from PWMs (convert PWM to log-odds and map to conv weights), then allow them to fine-tune with a smaller lr multiplier (e.g., 0.5× base lr) to retain interpretability. This approach is consistent with motif-centric interpretation practices described broadly in regulatory DL evaluation/interpretation toolkits (e.g., CREME focuses on perturbation-based motif logic extraction; knowledge base: Toneyan & Koo, 2024).",
        "data_augmentation": "Use augmentation that respects DNA biology and the MPRA experimental construct. If the assay design indicates orientation invariance (common for enhancer tiling without fixed promoter orientation), apply reverse-complement augmentation with p=0.5; otherwise set p=0.0 and rely on other augmentations. Apply small positional jitter when sequences contain flanks: randomly shift the window by up to ±5 bp (shift_max=5) and pad with 'N' at the ends; this helps the model become robust to slight boundary differences and synthesis artifacts. Apply random masking (as above) mask_prob=0.02 and optionally contiguous span masking with span_length=3 and span_prob=0.01 to simulate local errors and encourage distributed representations. Avoid arbitrary nucleotide substitution at high rates because it can destroy motifs; if used for robustness, keep mutation_rate<=0.005 (0.5% positions) and only outside known motif cores (based on PWM scan threshold, e.g., score > 8.0). For medium datasets (1k–10k), increase augmentation intensity slightly (mask_prob=0.03, shift_max=8) to reduce overfitting; for very large datasets (>100k), keep augmentation mild (mask_prob=0.01) and focus on QC/outlier handling as recommended by MPRA pipeline best-practice discussions (Rosen et al., 2025). If training includes CNN+attention, use stochastic depth (drop-path) with rate=0.1 in residual blocks as an additional augmentation-like regularizer.",
        "model_architectures_and_exact_parameters": "Baseline 1 (Linear k-mer): represent each sequence by counts of k-mers with k=6 (feature dim up to 4^6=4096, optionally reduce via hashing to 2048); train Ridge regression with alpha=1.0 and also ElasticNet with alpha=0.1, l1_ratio=0.1, both on transformed targets. Baseline 2 (Simple linear on GC/motif summaries): features = GC%, CpG count, max PWM scores for top 32 motifs; model = linear regression + HuberRegressor (epsilon=1.35) to quantify robustness. Model A (CNN): Input (L=200, C=4) -> Conv1D(64 filters, kernel=15, stride=1, padding='same') + BatchNorm + GELU + Dropout(0.2); then 3 residual blocks each: Conv1D(64, k=11) -> GELU -> Conv1D(64, k=11) with skip, Dropout(0.2); then MaxPool1D(pool=2) to length 100; then Conv1D(128, k=7) + GELU + Dropout(0.3); GlobalAveragePooling; MLP head: Dense(256) + GELU + Dropout(0.3) + Dense(1). Model B (CNN+Attention): same CNN stem up to length 100 and channels 128, then add 2 Transformer encoder blocks with d_model=128, n_heads=8, ff_dim=512, dropout=0.1, attention_dropout=0.1, layernorm eps=1e-5; then attention pooling (learned query) to a 128-d vector; MLP head Dense(256)->GELU->Dropout(0.3)->Dense(1). Initialize conv/linear weights with Xavier/Glorot uniform (gain=1.0) and set final layer bias to mean(y_train_transformed) to speed convergence. Estimated capacity targets: CNN ~1–3M params, CNN+Attention ~3–6M params; keep parameter count within this band to avoid overfitting on typical MPRA sizes. Train all neural models with identical optimizer/scheduler/early stopping for fair comparison, varying only architecture modules.",
        "hyperparameter_search_plan": "Run an executable Optuna study with 50 trials per architecture family (CNN and CNN+Attention separately) using the same train/val split and early stopping rules. Search space: lr ∈ [1e-4, 3e-3] log-uniform; weight_decay ∈ [1e-6, 3e-4] log-uniform; dropout ∈ [0.1, 0.5] uniform; kernel_size ∈ {7, 11, 15}; filters ∈ {64, 128}; num_res_blocks ∈ {2, 3, 4}; for attention models additionally search n_heads ∈ {4, 8}, n_layers ∈ {1, 2, 3}, ff_dim ∈ {256, 512, 768}, attention_dropout ∈ [0.0, 0.2]. Also tune Huber delta ∈ {0.5, 1.0, 1.5} on the transformed scale and λ_corr ∈ {0.0, 0.05, 0.1}; constrain total auxiliary weight (λ_corr+λ_rank+λ_motif) <= 0.2 to maintain regression focus. Use the objective as max(val_pearson) with a pruning strategy (MedianPruner) after 10 epochs to save compute; fix max_epochs=100 but rely on early stopping. Record trial-level metrics: best val_pearson, val_spearman, val_loss, and calibration slope; reject models with calibration slope outside [0.8, 1.2] even if correlation is high. After selecting top 3 trials, retrain each with 3 seeds and report mean±std to ensure robustness. This search plan is designed to be computationally feasible and aligned with MPRA regression goals, while controlling for overfitting via early stopping and regularization.",
        "training_pipeline_workflow_and_controls": "Step 1: Ingest raw MPRA counts (RNA/DNA per barcode), apply barcode QC (DNA>=10) and robust aggregation to element-level activity, consistent with knowledge-base emphasis on barcode-level modeling/outliers (Keukeleire et al., 2025). Step 2: Fit target transform on training only (z-score/robust/Yeo–Johnson) according to the skewness/outlier policy; store transformer for inverse mapping. Step 3: Build stratified splits by activity quantiles and by sequence cluster/parent to prevent leakage; lock splits for all experiments. Step 4: Train baselines first (k-mer ridge, motif summary linear/HuberRegressor) to set a sanity floor and detect data leakage; require that neural models beat baselines by at least +0.03 Pearson to justify complexity. Step 5: Train CNN and CNN+Attention with the shared recipe: AdamW(lr=1e-3, wd=1e-4), warmup_steps=500, cosine to min_lr=1e-6, batch_size=128, clip_norm=1.0, Huber(delta=1.0) + optional λ_corr=0.1; early stop on val_pearson with patience=10. Step 6: Run the experimental matrix and ablations: loss (MSE vs Huber), scheduler (cosine vs plateau), augmentation (none vs RC/jitter/mask), and priors (no motif channels vs motif channels + λ_motif=0.05). Step 7: Final evaluation on test with locked checkpoint selection rules; report Pearson/Spearman/R2/MAE and include interpretability checks via motif perturbation consistency (inspired by perturbation-based regulatory logic analysis tools like CREME; Toneyan & Koo, 2024). Step 8: Document all hyperparameters, random seeds, and transformations; export model cards and training curves for publication-grade reproducibility."
      }
    },
    "model_design": {
      "design_recommendations": "Dataset characterization and fixed-length selection: The dataset is MPRA-like (sequence paired with a quantitative activity), implying input is a one-hot encoded DNA sequence of shape (batch, L, 4) and a scalar regression target (often log-transformed activity). With ~5.9k samples, this is a medium dataset, so the model should be moderately expressive but still heavily regularized; a large vanilla Transformer would likely overfit and is computationally wasteful. The fixed length L should be chosen from data statistics: set L to the median/most common length if sequences are mostly uniform; if there is a distribution, select L = 95th percentile length and pad shorter sequences with Ns encoded as all-zeros (or uniform 0.25 if you prefer), and truncate longer sequences centrally or from flanks depending on assay design. Preprocessing should include: (i) one-hot encoding with consistent A/C/G/T ordering, (ii) target normalization (z-score on training set or log1p then z-score), (iii) train/val/test split stratified by GC-content or activity quantiles to reduce distribution shift, and (iv) mild augmentation appropriate for MPRA such as reverse-complement augmentation at 50% probability if the assay is strand-invariant (otherwise disable). Training defaults (both models): AdamW optimizer (lr=1e-3 for baseline, lr=7e-4 for improved), weight_decay=1e-4, batch_size=64 (or 128 if GPU allows), epochs=100 with early stopping patience=12 on validation Pearson/Spearman and MSE, gradient clipping at 1.0, and cosine LR schedule with 5-epoch warmup (warmup_lr_start=1e-5). Evaluation metrics: report Pearson r, Spearman ρ, MSE, and R2 on held-out test; for MPRA it is common to emphasize rank correlation and replicate-consistency if replicates exist. Interpretability is mandatory: follow the spirit of prior sequence-to-function work that uses convolutional filters, attention maps, and in silico mutagenesis to understand learned motifs and dependencies (PMC: sequence-to-function frameworks for engineered riboregulators) and use IG/saliency settings as specified below."
    },
    "result_summary": {
      "design_recommendations": "1) Dataset characterization and preprocessing implications (regression MPRA context): Treat the dataset as MPRA-derived continuous expression, typically computed from RNA/DNA barcode count ratios; therefore, define and freeze a single target transformation before any splitting (recommend: log2(RNA/DNA + 1e-6) followed by z-score within experiment/batch if multiple batches). Before modeling, quantify sequence length distribution (mean/median/range) and remove/flag outliers beyond the designed oligo length (e.g., exclude sequences outside [L_design-2, L_design+2] bp, or pad/trim to exactly L_design with centered padding) so metrics are not confounded by inconsistent inputs. Quantify dataset size (N) and label distribution skew; if N > 10k, prioritize QC/outlier filtering (e.g., drop sequences with low DNA counts: DNA_count < 20 in >50% replicates; drop sequences with high replicate discordance: replicate Pearson r < 0.7), while if N < 1k, report wider uncertainty and consider augmentation only for training (e.g., reverse-complement augmentation at 1:1 ratio if biology allows). Ensure that replicate handling is consistent: if multiple barcodes/replicates per sequence exist, aggregate to a single target value per sequence using a robust estimator (median of replicate log-ratios; also report mean and MAD for QC). Align QC concepts with MPRA pipelines that emphasize stepwise quality monitoring and standardized metrics (esMPRA) and MPRA statistical considerations such as bias/variation sources (@MPRA) by explicitly reporting barcode-level depth distributions and replicate concordance as part of the final appendix. Finally, pre-register all evaluation parameters (seeds, folds, thresholds, transforms) in a run manifest (YAML/JSON) stored with outputs.\n\n2) Metric suite selection, definitions, and thresholds (primary + secondary metrics): Compute Pearson correlation r between y_true and y_pred as the primary ranking metric on the held-out test set (Pearson_test is the single-number headline), because it captures linear agreement of predicted activity with measured expression and is widely comparable across MPRA regression benchmarks. Also compute Spearman ρ to measure monotonic ranking performance (useful if the model is calibrated poorly but orders sequences correctly), R^2 to quantify explained variance (report both standard R^2 and, optionally, adjusted R^2 if including additional covariates), and MSE/MAE to quantify absolute errors in the target scale (recommend: MAE as the more robust error metric; report MSE to penalize large errors). Define metric computation precisely: Pearson/Spearman on the sample-level aggregated targets; R^2 = 1 - SSE/SST using the test-set mean of y_true for SST; MSE/MAE computed on the same target scale after final transformation (e.g., z-scored log-ratio). Establish explicit acceptance thresholds for “model is usable”: Pearson_test ≥ 0.50, Spearman_test ≥ 0.50, and R^2_test ≥ 0.20 (these are pragmatic MPRA-regression bars; adjust upward if baseline models already exceed them), and additionally require calibration sanity by MAE_test ≤ 0.75 (in z-score units) or an equivalent domain-specific bound. Always include a baseline comparator: (i) predicting the training mean (expected Pearson≈0), and (ii) a simple linear model on k-mer counts; require the final model to exceed baseline Pearson by ≥ 0.10 on test to be considered meaningfully improved. Report metrics both on the final hold-out test and as cross-validated means ± SD to separate “best-case performance” from “stability under resampling.”\n\n3) Validation strategy (single hold-out + 5-fold CV with explicit parameters): Use a single fixed hold-out test split of 15% of sequences, created once and never touched during model selection; the remaining 85% is used for training/validation and 5-fold cross-validation for robustness estimation. Use a fixed global random seed (seed_holdout = 202501) for the hold-out split and fixed fold seeds (seed_cv = 202502) to ensure exact reproducibility; document them in the parameter table and output manifest. To avoid label-distribution drift, stratify splits by expression bins: compute deciles on the full dataset target (10 bins by y quantiles) and apply stratified sampling such that each split/fold preserves the bin proportions (stratify_by_expr = true, n_bins = 10). Additionally, if multiple measurements per underlying sequence exist (e.g., multiple barcodes, conditions, or replicates), enforce group splitting (group_id = sequence_id) so that the same sequence never appears in both train and test/folds, preventing leakage. For 5-fold CV, run K=5, shuffle=true, stratified by expression bins, and report for each metric: mean ± standard deviation across the 5 held-out folds, plus the per-fold values in a supplementary table. Within each CV fold, allow an inner validation split for early stopping/hyperparameter selection (e.g., 10% of the fold’s training portion, seed_inner = 202503), but prohibit using the final 15% test set for any tuning. If external validation is available (e.g., a separate MPRA library or a different growth condition), evaluate the frozen final model there and report the full metric suite; otherwise, explicitly state that generalization is assessed only via hold-out + CV.\n\n4) Statistical testing design for model comparisons (correlation differences + multiple testing control): For each pair of models A vs B evaluated on the same test set, estimate uncertainty of Pearson r and Spearman ρ using nonparametric bootstrap with B = 10,000 resamples of test points (sampling with replacement, size = N_test), producing 95% confidence intervals via percentile method (2.5th–97.5th) and reporting the bootstrap mean and standard error. Define significance for correlation improvement by checking whether the bootstrap distribution of Δr = r_A - r_B excludes 0 at α = 0.05 (two-sided), and report the p-value as 2 * min(P(Δr ≤ 0), P(Δr ≥ 0)). Where assumptions allow and predictions are dependent (same y_true, correlated predictions), additionally apply a dependent-correlation test such as Steiger’s test (or Williams test variant) to compare r(y, A) vs r(y, B) accounting for r(A, B); report the test statistic, degrees of freedom, and p-value, and use it as a confirmatory analysis alongside bootstrap. For cross-validation comparisons, compute per-fold metric differences and apply a paired test on fold-wise values (recommended: Wilcoxon signed-rank on Δr across 5 folds due to small n; also report the mean Δr and its bootstrap CI over folds if repeating CV multiple times). Set the global significance level to α = 0.05 and correct for multiple pairwise comparisons across models using Benjamini–Hochberg FDR (q = 0.05); explicitly state the number of hypotheses (m) and report both raw p and BH-adjusted p (p_adj). To avoid p-hacking, predefine the comparison set (e.g., all models vs the current best baseline and vs each other only if within 0.02 Pearson) and report the full comparison matrix in supplementary materials.\n\n5) Error analysis and diagnostic visualizations (quantile bins, residuals, heteroscedasticity): Perform stratified error analysis by binning sequences into 10 equal-frequency bins by y_true (deciles) on the evaluated split (test or each CV fold) and compute per-bin MAE (and optionally median absolute error) to identify regimes where the model fails (e.g., extreme high-expression sequences). Report a table with columns: bin_index (1–10), y_true_range (min/max), n_bin, MAE_bin, and also include bias (mean residual) per bin; aggregate across folds by reporting mean ± SD per bin. Create a prediction-vs-truth scatter plot on the test set with: (i) y=x reference line, (ii) a fitted least-squares line (report slope, intercept), and (iii) the Pearson r annotated; for dense plots, use hexbin density with fixed gridsize (e.g., gridsize=50) to avoid overplotting. Analyze residuals e = y_pred - y_true: plot residual histogram and Q–Q plot, and compute summary stats (mean, SD, skewness); check heteroscedasticity by plotting |residual| vs y_true and performing a formal test (Breusch–Pagan at α=0.05) plus reporting the correlation between |e| and y_true. If strong heteroscedasticity exists, recommend reporting additionally a weighted error metric (e.g., MAE in z-space and MAE in original space, if available) and/or calibrating via isotonic regression on a validation set, but keep the primary metric unchanged for comparability. Finally, include an outlier analysis: list the top 1% absolute residual sequences, their true/pred values, GC%, and presence of known motifs, to connect quantitative error to biological features.\n\n6) Biological plausibility and interpretability (motifs, ISM, and -10/-35 enrichment for E. coli): Motif contribution from high-prediction sequences: take the top 1% (or top K=500, whichever is smaller) sequences by y_pred on the test set, extract enriched k-mers with k=6 and k=8 using a background of all test sequences (match GC content by stratified background sampling, e.g., 5 GC bins), and report top-N=20 enriched k-mers with log2 enrichment and BH-FDR adjusted p-values from Fisher’s exact test. For CNN-based models, convert first-layer convolutional filters into PWMs by collecting sequence windows that maximally activate each filter (e.g., top 1,000 windows), align them, and compute nucleotide frequencies with pseudocount 0.5; then report top-N=20 filters ranked by information content or association with high predictions, and optionally match to known bacterial motifs using a motif similarity tool (if available) while clearly stating matching thresholds (e.g., TOMTOM q<0.05). In silico mutagenesis (ISM): for each test sequence, mutate each position to the other three nucleotides, compute Δprediction, and derive per-position importance as the maximum absolute Δ across substitutions; summarize across sequences by reporting mean importance ± standard error (SE = SD/sqrt(n)) at each position, and provide stratified summaries for top-expression vs bottom-expression deciles. For statistical reporting of ISM, perform bootstrap over sequences (B=1,000 for ISM summaries due to compute cost) to generate 95% CIs for average importance at each position or for regional averages. E. coli -10/-35 box enrichment (optional but recommended when sequences are promoter-like): define windows relative to the annotated transcription start site (TSS): -35 region = [-40, -30], -10 region = [-15, -5]; define consensus-like matches using a PWM or simple consensus scoring (e.g., allow ≤1 mismatch to TTGACA for -35 and TATAAT for -10, or use a PWM with score threshold at the 80th percentile of genome-wide promoter matches). Test whether high-prediction sequences are enriched for strong -10/-35 matches compared with matched-background sequences using Fisher’s exact test (or logistic regression controlling for GC% and dinucleotide frequencies), report odds ratio with 95% CI, and apply BH-FDR across tested regions/motifs; this ties interpretability to known promoter biology and provides a mechanistic sanity check.\n\n7) Summary deliverables: evaluation & visualization checklist + parameter table + final report artifacts: Provide an “Evaluation & Visualization Checklist” that enumerates every required metric, split strategy, statistical test, diagnostic plot, and interpretability analysis, with a checkmark status per experiment run and links/paths to generated files. Provide a single “Parameter Table” (machine-readable JSON + human-readable markdown) containing: hold-out fraction=0.15, seed_holdout=202501, CV folds=5, seed_cv=202502, stratify_by_expr=true, expr_bins=10, bootstrap_resamples=10000, CI_level=95%, alpha=0.05, BH_FDR_q=0.05, ISM_bootstrap=1000, topN_kmers=20, kmer_sizes=[6,8], -10 window=[-15,-5], -35 window=[-40,-30], and any target-transform details. Final report should include a standardized set of tables/figures: (Table 1) dataset summary + QC metrics (replicate concordance, depth), (Table 2) hold-out test metrics for all models, (Table 3) 5-fold CV mean±SD metrics, (Table 4) pairwise statistical comparison matrix with Δr, CI, p, p_adj, (Table 5) decile-bin MAE and bias; (Fig 1) scatter/hexbin y_pred vs y_true with fit, (Fig 2) residual diagnostics (hist + |e| vs y_true + Q–Q), (Fig 3) MAE-by-decile barplot, (Fig 4) top motifs/k-mers and filter PWMs, (Fig 5) ISM average importance map with SE band, (Fig 6) -10/-35 enrichment odds ratios. Throughout, ground the MPRA-specific QC framing in established MPRA analysis toolkits/pipelines (e.g., esMPRA for stepwise QC reporting and @MPRA for MPRA statistical considerations), and include a reproducibility appendix listing software versions, exact seeds, and file hashes."
    }
  }
}